GMP-Bios-ab-001 | Pre-Made Abagovomab biosimilar, Whole Mab: Anti-CA125/MUC16 therapeutic antibody | Abagovomab | | CA125/MUC16 | Whole mAb |  |
GMP-Bios-ab-002 | Pre-Made Abelacimab biosimilar, Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA therapeutic antibody | Abelacimab | | F11 | Whole mAb |  |
GMP-Bios-ab-003 | Pre-Made Abituzumab biosimilar, Whole mAb, Anti-ITGAV Antibody: Anti-CD51/MSK8/VNRA/VTNR therapeutic antibody | Abituzumab | | ITGAV | Whole mAb |  |
GMP-Bios-ab-004 | Pre-Made Abrezekimab biosimilar, Fab, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Abrezekimab | | IL13 | Fab |  |
GMP-Bios-ab-005 | Pre-Made Abrilumab biosimilar, Whole mAb, Anti-α4β7/Integrin alpha 4 beta 7 Antibody: Anti-LPAM‑1 therapeutic antibody | Abrilumab | | α4β7/ Integrin alpha 4 beta 7 | Whole mAb |  |
GMP-Bios-ab-006 | Pre-Made Acapatamab biosimilar, Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody | Acapatamab | | FOLH1/GCPII;CD3E | Bispecific scFv |  |
GMP-Bios-ab-007 | Pre-Made Acasunlimab biosimilar, Bispecific mAb, Anti-CD274/PD-L1;TNFRSF9/CD137
Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1;ILA/4-1BB/CDw137 therapeutic antibody | Acasunlimab | | CD274/PD-L1; TNFRSF9/CD137 | Bispecific mAb |  |
GMP-Bios-ab-008 | Pre-Made Actoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody | Actoxumab | | Toxin A | Whole mAb |  |
GMP-Bios-ab-009 | Pre-Made Adalimumab biosimilar, Whole mAb, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Adalimumab | | TNFA/TNF | Whole mAb |  |
GMP-Bios-ab-010 | Pre-Made Adebrelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Adebrelimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-011 | Pre-Made Aducanumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Aducanumab | | APP | Whole mAb |  |
GMP-Bios-ab-012 | Pre-Made Afasevikumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Afasevikumab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-013 | Pre-Made Afutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Afutuzumab | Obinutuzumab | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-014 | Pre-Made Alacizumab biosimilar, di-Fab, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody | Alacizumab | | KDR | di-Fab |  |
GMP-Bios-ab-015 | Pre-Made Alemtuzumab biosimilar, Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody | Alemtuzumab | | CD52 | Whole mAb |  |
GMP-Bios-ab-016 | Pre-Made Alirocumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Alirocumab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-017 | Pre-Made Alomfilimab biosimilar, Whole mAb, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody | Alomfilimab | | ICOS | Whole mAb |  |
GMP-Bios-ab-018 | Pre-Made Alnuctamab biosimilar, Bispecific mAb with Domain Crossover, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Alnuctamab | | TNFRSF17;CD3E | Bispecific mAb with Domain Crossover |  |
GMP-Bios-ab-019 | Pre-Made Alsevalimab biosimilar, Whole mAb, Anti-VTCN1 Antibody: Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 therapeutic antibody | Alsevalimab | | VTCN1 | Whole mAb |  |
GMP-Bios-ab-020 | Pre-Made Amatuximab biosimilar, Whole mAb, Anti-MSLN Antibody: Anti-MPF/SMRP therapeutic antibody | Amatuximab | | MSLN | Whole mAb |  |
GMP-Bios-ab-021 | Pre-Made Amivantamab biosimilar, Bispecific mAb, Anti-EGFR;MET Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody | Amivantamab | | EGFR;MET | Bispecific mAb |  |
GMP-Bios-ab-022 | Pre-Made Amlitelimab biosimilar, Whole mAb, Anti-TNFSF4/OX40 Antibody: Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1 therapeutic antibody | Amlitelimab | | TNFSF4/OX40 | Whole mAb |  |
GMP-Bios-ab-023 | Pre-Made Anbenitamab biosimilar, Bispecific mAb: Anti-ERBB2 (Domain II);ERBB2 (Domain IV) therapeutic antibody | Anbenitamab | | ERBB2 (Domain II); ERBB2 (Domain IV) | Bispecific mAb |  |
GMP-Bios-ab-024 | Pre-Made Andecaliximab biosimilar, Whole mAb, Anti-MMP9/MMP-9 Antibody: Anti-CLG4B/GELB/MANDP2 therapeutic antibody | Andecaliximab | | MMP9/MMP-9 | Whole mAb |  |
GMP-Bios-ab-025 | Pre-Made Anetumab biosimilar, Whole mAb ADC, Anti-MSLN Antibody: Anti-MPF/SMRP therapeutic antibody | Anetumab | | MSLN | Whole mAb ADC |  |
GMP-Bios-ab-026 | Pre-Made Anifrolumab biosimilar, Whole mAb, Anti-IFNAR1 Antibody: Anti-AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC therapeutic antibody | Anifrolumab | | IFNAR1 | Whole mAb |  |
GMP-Bios-ab-027 | Pre-Made Anrukinzumab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Anrukinzumab | | IL13 | Whole mAb |  |
GMP-Bios-ab-028 | Pre-Made Ansuvimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic antibody | Ansuvimab | | Zaire Ebolavirus GP1 | Whole mAb |  |
GMP-Bios-ab-029 | Pre-Made Apamistamab biosimilar, Whole mAb Radiolabelled, Anti-PTPRC Antibody: Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200 therapeutic antibody | Apamistamab | | PTPRC | Whole mAb Radiolabelled |  |
GMP-Bios-ab-030 | Pre-Made Apitegromab biosimilar, Whole Mab: Anti-pro-GDF-8 therapeutic antibody | Apitegromab | | pro-GDF-8 | Whole mAb |  |
GMP-Bios-ab-031 | Pre-Made Aprutumab biosimilar, Whole mAb ADC, Anti-FGFR2 Antibody: Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25 therapeutic antibody | Aprutumab | | FGFR2 | Whole mAb ADC |  |
GMP-Bios-ab-032 | Pre-Made Ascrinvacumab biosimilar, Whole mAb, Anti-ACVRL1 Antibody: Anti-ACVRLK1/ALK-1/ALK1/HHT/HHT2/ORW2/SKR3/TSR-I therapeutic antibody | Ascrinvacumab | | ACVRL1 | Whole mAb |  |
GMP-Bios-ab-033 | Pre-Made Astegolimab biosimilar, Whole mAb, Anti-IL1RL1/ST2 Antibody: Anti-DER4/FIT-1/IL33R/T1 therapeutic antibody | Astegolimab | | IL1RL1/ST2 | Whole mAb |  |
GMP-Bios-ab-034 | Pre-Made Atezolizumab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Atezolizumab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-035 | Pre-Made Atibuclimab biosimilar, Whole Mab: Anti-CD14 therapeutic antibody | Atibuclimab | | CD14 | Whole mAb |  |
GMP-Bios-ab-036 | Pre-Made Atidortoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody | Atidortoxumab | | Toxin A | Whole mAb |  |
GMP-Bios-ab-037 | Pre-Made Atinumab biosimilar, Whole mAb, Anti-RTN4 Antibody: Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2 therapeutic antibody | Atinumab | | RTN4 | Whole mAb |  |
GMP-Bios-ab-038 | Pre-Made Atoltivimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody | Atoltivimab | | Zaire Ebolavirus GP | Whole mAb |  |
GMP-Bios-ab-039 | Pre-Made Avdoralimab biosimilar, Whole mAb, Anti-C5AR1 Antibody: Anti-C5AR/C5R1/CD88 therapeutic antibody | Avdoralimab | | C5AR1 | Whole mAb |  |
GMP-Bios-ab-040 | Pre-Made Avelumab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Avelumab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-041 | Pre-Made Avizakimab biosimilar, Whole mAb, Anti-IL21 Antibody: Anti-CVID11/IL-21/Za11 therapeutic antibody | Avizakimab | | IL21 | Whole mAb |  |
GMP-Bios-ab-042 | Pre-Made Axatilimab biosimilar, Whole mAb, Anti-CSF1R Antibody: Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R therapeutic antibody | Axatilimab | | CSF1R | Whole mAb |  |
GMP-Bios-ab-043 | Pre-Made Azintuxizumab biosimilar, Whole mAb ADC, Anti-SLAMF7/CS1 Antibody: Anti-19A/CD319/CRACC therapeutic antibody | Azintuxizumab | | SLAMF7/CS1 | Whole mAb ADC |  |
GMP-Bios-ab-044 | Pre-Made Balstilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Balstilimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-045 | Pre-Made Bamlanivimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike therapeutic antibody | Bamlanivimab | | SARS-CoV-2 Spike | Whole mAb |  |
GMP-Bios-ab-046 | Pre-Made Bapineuzumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Bapineuzumab | | APP | Whole mAb |  |
GMP-Bios-ab-047 | Pre-Made Bapotulimab biosimilar, Whole mAb, Anti-ILDR2 Antibody: Anti-C1orf32/dJ782G3.1 therapeutic antibody | Bapotulimab | | ILDR2 | Whole mAb |  |
GMP-Bios-ab-048 | Pre-Made Barecetamab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Barecetamab | | ERBB3/Erbb-3 | Whole mAb |  |
GMP-Bios-ab-049 | Pre-Made Basiliximab biosimilar, Whole mAb, Anti-IL2RA Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody | Basiliximab | | IL2RA | Whole mAb |  |
GMP-Bios-ab-050 | Pre-Made Batoclimab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody | Batoclimab | | FCGRT | Whole mAb |  |
GMP-Bios-ab-051 | Pre-Made Bavituximab biosimilar, Whole Mab: Anti-Phosphatidylserine therapeutic antibody | Bavituximab | | Phosphatidylserine | Whole mAb |  |
GMP-Bios-ab-052 | Pre-Made Bedinvetmab biosimilar, Canine Whole Mab: Anti-Canine NGFB therapeutic antibody | Bedinvetmab | | Canine NGFB | Canine Whole mAb |  |
GMP-Bios-ab-053 | Pre-Made Befovacimab biosimilar, Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI therapeutic antibody | Befovacimab | | TFPI | Whole mAb |  |
GMP-Bios-ab-054 | Pre-Made Begelomab biosimilar, Whole mAb, Anti-DPP4/DPP-4 Antibody: Anti-ADABP/ADCP2/CD26/DPPIV/TP103 therapeutic antibody | Begelomab | | DPP4/DPP-4 | Whole mAb |  |
GMP-Bios-ab-055 | Pre-Made Belantamab biosimilar, Whole mAb ADC, Anti-TNFRSF17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibody | Belantamab | | TNFRSF17 | Whole mAb ADC |  |
GMP-Bios-ab-056 | Pre-Made Belimumab biosimilar, Whole mAb, Anti-TNFSF13B Antibody: Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4 therapeutic antibody | Belimumab | | TNFSF13B | Whole mAb |  |
GMP-Bios-ab-057 | Pre-Made Bemarituzumab biosimilar, Whole mAb, Anti-FGFR2 Antibody: Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25 therapeutic antibody | Bemarituzumab | | FGFR2 | Whole mAb |  |
GMP-Bios-ab-058 | Pre-Made Benralizumab biosimilar, Whole mAb, Anti-IL5RA Antibody: Anti-CD125/CDw125/HSIL5R3/IL5R therapeutic antibody | Benralizumab | | IL5RA | Whole mAb |  |
GMP-Bios-ab-059 | Pre-Made Bentracimab biosimilar, Whole Mab: Anti-AR-C124910XX therapeutic antibody | Bentracimab | | AR-C124910XX | Whole mAb |  |
GMP-Bios-ab-060 | Pre-Made Benufutamab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody | Benufutamab | | TNFRSF10B/TRAIL-R2 | Whole mAb |  |
GMP-Bios-ab-061 | Pre-Made Bepranemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40 therapeutic antibody | Bepranemab | | MAPT | Whole mAb |  |
GMP-Bios-ab-062 | Pre-Made Berlimatoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody | Berlimatoxumab | | Toxin A | Whole mAb |  |
GMP-Bios-ab-063 | Pre-Made Bermekimab biosimilar, Whole mAb, Anti-IL1A Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha therapeutic antibody | Bermekimab | | IL1A | Whole mAb |  |
GMP-Bios-ab-064 | Pre-Made Bersanlimab biosimilar, Whole mAb, Anti-ICAM1 Antibody: Anti-BB2/CD54/P3.58 therapeutic antibody | Bersanlimab | | ICAM1 | Whole mAb |  |
GMP-Bios-ab-065 | Pre-Made Bevacizumab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody | Bevacizumab | | VEGFA | Whole mAb |  |
GMP-Bios-ab-066 | Pre-Made Bexmarilimab biosimilar, Whole mAb, Anti-STAB1 Antibody: Anti-CLEVER-1/FEEL-1/FEEL1/FELE-1/FEX1/SCARH2/STAB-1 therapeutic antibody | Bexmarilimab | | STAB1 | Whole mAb |  |
GMP-Bios-ab-067 | Pre-Made Bezlotoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody | Bezlotoxumab | | Toxin A | Whole mAb |  |
GMP-Bios-ab-068 | Pre-Made Bifikafusp biosimilar, Whole mAb Fusion: Anti-FN extra domain B therapeutic antibody | Bifikafusp | | FN extra domain B | Whole mAb Fusion |  |
GMP-Bios-ab-069 | Pre-Made Bimagrumab biosimilar, Whole mAb, Anti-ACVR2B Antibody: Anti-ACTRIIB/ActR-IIB/HTX4 therapeutic antibody | Bimagrumab | | ACVR2B | Whole mAb |  |
GMP-Bios-ab-070 | Pre-Made Bimekizumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Bimekizumab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-071 | Pre-Made Bintrafusp biosimilar, Whole mAb Fusion, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Bintrafusp | | CD274/PD-L1 | Whole mAb Fusion |  |
GMP-Bios-ab-072 | Pre-Made Birtamimab biosimilar, Whole mAb, Anti-SAA1 Antibody: Anti-PIG4/SAA/SAA2/TP53I4 therapeutic antibody | Birtamimab | | SAA1 | Whole mAb |  |
GMP-Bios-ab-073 | Pre-Made Bleselumab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Bleselumab | | CD40 | Whole mAb |  |
GMP-Bios-ab-074 | Pre-Made Blinatumomab biosimilar, Bispecific T-Cell Engager, Anti-CD19;CD3E Antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody | Blinatumomab | | CD19;CD3E | Bispecific T-Cell Engager |  |
GMP-Bios-ab-075 | Pre-Made Blontuvetmab biosimilar, Canine Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Blontuvetmab | | MS4A1/CD20 | Canine Whole mAb |  |
GMP-Bios-ab-076 | Pre-Made Blosozumab biosimilar, Whole mAb, Anti-SOST Antibody: Anti-CDD/DAND6/VBCH therapeutic antibody | Blosozumab | | SOST | Whole mAb |  |
GMP-Bios-ab-077 | Pre-Made Bococizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Bococizumab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-078 | Pre-Made Botensilimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Botensilimab | | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-079 | Pre-Made Brazikumab biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody: Anti-IL23P19/P19/SGRF therapeutic antibody | Brazikumab | | IL23A/IL23 | Whole mAb |  |
GMP-Bios-ab-080 | Pre-Made Brentuximab biosimilar, Whole mAb ADC, Anti-TNFRSF8 Antibody: Anti-CD30/Ki-1/D1S166E therapeutic antibody | Brentuximab | | TNFRSF8 | Whole mAb ADC |  |
GMP-Bios-ab-081 | Pre-Made Briakinumab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody | Briakinumab | | IL12B | Whole mAb |  |
GMP-Bios-ab-082 | Pre-Made Brodalumab biosimilar, Whole mAb, Anti-IL17RA/IL17R Antibody: Anti-CANDF5/CD217/CDw217RAR/IMD51/hIL-17R therapeutic antibody | Brodalumab | | IL17RA/IL17R | Whole mAb |  |
GMP-Bios-ab-083 | Pre-Made Brolucizumab biosimilar, scFv, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody | Brolucizumab | | VEGFA | scFv |  |
GMP-Bios-ab-084 | Pre-Made Brontictuzumab biosimilar, Whole mAb, Anti-NOTCH1 Antibody: Anti-AOS5/AOVD1/TAN1/hN1 therapeutic antibody | Brontictuzumab | | NOTCH1 | Whole mAb |  |
GMP-Bios-ab-085 | Pre-Made Budigalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Budigalimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-086 | Pre-Made Burosumab biosimilar, Whole mAb, Anti-FGF23 Antibody: Anti-ADHR/FGFN/HFTC2/HPDR2/HYPF/PHPTC therapeutic antibody | Burosumab | | FGF23 | Whole mAb |  |
GMP-Bios-ab-087 | Pre-Made Cabiralizumab biosimilar, Whole mAb, Anti-CSF1R Antibody: Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R therapeutic antibody | Cabiralizumab | | CSF1R | Whole mAb |  |
GMP-Bios-ab-088 | Pre-Made Cadonilimab biosimilar, Bispecific Mixed mAb and scFv, Anti-PDCD1/PD-1;CTLA4/CTLA-4 antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Cadonilimab | | PDCD1/PD-1; CTLA4/CTLA-4 | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-089 | Pre-Made Camidanlumab biosimilar, Whole mAb ADC, Anti-IL2RA Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody | Camidanlumab | | IL2RA | Whole mAb ADC |  |
GMP-Bios-ab-090 | Pre-Made Camrelizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Camrelizumab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-091 | Pre-Made Canakinumab biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody | Canakinumab | | IL1B | Whole mAb |  |
GMP-Bios-ab-092 | Pre-Made Cantuzumab biosimilar, Whole mAb ADC, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | Cantuzumab | | MUC1 | Whole mAb ADC |  |
GMP-Bios-ab-093 | Pre-Made Caplacizumab biosimilar, Nanobody, Anti-VWF Antibody: Anti-F8VWF/VWD therapeutic antibody | Caplacizumab | | VWF | Nanobody |  |
GMP-Bios-ab-094 | Pre-Made Carlumab biosimilar, Whole mAb, Anti-CCL2 Antibody: Anti-HC11/MCAF/MCP1/MCP-1/SCYA2/GDCF-2/SMC-CF/HSMCR30 therapeutic antibody | Carlumab | | CCL2 | Whole mAb |  |
GMP-Bios-ab-095 | Pre-Made Carotuximab biosimilar, Whole mAb, Anti-ENG Antibody: Anti-END/HHT1/ORW1 therapeutic antibody | Carotuximab | | ENG | Whole mAb |  |
GMP-Bios-ab-096 | Pre-Made Casirivimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Casirivimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-097 | Pre-Made Cemiplimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Cemiplimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-098 | Pre-Made Cendakimab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Cendakimab | | IL13 | Whole mAb |  |
GMP-Bios-ab-099 | Pre-Made Cergutuzumab biosimilar, Whole mAb Fusion, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody | Cergutuzumab | | CEACAM5/CD66e | Whole mAb Fusion |  |
GMP-Bios-ab-100 | Pre-Made Certolizumab biosimilar, Fab, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Certolizumab | | TNFA/TNF | Fab |  |
GMP-Bios-ab-101 | Pre-Made Cetrelimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Cetrelimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-102 | Pre-Made Cetuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Cetuximab | | EGFR | Whole mAb |  |
GMP-Bios-ab-103 | Pre-Made Cevostamab biosimilar, Bispecific mAb: Anti-FCRL5;CD3 therapeutic antibody | Cevostamab | | FCRL5;CD3 | Bispecific mAb |  |
GMP-Bios-ab-104 | Pre-Made Cibisatamab biosimilar, Bispecific mAb with Domain Crossover: Anti-CEACAM5;CD3E therapeutic antibody | Cibisatamab | | CEACAM5;CD3E | Bispecific mAb with Domain Crossover |  |
GMP-Bios-ab-105 | Pre-Made Cilgavimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Cilgavimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-106 | Pre-Made Cinpanemab biosimilar, Whole mAb, Anti-SNCA Antibody: Anti-NACP/PARK1/PARK4/PD1 therapeutic antibody | Cinpanemab | | SNCA | Whole mAb |  |
GMP-Bios-ab-107 | Pre-Made Citatuzumab biosimilar, Fab Fusion, Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody | Citatuzumab | | EPCAM | Fab Fusion |  |
GMP-Bios-ab-108 | Pre-Made Cixutumumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Cixutumumab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-109 | Pre-Made Claudiximab biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody | Claudiximab | zolbetuximab | CLDN18 | Whole mAb |  |
GMP-Bios-ab-110 | Pre-Made Clazakizumab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody | Clazakizumab | | IL6 | Whole mAb |  |
GMP-Bios-ab-111 | Pre-Made Clervonafusp biosimilar, di-Fab Fusion, Anti-SLC29A2/ENT2 Antibody: Anti-DER12/HNP36 therapeutic antibody | Clervonafusp | | SLC29A2/ENT2 | di-Fab Fusion |  |
GMP-Bios-ab-112 | Pre-Made Clivatuzumab biosimilar, Whole mAb Radiolabelled, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | Clivatuzumab | | MUC1 | Whole mAb Radiolabelled |  |
GMP-Bios-ab-113 | Pre-Made Cobolimab biosimilar, Whole mAb, Anti-HAVCR2/TIM3 Antibody: Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2 therapeutic antibody | Cobolimab | | HAVCR2/TIM3 | Whole mAb |  |
GMP-Bios-ab-114 | Pre-Made Codrituzumab biosimilar, Whole mAb, Anti-GPC3 Antibody: Anti-DGSX/GTR2-2/MXR7/OCI-5/SDYS/SGB/SGBS/SGBS1 therapeutic antibody | Codrituzumab | | GPC3 | Whole mAb |  |
GMP-Bios-ab-115 | Pre-Made Cofetuzumab biosimilar, Whole mAb ADC, Anti-PTK7 Antibody: Anti-CCK-4/CCK4 therapeutic antibody | Cofetuzumab | | PTK7 | Whole mAb ADC |  |
GMP-Bios-ab-116 | Pre-Made Coltuximab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody | Coltuximab | | CD19 | Whole mAb ADC |  |
GMP-Bios-ab-117 | Pre-Made Conatumumab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody | Conatumumab | | TNFRSF10B/ TRAIL-R2 | Whole mAb |  |
GMP-Bios-ab-118 | Pre-Made Concizumab biosimilar, Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI therapeutic antibody | Concizumab | | TFPI | Whole mAb |  |
GMP-Bios-ab-119 | Pre-Made Coprelotamab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Coprelotamab | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-ab-120 | Pre-Made Cosfroviximab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody | Cosfroviximab | | Zaire Ebolavirus GP | Whole mAb |  |
GMP-Bios-ab-121 | Pre-Made Cosibelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Cosibelimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-122 | Pre-Made Crenezumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Crenezumab | | APP | Whole mAb |  |
GMP-Bios-ab-123 | Pre-Made Crizanlizumab biosimilar, Whole mAb, Anti-SELP Antibody: Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL therapeutic antibody | Crizanlizumab | | SELP | Whole mAb |  |
GMP-Bios-ab-124 | Pre-Made Crotedumab biosimilar, Whole mAb, Anti-GCGR Antibody: Anti-GGR/GL-R/MVAH therapeutic antibody | Crotedumab | | GCGR | Whole mAb |  |
GMP-Bios-ab-125 | Pre-Made Crovalimab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Crovalimab | | C5/CO5 | Whole mAb |  |
GMP-Bios-ab-126 | Pre-Made Cudarolimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Cudarolimab | | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-127 | Pre-Made Cusatuzumab biosimilar, Whole mAb, Anti-CD70/CD27-L Antibody: Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A therapeutic antibody | Cusatuzumab | | CD70/CD27-L | Whole mAb |  |
GMP-Bios-ab-128 | Pre-Made Dacetuzumab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Dacetuzumab | | CD40 | Whole mAb |  |
GMP-Bios-ab-129 | Pre-Made Daclizumab biosimilar, Whole mAb, Anti-IL2RA Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody | Daclizumab | | IL2RA | Whole mAb |  |
GMP-Bios-ab-130 | Pre-Made Dafsolimab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Dafsolimab | | CD3E | Whole mAb |  |
GMP-Bios-ab-131 | Pre-Made Dalotuzumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Dalotuzumab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-132 | Pre-Made Dapirolizumab biosimilar, Fab, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody | Dapirolizumab | | CD40LG | Fab |  |
GMP-Bios-ab-133 | Pre-Made Daratumumab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody | Daratumumab | | CD38 | Whole mAb |  |
GMP-Bios-ab-134 | Pre-Made Datopotamab biosimilar, Whole mAb, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody | Datopotamab | | TACSTD2 | Whole mAb |  |
GMP-Bios-ab-135 | Pre-Made Daxdilimab biosimilar, Whole mAb, Anti-LILRA4/ILT7 Antibody: Anti-CD85g therapeutic antibody | Daxdilimab | | LILRA4/ILT7 | Whole mAb |  |
GMP-Bios-ab-136 | Pre-Made Dectrekumab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Dectrekumab | | IL13 | Whole mAb |  |
GMP-Bios-ab-137 | Pre-Made Demcizumab biosimilar, Whole mAb, Anti-DLL4 Antibody: Anti-AOS6/delta4/hdelta2 therapeutic antibody | Demcizumab | | DLL4 | Whole mAb |  |
GMP-Bios-ab-138 | Pre-Made Demupitamab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Demupitamab | | EGFR | Whole mAb |  |
GMP-Bios-ab-139 | Pre-Made Denintuzumab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody | Denintuzumab | | CD19 | Whole mAb ADC |  |
GMP-Bios-ab-140 | Pre-Made Denosumab biosimilar, Whole mAb, Anti-TNFSF11/ODF Antibody: Anti-OPGL/sCD254/OPTB2/RANKL/TNLG6B/TRANCE/hRANKL2 therapeutic antibody | Denosumab | | TNFSF11/ODF | Whole mAb |  |
GMP-Bios-ab-141 | Pre-Made Depatuxizumab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Depatuxizumab | | EGFR | Whole mAb ADC |  |
GMP-Bios-ab-142 | Pre-Made Depemokimab biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody | Depemokimab | | IL5 | Whole mAb |  |
GMP-Bios-ab-143 | Pre-Made Derlotuximab biosimilar, Whole mAb Radiolabelled: Anti-DNA/H1 Complex therapeutic antibody | Derlotuximab | | DNA/H1 Complex | Whole mAb Radiolabelled |  |
GMP-Bios-ab-144 | Pre-Made Dezamizumab biosimilar, Whole mAb, Anti-APCS Antibody: Anti-HEL-S-92n/PTX2/SAP therapeutic antibody | Dezamizumab | | APCS | Whole mAb |  |
GMP-Bios-ab-145 | Pre-Made Dilpacimab biosimilar, Bispecific mAb, Anti-DLL4;VEGFA Antibody: Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1 therapeutic antibody | Dilpacimab | | DLL4;VEGFA | Bispecific mAb |  |
GMP-Bios-ab-146 | Pre-Made Dinutuximab biosimilar, Whole Mab: Anti-Ganglioside GD2 therapeutic antibody | Dinutuximab | | Ganglioside GD2 | Whole mAb |  |
GMP-Bios-ab-147 | Pre-Made Diridavumab biosimilar, Whole Mab: Anti-Influenza A HA2 therapeutic antibody | Diridavumab | | Influenza A HA2 | Whole mAb |  |
GMP-Bios-ab-148 | Pre-Made Disitamab biosimilar, Whole mAb ADC, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Disitamab | | ERBB2/HER2 | Whole mAb ADC |  |
GMP-Bios-ab-149 | Pre-Made Divozilimab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Divozilimab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-150 | Pre-Made Docaravimab biosimilar, Whole mAb (Mouse): Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-III therapeutic antibody | Docaravimab | | Rabies Virus Strain ERA GP Ectodomain Epitope G-III | Whole mAb (Mouse) |  |
GMP-Bios-ab-151 | Pre-Made Domagrozumab biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody: Anti-GDF8/MSLHP therapeutic antibody | Domagrozumab | | MSTN/GDF-8 | Whole mAb |  |
GMP-Bios-ab-152 | Pre-Made Domvanalimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody | Domvanalimab | | TIGIT | Whole mAb |  |
GMP-Bios-ab-153 | Pre-Made Donanemab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Donanemab | | APP | Whole mAb |  |
GMP-Bios-ab-154 | Pre-Made Dostarlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Dostarlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-155 | Pre-Made Dovanvetmab biosimilar, Feline Whole Mab: Anti-IL31 (Feline) therapeutic antibody | Dovanvetmab | | IL31 (Feline) | Feline Whole mAb |  |
GMP-Bios-ab-156 | Pre-Made Drozitumab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody | Drozitumab | | TNFRSF10B /TRAIL-R2 | Whole mAb |  |
GMP-Bios-ab-157 | Pre-Made Duligotuzumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Duligotuzumab | Duligotumab | ERBB3/Erbb-3 | Whole mAb |  |
GMP-Bios-ab-158 | Pre-Made Dupilumab biosimilar, Whole mAb, Anti-IL4R Antibody: Anti-CD124 therapeutic antibody | Dupilumab | | IL4R | Whole mAb |  |
GMP-Bios-ab-159 | Pre-Made Durvalumab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Durvalumab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-160 | Pre-Made Dusigitumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody | Dusigitumab | | IGF1;IGF2 | Whole mAb |  |
GMP-Bios-ab-161 | Pre-Made Duvortuxizumab biosimilar, Bispecific scFv with Crossover, Anti-CD19;CD3E antibody: Anti-B4/CVID3;T3E/TCRE/IMD18 therapeutic antibody | Duvortuxizumab | | CD19;CD3E | Bispecific scFv with Crossover |  |
GMP-Bios-ab-162 | Pre-Made Ebdarokimab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody | Ebdarokimab | | IL12B | Whole mAb |  |
GMP-Bios-ab-163 | Pre-Made Ebronucimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Ebronucimab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-164 | Pre-Made Eculizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Eculizumab | | C5/CO5 | Whole mAb |  |
GMP-Bios-ab-165 | Pre-Made Edrecolomab biosimilar, Whole mAb, Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody | Edrecolomab | | EPCAM | Whole mAb |  |
GMP-Bios-ab-166 | Pre-Made Efalizumab biosimilar, Whole mAb, Anti-ITGAL Antibody: Anti-CD11A/LFA-1/LFA1A therapeutic antibody | Efalizumab | | ITGAL | Whole mAb |  |
GMP-Bios-ab-167 | Pre-Made Efungumab biosimilar, scFv: Anti-Heat Shock Protein 90 Homolog therapeutic antibody | Efungumab | | Heat Shock Protein 90 Homolog | scFv |  |
GMP-Bios-ab-168 | Pre-Made Eldelumab biosimilar, Whole mAb, Anti-CXCL10 Antibody: Anti-C7/IFI10/INP10/IP-10/SCYB10/crg-2/gIP-10/mob-1 therapeutic antibody | Eldelumab | | CXCL10 | Whole mAb |  |
GMP-Bios-ab-169 | Pre-Made Elezanumab biosimilar, Whole mAb, Anti-RGMA Antibody: Anti-RGM therapeutic antibody | Elezanumab | | RGMA | Whole mAb |  |
GMP-Bios-ab-170 | Pre-Made Elgemtumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Elgemtumab | | ERBB3/Erbb-3 | Whole mAb |  |
GMP-Bios-ab-171 | Pre-Made Elipovimab biosimilar, Whole Mab: Anti-HIV-1 gp120 therapeutic antibody | Elipovimab | | HIV-1 gp120 | Whole mAb |  |
GMP-Bios-ab-172 | Pre-Made Elotuzumab biosimilar, Whole mAb, Anti-SLAMF7/CS1 Antibody: Anti-19A/CD319/CRACC therapeutic antibody | Elotuzumab | | SLAMF7/CS1 | Whole mAb |  |
GMP-Bios-ab-173 | Pre-Made Eluvixtamab biosimilar, Bispecific scFv, Anti-CD33;CD3E Antibody: Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18 therapeutic antibody | Eluvixtamab | | CD33;CD3E | Bispecific scFv |  |
GMP-Bios-ab-174 | Pre-Made Emactuzumab biosimilar, Whole mAb, Anti-CSF1R Antibody: Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R therapeutic antibody | Emactuzumab | | CSF1R | Whole mAb |  |
GMP-Bios-ab-175 | Pre-Made Emapalumab biosimilar, Whole mAb, Anti-IFNG Antibody: Anti-IFG/IFI/IMD69 therapeutic antibody | Emapalumab | | IFNG | Whole mAb |  |
GMP-Bios-ab-176 | Pre-Made Emerfetamab biosimilar, Bispecific scFv, Anti-CD33;CD3E Antibody: Anti-p67/SIGLEC3/SIGLEC-3;T3E/TCRE/IMD18 therapeutic antibody | Emerfetamab | | CD33;CD3E | Bispecific scFv |  |
GMP-Bios-ab-177 | Pre-Made Emicizumab biosimilar, Bispecific mAb, Anti-F9;F10 Antibody: Anti-FIX/HEMB/P19/PTC/THPH8;FX/FXA therapeutic antibody | Emicizumab | | F9;F10 | Bispecific mAb |  |
GMP-Bios-ab-178 | Pre-Made Emibetuzumab biosimilar, Whole mAb, Anti-MET Antibody: Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody | Emibetuzumab | | MET | Whole mAb |  |
GMP-Bios-ab-179 | Pre-Made Enapotamab biosimilar, Whole mAb ADC, Anti-AXL Antibody: Anti-ARK/UFO/JTK11/Tyro7 therapeutic antibody | Enapotamab | | AXL | Whole mAb ADC |  |
GMP-Bios-ab-180 | Pre-Made Enavatuzumab biosimilar, Whole mAb, Anti-TNFRSF12A Antibody: Anti-CD2664/TWEAKR therapeutic antibody | Enavatuzumab | | TNFRSF12A | Whole mAb |  |
GMP-Bios-ab-181 | Pre-Made Encelimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody | Encelimab | | LAG3 | Whole mAb |  |
GMP-Bios-ab-182 | Pre-Made Enfortumab biosimilar, Whole mAb ADC, Anti-PVRL4/NECTIN4 Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic antibody | Enfortumab | | PVRL4/NECTIN4 | Whole mAb ADC |  |
GMP-Bios-ab-183 | Pre-Made Enibarcimab biosimilar, Whole mAb, Anti-ADM Antibody: Anti-AM/PAMP therapeutic antibody | Enibarcimab | | ADM | Whole mAb |  |
GMP-Bios-ab-184 | Pre-Made Enoblituzumab biosimilar, Whole mAb, Anti-CD276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody | Enoblituzumab | | CD276 | Whole mAb |  |
GMP-Bios-ab-185 | Pre-Made Enokizumab biosimilar, Whole mAb, Anti-IL9 Antibody: Anti-HP40/IL-9/P40 therapeutic antibody | Enokizumab | | IL9 | Whole mAb |  |
GMP-Bios-ab-186 | Pre-Made Enoticumab biosimilar, Whole mAb, Anti-DLL4 Antibody: Anti-AOS6/delta4/hdelta2 therapeutic antibody | Enoticumab | | DLL4 | Whole mAb |  |
GMP-Bios-ab-187 | Pre-Made Ensituximab biosimilar, Whole mAb, Anti-MUC5AC Antibody: Anti-MUC5/TBM/leBin therapeutic antibody | Ensituximab | | MUC5AC | Whole mAb |  |
GMP-Bios-ab-188 | Pre-Made Envafolimab biosimilar, Single Domain Variable Fragment;H, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1 therapeutic antibody | Envafolimab | | CD274/PD-L1 | Single Domain Variable Fragment;H |  |
GMP-Bios-ab-189 | Pre-Made Epcoritamab biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Epcoritamab | | CD3E;MS4A1/CD20 | Bispecific mAb |  |
GMP-Bios-ab-190 | Pre-Made Epratuzumab biosimilar, Whole mAb, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody | Epratuzumab | | CD22 | Whole mAb |  |
GMP-Bios-ab-191 | Pre-Made Eptinezumab biosimilar, Whole mAb, Anti-CALCA;CALCB Antibody: Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2 therapeutic antibody | Eptinezumab | | CALCA;CALCB | Whole mAb |  |
GMP-Bios-ab-192 | Pre-Made Eramkafusp biosimilar, Whole mAb Fusion, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Eramkafusp | | MS4A1/CD20 | Whole mAb Fusion |  |
GMP-Bios-ab-193 | Pre-Made Erenumab biosimilar, Whole mAb, Anti-CALCRL/CGRPR Antibody: Anti-CRLR/LMPHM8 therapeutic antibody | Erenumab | | CALCRL/CGRPR | Whole mAb |  |
GMP-Bios-ab-194 | Pre-made Erfonrilimab biosimilar, Bispecific Single Domains (VH-VH'-CH), Anti-CD274/PD-L1;CTLA4/CTLA-4 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Erfonrilimab | | CD274/PD-L1;CTLA4/CTLA-4 | Bispecific Single Domains (VH-VH'-CH) |  |
GMP-Bios-ab-195 | Pre-Made Etaracizumab biosimilar, Whole mAb, Anti-ITGAV;ITGB3 Antibody: Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2 therapeutic antibody | Etaracizumab | | ITGAV;ITGB3 | Whole mAb |  |
GMP-Bios-ab-196 | Pre-Made Etesevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Etesevimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-197 | Pre-Made Etevritamab biosimilar, Bispecific scFv, Anti-EGFR;CD3E Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;T3E/TCRE/IMD18 therapeutic antibody | Etevritamab | | EGFR;CD3E | Bispecific scFv |  |
GMP-Bios-ab-198 | Pre-Made Etigilimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody | Etigilimab | | TIGIT | Whole mAb |  |
GMP-Bios-ab-199 | Pre-Made Etokimab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Etokimab | | IL13 | Whole mAb |  |
GMP-Bios-ab-200 | Pre-Made Etrolizumab biosimilar, Whole Mab: Anti-ITGA4;ITGB7;ITGAE;ITGB7 therapeutic antibody | Etrolizumab | | ITGA4;ITGB7; ITGAE;ITGB7 | Whole mAb |  |
GMP-Bios-ab-201 | Pre-Made Evinacumab biosimilar, Whole mAb, Anti-ANGPTL3 Antibody: Anti-ANG-5/ANGPT5/ANL3/FHBL2 therapeutic antibody | Evinacumab | | ANGPTL3 | Whole mAb |  |
GMP-Bios-ab-202 | Pre-Made Evolocumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Evolocumab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-203 | Pre-Made Ezabenlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Ezabenlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-204 | Pre-Made Faricimab biosimilar, Bispecific mAb, Anti-VEGFA;ANGPT2 Antibody: Anti-VPF/VEGF/MVCD1;AGPT2/ANG2/LMPHM10 therapeutic antibody | Faricimab | | VEGFA;ANGPT2 | Bispecific mAb |  |
GMP-Bios-ab-205 | Pre-Made Farletuzumab biosimilar, Whole mAb, Anti-FOLR1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody | Farletuzumab | | FOLR1 | Whole mAb |  |
GMP-Bios-ab-206 | Pre-Made Fasinumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody | Fasinumab | | NGFB/NGF | Whole mAb |  |
GMP-Bios-ab-207 | Pre-Made Feladilimab biosimilar, Whole mAb, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody | Feladilimab | | ICOS | Whole mAb |  |
GMP-Bios-ab-208 | Pre-Made Felzartamab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody | Felzartamab | | CD38 | Whole mAb |  |
GMP-Bios-ab-209 | Pre-Made Fezakinumab biosimilar, Whole mAb, Anti-IL22 Antibody: Anti-IL-21/IL-22/IL-D110/IL-TIF/ILTIF/TIFIL-23/TIFa/zcyto18 therapeutic antibody | Fezakinumab | | IL22 | Whole mAb |  |
GMP-Bios-ab-210 | Pre-Made Fianlimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody | Fianlimab | | LAG3 | Whole mAb |  |
GMP-Bios-ab-211 | Pre-Made Fibatuzumab biosimilar, Whole mAb, Anti-EPHA3 Antibody: Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic antibody | Fibatuzumab | Ifabotuzumab | EPHA3 | Whole mAb |  |
GMP-Bios-ab-212 | Pre-Made Ficlatuzumab biosimilar, Whole mAb, Anti-HGF Antibody: Anti-DFNB39/F-TCF/HPTA/SF therapeutic antibody | Ficlatuzumab | | HGF | Whole mAb |  |
GMP-Bios-ab-213 | Pre-Made Figitumumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Figitumumab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-214 | Pre-Made Firivumab biosimilar, Whole Mab: Anti-Influenza A HA therapeutic antibody | Firivumab | | Influenza A HA | Whole mAb |  |
GMP-Bios-ab-215 | Pre-Made Finotonlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Finotonlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-216 | Pre-Made Flanvotumab biosimilar, Whole mAb, Anti-TYRP1 Antibody: Anti-TRP/CAS2/CATB/GP75/OCA3/TRP1/TYRP/b-PROTEIN therapeutic antibody | Flanvotumab | | TYRP1 | Whole mAb |  |
GMP-Bios-ab-217 | Pre-Made Fletikumab biosimilar, Whole mAb, Anti-IL20 Antibody: Anti-IL-20/IL10D/ZCYTO10 therapeutic antibody | Fletikumab | | IL20 | Whole mAb |  |
GMP-Bios-ab-218 | Pre-Made Flotetuzumab biosimilar, Bispecific scFv with Crossover, Anti-IL3RA;CD3E Antibody: Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18 therapeutic antibody | Flotetuzumab | | IL3RA;CD3E | Bispecific scFv with Crossover |  |
GMP-Bios-ab-219 | Pre-Made Fontolizumab biosimilar, Whole mAb, Anti-IFNG Antibody: Anti-IFG/IFI/IMD69 therapeutic antibody | Fontolizumab | | IFNG | Whole mAb |  |
GMP-Bios-ab-220 | Pre-Made Foralumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Foralumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-221 | Pre-Made Foravirumab biosimilar, Whole Mab: Anti-RV Antigenic Site III therapeutic antibody | Foravirumab | | RV Antigenic Site III | Whole mAb |  |
GMP-Bios-ab-222 | Pre-Made Fremanezumab biosimilar, Whole mAb, Anti-CALCA;CALCB Antibody: Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2 therapeutic antibody | Fremanezumab | | CALCA;CALCB | Whole mAb |  |
GMP-Bios-ab-223 | Pre-Made Fresolimumab biosimilar, Whole mAb, Anti-TGFB/TGFB1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody | Fresolimumab | | TGFB/TGFB1 | Whole mAb |  |
GMP-Bios-ab-224 | Pre-Made Frovocimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Frovocimab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-225 | Pre-Made Frunevetmab biosimilar, Feline Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody | Frunevetmab | | NGFB/NGF | Feline Whole mAb |  |
GMP-Bios-ab-226 | Pre-Made Fulranumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody | Fulranumab | | NGFB/NGF | Whole mAb |  |
GMP-Bios-ab-227 | Pre-Made Futuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Futuximab | | EGFR | Whole mAb |  |
GMP-Bios-ab-228 | Pre-Made Galcanezumab biosimilar, Whole mAb, Anti-CALCA;CALCB Antibody: Anti-CT/KC/PCT/CGRP/CALC1/CGRP1/CGRP-I/CGRP-alpha;CALC2/CGRP-II/CGRP2 therapeutic antibody | Galcanezumab | | CALCA;CALCB | Whole mAb |  |
GMP-Bios-ab-229 | Pre-Made Galiximab biosimilar, Whole mAb, Anti-CD80 Antibody: Anti-B7/BB1/B7-1/B7.1/LAB7/CD28LG/CD28LG1 therapeutic antibody | Galiximab | | CD80 | Whole mAb |  |
GMP-Bios-ab-230 | Pre-Made Gancotamab biosimilar, scFv, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Gancotamab | | ERBB2/HER2 | scFv |  |
GMP-Bios-ab-231 | Pre-Made Ganitumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Ganitumab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-232 | Pre-Made Gantenerumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Gantenerumab | | APP | Whole mAb |  |
GMP-Bios-ab-233 | Pre-Made Garadacimab biosimilar, Whole mAb, Anti-F12 Antibody: Anti-HAE3/HAEX/HAF therapeutic antibody | Garadacimab | | F12 | Whole mAb |  |
GMP-Bios-ab-234 | Pre-Made Garetosmab biosimilar, Whole mAb, Anti-INHBA/ACT Antibody: Anti-EDF/FRP therapeutic antibody | Garetosmab | | INHBA/ACT | Whole mAb |  |
GMP-Bios-ab-235 | Pre-Made Garivulimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Garivulimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-236 | Pre-Made Gatipotuzumab biosimilar, Whole mAb, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | Gatipotuzumab | PankoMab | MUC1 | Whole mAb |  |
GMP-Bios-ab-237 | Pre-Made Gatralimab biosimilar, Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody | Gatralimab | | CD52 | Whole mAb |  |
GMP-Bios-ab-238 | Pre-Made Gedivumab biosimilar, Whole Mab: Anti-Influenza A HA therapeutic antibody | Gedivumab | | Influenza A HA | Whole mAb |  |
GMP-Bios-ab-239 | Pre-Made Gemtuzumab biosimilar, Whole mAb ADC, Anti-CD33 Antibody: Anti-p67/SIGLEC3/SIGLEC-3 therapeutic antibody | Gemtuzumab | | CD33 | Whole mAb ADC |  |
GMP-Bios-ab-240 | Pre-Made Geptanolimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Geptanolimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-241 | Pre-Made Gevokizumab biosimilar, Whole mAb, Anti-IL1B Antibody: Anti-IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody | Gevokizumab | | IL1B | Whole mAb |  |
GMP-Bios-ab-242 | Pre-Made Giloralimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Giloralimab | | CD40 | Whole mAb |  |
GMP-Bios-ab-243 | Pre-Made Gilvetmab biosimilar, Canine Whole Mab: Anti-PDCD1 (Canine) therapeutic antibody | Gilvetmab | | PDCD1 (Canine) | Canine Whole mAb |  |
GMP-Bios-ab-244 | Pre-Made Gimsilumab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody | Gimsilumab | | CSF2 | Whole mAb |  |
GMP-Bios-ab-245 | Pre-Made Girentuximab biosimilar, Whole mAb Radiolabelled, Anti-CA9/CA-IX Antibody: Anti-CAIX/MN therapeutic antibody | Girentuximab | | CA9/CA-IX | Whole mAb Radiolabelled |  |
GMP-Bios-ab-246 | Pre-Made Glembatumumab biosimilar, Whole mAb ADC, Anti-GPNMB Antibody: Anti-HGFIN/NMB/PLCA3 therapeutic antibody | Glembatumumab | | GPNMB | Whole mAb ADC |  |
GMP-Bios-ab-247 | Pre-Made Glenzocimab biosimilar, Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI therapeutic antibody | Glenzocimab | | GP6 | Fab |  |
GMP-Bios-ab-248 | Pre-Made Glofitamab biosimilar, Bispecific mAb with Domain Crossover, Anti-CD3E;MS4A1/CD20 antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7therapeutic antibody | Glofitamab | | CD3E;MS4A1/CD20 | Bispecific mAb with Domain Crossover |  |
GMP-Bios-ab-249 | Pre-Made Golimumab biosimilar, Whole mAb, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Golimumab | | TNFA/TNF | Whole mAb |  |
GMP-Bios-ab-250 | Pre-Made Gomiliximab biosimilar, Whole mAb, Anti-FCER2/CD23 Antibody: Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF therapeutic antibody | Gomiliximab | | FCER2/CD23 | Whole mAb |  |
GMP-Bios-ab-251 | Pre-Made Gontivimab biosimilar, Bispecific Single Domains (VH-VH'-VH’): Anti-RSV gpF therapeutic antibody | Gontivimab | | RSV gpF | Bispecific Single Domains (VH-VH'-VH’) |  |
GMP-Bios-ab-252 | Pre-Made Gosuranemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40 therapeutic antibody | Gosuranemab | | MAPT | Whole mAb |  |
GMP-Bios-ab-253 | Pre-Made Gremubamab biosimilar, Bispecific mAb: Anti-PcrV type III secretion system; Polysaccharide synthesis locus (Pseudomonas) therapeutic antibody | Gremubamab | | PcrV type III secretion system; Polysaccharide synthesis locus (Pseudomonas) | Bispecific mAb |  |
GMP-Bios-ab-254 | Pre-Made Grisnilimab biosimilar, Whole mAb, Anti-CD7 Antibody: Anti-GP40/TP41/Tp40/LEU-9 therapeutic antibody | Grisnilimab | | CD7 | Whole mAb |  |
GMP-Bios-ab-255 | Pre-Made Guselkumab biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody: Anti-IL23P19/P19/SGRF therapeutic antibody | Guselkumab | | IL23A/IL23 | Whole mAb |  |
GMP-Bios-ab-256 | Pre-Made Ianalumab biosimilar, Whole mAb, Anti-TNFRSF13C Antibody: Anti-BAFF-R/BAFFR/BROMIX/CD268/CVID4/prolixin therapeutic antibody | Ianalumab | | TNFRSF13C | Whole mAb |  |
GMP-Bios-ab-257 | Pre-Made Ibalizumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Ibalizumab | | CD4 | Whole mAb |  |
GMP-Bios-ab-258 | Pre-Made Icatolimab biosimilar, Whole mAb, Anti-BTLA Antibody: Anti-CD272 therapeutic antibody | Icatolimab | Tifcemalimab | BTLA | Whole mAb |  |
GMP-Bios-ab-259 | Pre-Made Icrucumab biosimilar, Whole mAb, Anti-FLT1/FLT-1 Antibody: Anti-VEGFR-1/VEGFR1 therapeutic antibody | Icrucumab | | FLT1/FLT-1 | Whole mAb |  |
GMP-Bios-ab-260 | Pre-Made Idactamab biosimilar, Whole mAb, Anti-SLC1A5 Antibody: Anti-AAAT/ASCT2/ATBO/M7V1/M7VS1/R16/RDRC therapeutic antibody | Idactamab | | SLC1A5 | Whole mAb |  |
GMP-Bios-ab-261 | Pre-Made Idarucizumab biosimilar, Fab: Anti-Dabigatran therapeutic antibody | Idarucizumab | | Dabigatran | Fab |  |
GMP-Bios-ab-262 | Pre-Made Ieramilimab biosimilar, Whole Mab: Anti-CD223/LAG3 therapeutic antibody | Ieramilimab | | CD223/LAG3 | Whole mAb |  |
GMP-Bios-ab-263 | Pre-Made Ifabotuzumab biosimilar, Whole mAb, Anti-EPHA3 Antibody: Anti-EK4/ETK/ETK1/HEK/HEK4/TYRO4 therapeutic antibody | Ifabotuzumab | Fibatuzumab | EPHA3 | Whole mAb |  |
GMP-Bios-ab-264 | Pre-Made Iladatuzumab biosimilar, Whole mAb ADC, Anti-CD79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody | Iladatuzumab | | CD79B | Whole mAb ADC |  |
GMP-Bios-ab-265 | Pre-Made Imalumab biosimilar, Whole mAb, Anti-MIF Antibody: Anti-GIF/GLIF/MMIF therapeutic antibody | Imalumab | | MIF | Whole mAb |  |
GMP-Bios-ab-266 | Pre-Made Imaprelimab biosimilar, Whole mAb, Anti-MCAM Antibody: Anti-CD146/HEMCAM/METCAM8/MelCAM therapeutic antibody | Imaprelimab | | MCAM | Whole mAb |  |
GMP-Bios-ab-267 | Pre-Made Imdevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Imdevimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-268 | Pre-Made Imgatuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Imgatuzumab | | EGFR | Whole mAb |  |
GMP-Bios-ab-269 | Pre-Made Imsidolimab biosimilar, Whole mAb, Anti-IL36R/IL1RL2 Antibody: Anti-IL1RRP2/IL-1Rrp2/IL1R-rp2 therapeutic antibody | Imsidolimab | | IL36R/IL1RL2 | Whole mAb |  |
GMP-Bios-ab-270 | Pre-Made Inclacumab biosimilar, Whole mAb, Anti-SELP Antibody: Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL therapeutic antibody | Inclacumab | | SELP | Whole mAb |  |
GMP-Bios-ab-271 | Pre-Made Indatuximab biosimilar, Whole mAb ADC, Anti-SDC1 Antibody: Anti-SDC/CD138/SYND1/syndecan therapeutic antibody | Indatuximab | | SDC1 | Whole mAb ADC |  |
GMP-Bios-ab-272 | Pre-Made Indusatumab biosimilar, Whole mAb ADC, Anti-GUCY2C Antibody: Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic antibody | Indusatumab | | GUCY2C | Whole mAb ADC |  |
GMP-Bios-ab-273 | Pre-Made Inebilizumab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody | Inebilizumab | | CD19 | Whole mAb |  |
GMP-Bios-ab-274 | Pre-Made Infliximab biosimilar, Whole mAb, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Infliximab | | TNFA/TNF | Whole mAb |  |
GMP-Bios-ab-275 | Pre-Made Inotuzumab biosimilar, Whole mAb ADC, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody | Inotuzumab | | CD22 | Whole mAb ADC |  |
GMP-Bios-ab-276 | Pre-Made Intetumumab biosimilar, Whole mAb, Anti-ITGAV;ITGB3 Antibody: Anti-CD51/MSK8/VNRA/VTNR;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2 therapeutic antibody | Intetumumab | | ITGAV;ITGB3 | Whole mAb |  |
GMP-Bios-ab-277 | Pre-Made Ipilimumab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Ipilimumab | | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-278 | Pre-Made Iratumumab biosimilar, Whole mAb, Anti-TNFRSF8 Antibody: Anti-CD30/Ki-1/D1S166E therapeutic antibody | Iratumumab | | TNFRSF8 | Whole mAb |  |
GMP-Bios-ab-279 | Pre-Made Isatuximab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody | Isatuximab | | CD38 | Whole mAb |  |
GMP-Bios-ab-280 | Pre-Made Iscalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Iscalimab | | CD40 | Whole mAb |  |
GMP-Bios-ab-281 | Pre-Made Isecarosmab biosimilar, Bispecific Single Domains (VH-VH'), Anti-ADAMTSL5;ALB Antibody: Anti-THSD6;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibody | Isecarosmab | | ADAMTSL5;ALB | Bispecific Single Domains (VH-VH') |  |
GMP-Bios-ab-282 | Pre-Made Istiratumab biosimilar, Bispecific Mixed mAb and scFv, Anti-IGF1R;ERBB3/Erbb-3 Antibody: Anti-IGFR/CD221/IGFIR/JTK13;FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-c-erbB3/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Istiratumab | | IGF1R;ERBB3/Erbb-3 | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-283 | Pre-Made Itepekimab biosimilar, Whole mAb, Anti-IL33 Antibody: Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV therapeutic antibody | Itepekimab | | IL33 | Whole mAb |  |
GMP-Bios-ab-284 | Pre-Made Itolizumab biosimilar, Whole Mab: Anti-CD6/TP120 therapeutic antibody | Itolizumab | | CD6/TP120 | Whole mAb |  |
GMP-Bios-ab-285 | Pre-Made Ivuxolimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Ivuxolimab | | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-286 | Pre-Made Ixekizumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Ixekizumab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-287 | Pre-Made Izuralimab biosimilar, Bispecific Mixed mAb and scFv, Anti-ICOS;PDCD1/PD-1 antibody: Anti-AILIM/CD278/CVID1;CD279/SLEB2/hPD-1/hPD-l/hSLE1 therapeutic antibody | Izuralimab | | ICOS;PDCD1/PD-1 | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-288 | Pre-Made Labetuzumab biosimilar, Whole mAb ADC, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody | Labetuzumab | | CEACAM5/CD66e | Whole mAb ADC |  |
GMP-Bios-ab-289 | Pre-Made Lacnotuzumab biosimilar, Whole mAb, Anti-CSF1 Antibody: Anti-MCSF/CSF-1 therapeutic antibody | Lacnotuzumab | | CSF1 | Whole mAb |  |
GMP-Bios-ab-290 | Pre-Made Lacutamab biosimilar, Whole mAb, Anti-KIR3DL2/CD158k Antibody: Anti-3DL2/CD158K/KIR-3DL2/NKAT-4/NKAT4/NKAT4B/p140 therapeutic antibody | Lacutamab | | KIR3DL2/CD158k | Whole mAb |  |
GMP-Bios-ab-291 | Pre-Made Ladiratuzumab biosimilar, Whole mAb ADC, Anti-SLC39A6 Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic antibody | Ladiratuzumab | | SLC39A6 | Whole mAb ADC |  |
GMP-Bios-ab-292 | Pre-Made Lambrolizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Lambrolizumab | pembrolizumab | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-293 | Pre-Made Lampalizumab biosimilar, Fab, Anti-CFD Antibody: Anti-ADIPSIN/ADN/DF/PFD therapeutic antibody | Lampalizumab | | CFD | Fab |  |
GMP-Bios-ab-294 | Pre-Made Lanadelumab biosimilar, Whole mAb, Anti-KLKB1 Antibody: Anti-KLK3/PKK/PKKD/PPK therapeutic antibody | Lanadelumab | | KLKB1 | Whole mAb |  |
GMP-Bios-ab-295 | Pre-Made Landogrozumab biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody: Anti-GDF8/MSLHP therapeutic antibody | Landogrozumab | | MSTN/GDF-8 | Whole mAb |  |
GMP-Bios-ab-296 | Pre-Made Laprituximab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Laprituximab | | EGFR | Whole mAb ADC |  |
GMP-Bios-ab-297 | Pre-Made Larcaviximab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody | Larcaviximab | | Zaire Ebolavirus GP | Whole mAb |  |
GMP-Bios-ab-298 | Pre-Made Latozinemab biosimilar, Whole mAb, Anti-SORT1 Antibody: Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic antibody | Latozinemab | | SORT1 | Whole mAb |  |
GMP-Bios-ab-299 | Pre-Made Lebrikizumab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Lebrikizumab | | IL13 | Whole mAb |  |
GMP-Bios-ab-300 | Pre-Made Lecanemab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Lecanemab | | APP | Whole mAb |  |
GMP-Bios-ab-301 | Pre-Made Lemzoparlimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody | Lemzoparlimab | | CD47 | Whole mAb |  |
GMP-Bios-ab-302 | Pre-Made Lenvervimab biosimilar, Whole Mab: Anti-HBV therapeutic antibody | Lenvervimab | | HBV | Whole mAb |  |
GMP-Bios-ab-303 | Pre-Made Lenzilumab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody | Lenzilumab | | CSF2 | Whole mAb |  |
GMP-Bios-ab-304 | Pre-Made Leronlimab biosimilar, Whole mAb, Anti-CCR5 Antibody: Anti-CKR5/CCR-5/CD195/CKR-5/CCCKR5/CMKBR5/IDDM22/CC-CKR-5 therapeutic antibody | Leronlimab | | CCR5 | Whole mAb |  |
GMP-Bios-ab-305 | Pre-Made Lesofavumab biosimilar, Whole Mab: Anti-Influenza B Virus therapeutic antibody | Lesofavumab | | Influenza B Virus | Whole mAb |  |
GMP-Bios-ab-306 | Pre-Made Letaplimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody | Letaplimab | | CD47 | Whole mAb |  |
GMP-Bios-ab-307 | Pre-Made Letolizumab biosimilar, Single Domain Variable Fragment;H, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody | Letolizumab | | CD40LG | Single Domain Variable Fragment;H |  |
GMP-Bios-ab-308 | Pre-Made Levilimab biosimilar, Whole mAb, Anti-IL6R Antibody: Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80 therapeutic antibody | Levilimab | | IL6R | Whole mAb |  |
GMP-Bios-ab-309 | Pre-Made Lexatumumab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody | Lexatumumab | | TNFRSF10B/TRAIL-R2 | Whole mAb |  |
GMP-Bios-ab-310 | Pre-Made Licaminlimab biosimilar, scFv, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Licaminlimab | | TNFA/TNF | scFv |  |
GMP-Bios-ab-311 | Pre-Made Lifastuzumab biosimilar, Whole mAb ADC, Anti-SLC34A2 Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic antibody | Lifastuzumab | | SLC34A2 | Whole mAb ADC |  |
GMP-Bios-ab-312 | Pre-Made Ligelizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody | Ligelizumab | | IGHE/IgE | Whole mAb |  |
GMP-Bios-ab-313 | Pre-Made Lilotomab biosimilar, Whole mAb ADC, Anti-CD37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody | Lilotomab | | CD37 | Whole mAb ADC |  |
GMP-Bios-ab-314 | Pre-Made Lintuzumab biosimilar, Whole mAb Radiolabelled, Anti-CD33 Antibody: Anti-p67/SIGLEC3/SIGLEC-3 therapeutic antibody | Lintuzumab | | CD33 | Whole mAb Radiolabelled |  |
GMP-Bios-ab-315 | Pre-Made Lirentelimab biosimilar, Whole mAb, Anti-SIGLEC8/Siglec-8 Antibody: Anti-SAF2 therapeutic antibody | Lirentelimab | | SIGLEC8/Siglec-8 | Whole mAb |  |
GMP-Bios-ab-316 | Pre-Made Lirilumab biosimilar, Whole Mab: Anti-KIRD2 therapeutic antibody | Lirilumab | | KIRD2 | Whole mAb |  |
GMP-Bios-ab-317 | Pre-Made Lodapolimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Lodapolimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-318 | Pre-Made Lodelcizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Lodelcizumab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-319 | Pre-Made Lokivetmab biosimilar, Canine Whole Mab: Anti-IL31 therapeutic antibody | Lokivetmab | | IL31 | Canine Whole mAb |  |
GMP-Bios-ab-320 | Pre-Made Loncastuximab biosimilar, Whole mAb ADC, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody | Loncastuximab | | CD19 | Whole mAb ADC |  |
GMP-Bios-ab-321 | Pre-Made Lonigutamab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Lonigutamab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-322 | Pre-Made Lorukafusp biosimilar, Whole mAb Fusion: Anti-Ganglioside GD2 therapeutic antibody | Lorukafusp | | Ganglioside GD2 | Whole mAb Fusion |  |
GMP-Bios-ab-323 | Pre-Made Lorvotuzumab biosimilar, Whole mAb ADC, Anti-NCAM1 Antibody: Anti-CD56/NCAM/MSK39 therapeutic antibody | Lorvotuzumab | | NCAM1 | Whole mAb ADC |  |
GMP-Bios-ab-324 | Pre-Made Losatuxizumab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Losatuxizumab | | EGFR | Whole mAb ADC |  |
GMP-Bios-ab-325 | Pre-Made Lucatumumab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Lucatumumab | | CD40 | Whole mAb |  |
GMP-Bios-ab-326 | Pre-Made Lulizumab biosimilar, Single Domain Variable Fragment;L, Anti-CD28 Antibody: Anti-Tp44 therapeutic antibody | Lulizumab | | CD28 | Single Domain Variable Fragment;L |  |
GMP-Bios-ab-327 | Pre-Made Lumiliximab biosimilar, Whole mAb, Anti-FCER2/CD23 Antibody: Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF therapeutic antibody | Lumiliximab | | FCER2/CD23 | Whole mAb |  |
GMP-Bios-ab-328 | Pre-Made Lumretuzumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Lumretuzumab | | ERBB3/Erbb-3 | Whole mAb |  |
GMP-Bios-ab-329 | Pre-Made Lupartumab biosimilar, Whole mAb ADC, Anti-LYPD3 Antibody: Anti-C4.4A therapeutic antibody | Lupartumab | | LYPD3 | Whole mAb ADC |  |
GMP-Bios-ab-330 | Pre-Made Lusvertikimab biosimilar, Whole mAb, Anti-IL7R Antibody: Anti-CD127/CDW127 therapeutic antibody | Lusvertikimab | | IL7R | Whole mAb |  |
GMP-Bios-ab-331 | Pre-Made Lutikizumab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL1A;IL1B Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody | Lutikizumab | | IL1A;IL1B | Bispecific Dual Variable Domain IG |  |
GMP-Bios-ab-332 | Pre-Made Maftivimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody | Maftivimab | | Zaire Ebolavirus GP | Whole mAb |  |
GMP-Bios-ab-333 | Pre-Made Magrolimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody | Magrolimab | | CD47 | Whole mAb |  |
GMP-Bios-ab-334 | Pre-Made Manelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Manelimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-335 | Pre-Made Margetuximab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Margetuximab | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-ab-336 | Pre-Made Marstacimab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Marstacimab | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-ab-337 | Pre-Made Matuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Matuzumab | | EGFR | Whole mAb |  |
GMP-Bios-ab-338 | Pre-Made Mavezelimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody | Mavezelimab | Favezelimab | LAG3 | Whole mAb |  |
GMP-Bios-ab-339 | Pre-Made Mavrilimumab biosimilar, Whole mAb, Anti-CSF2RA Antibody: Anti-GMR/CD116/CSF2R/SMDP4/CDw116GMR-alpha/GMCSFR-alpha/GM-CSF-R-alpha therapeutic antibody | Mavrilimumab | | CSF2RA | Whole mAb |  |
GMP-Bios-ab-340 | Pre-Made Melrilimab biosimilar, Whole mAb, Anti-IL1RL1/ST2 Antibody: Anti-DER4/FIT-1/IL33R/T1 therapeutic antibody | Melrilimab | | IL1RL1/ST2 | Whole mAb |  |
GMP-Bios-ab-341 | Pre-Made Mepolizumab biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody | Mepolizumab | | IL5 | Whole mAb |  |
GMP-Bios-ab-342 | Pre-Made Mezagitamab biosimilar, Whole mAb, Anti-CD38 Antibody: Anti-ADPRC1/ADPRC 1 therapeutic antibody | Mezagitamab | | CD38 | Whole mAb |  |
GMP-Bios-ab-343 | Pre-Made Mibavademab biosimilar, Whole mAb, Anti-LEPR Antibody: Anti-CD295/OB-R/OBR therapeutic antibody | Mibavademab | | LEPR | Whole mAb |  |
GMP-Bios-ab-344 | Pre-Made Milatuzumab biosimilar, Whole mAb, Anti-CD74 Antibody: Anti-CLIP/DHLAG/HLADG/II/Ia-GAMMA/p33 therapeutic antibody | Milatuzumab | | CD74 | Whole mAb |  |
GMP-Bios-ab-345 | Pre-Made Mipasetamab biosimilar, Whole mAb, Anti-AXL Antibody: Anti-ARK/UFO/JTK11/Tyro7 therapeutic antibody | Mipasetamab | | AXL | Whole mAb |  |
GMP-Bios-ab-346 | Pre-Made Miptenalimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody | Miptenalimab | | LAG3 | Whole mAb |  |
GMP-Bios-ab-347 | Pre-Made Mirikizumab biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody: Anti-IL23P19/P19/SGRF therapeutic antibody | Mirikizumab | | IL23A/IL23 | Whole mAb |  |
GMP-Bios-ab-348 | Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody (Pre-made Miromavimab biosimilar,Whole mAb (Mouse)) | Miromavimab | | Rabies Virus Strain ERA GP Ectodomain Epitope G-II | Whole mAb (Mouse) |  |
GMP-Bios-ab-349 | Pre-Made Mirvetuximab biosimilar, Whole mAb ADC, Anti-FOLR1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody | Mirvetuximab | | FOLR1 | Whole mAb ADC |  |
GMP-Bios-ab-350 | Pre-Made Mirzotamab biosimilar, Whole mAb, Anti-CD276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody | Mirzotamab | | CD276 | Whole mAb |  |
GMP-Bios-ab-351 | Pre-Made Mitazalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Mitazalimab | Vanalimab | CD40 | Whole mAb |  |
GMP-Bios-ab-352 | Pre-Made Modakafusp biosimilar, Whole mAb Fusion: Anti-ADPRC therapeutic antibody | Modakafusp | | ADPRC | Whole mAb Fusion |  |
GMP-Bios-ab-353 | Pre-Made Modotuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Modotuximab | Zatuximab | EGFR | Whole mAb |  |
GMP-Bios-ab-354 | Pre-Made Mogamulizumab biosimilar, Whole mAb, Anti-CCR4 Antibody: Anti-CKR4/K5-5/CD194/CMKBR4/ChemR13/CC-CKR-4/HGCN:14099 therapeutic antibody | Mogamulizumab | | CCR4 | Whole mAb |  |
GMP-Bios-ab-355 | Pre-Made Monalizumab biosimilar, Whole mAb, Anti-KLRC1/NKG2A Antibody: Anti-CD159A/NKG2 therapeutic antibody | Monalizumab | | KLRC1/NKG2A | Whole mAb |  |
GMP-Bios-ab-356 | Pre-Made Mosunetuzumab biosimilar, Bispecific mAb, Anti-CD3E;MS4A1/CD20 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Mosunetuzumab | | CD3E;MS4A1/CD20 | Bispecific mAb |  |
GMP-Bios-ab-357 | Pre-Made Motavizumab biosimilar, Whole Mab: Anti-RSV gpF therapeutic antibody | Motavizumab | | RSV gpF | Whole mAb |  |
GMP-Bios-ab-358 | Pre-Made Moxetumomab biosimilar, Fv Fusion, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody | Moxetumomab | | CD22 | Fv Fusion |  |
GMP-Bios-ab-359 | Pre-Made Murlentamab biosimilar, Whole mAb, Anti-AMHR2 Antibody: Anti-AMHR/MISR2/MISRII/MRII therapeutic antibody | Murlentamab | | AMHR2 | Whole mAb |  |
GMP-Bios-ab-360 | Pre-Made Muromonab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Muromonab | | CD3E | Whole mAb |  |
GMP-Bios-ab-361 | Pre-Made Nadecnemab biosimilar, Whole mAb, Anti-GFRA3 Antibody: Anti-GDNFR3 therapeutic antibody | Nadecnemab | | GFRA3 | Whole mAb |  |
GMP-Bios-ab-362 | Pre-Made Namilumab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody | Namilumab | | CSF2 | Whole mAb |  |
GMP-Bios-ab-363 | Pre-Made Naptumomab biosimilar, Fab Fusion, Anti-TPBG Antibody: Anti-5T4/M6P1/5T4AG/WAIF1 therapeutic antibody | Naptumomab | | TPBG | Fab Fusion |  |
GMP-Bios-ab-364 | Pre-Made Naratuximab biosimilar, Whole mAb ADC, Anti-CD37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody | Naratuximab | | CD37 | Whole mAb ADC |  |
GMP-Bios-ab-365 | Pre-Made Narnatumab biosimilar, Whole mAb, Anti-MST1R/RON Antibody: Anti-RON/SEA/PTK8/CD136/NPCA3/CDw136 therapeutic antibody | Narnatumab | | MST1R/RON | Whole mAb |  |
GMP-Bios-ab-366 | Pre-Made Narsoplimab biosimilar, Whole mAb, Anti-MASP2 Antibody: Anti-MAP-2/MAP19/MASP-2/MASP1P1/sMAP therapeutic antibody | Narsoplimab | | MASP2 | Whole mAb |  |
GMP-Bios-ab-367 | Pre-Made Natalizumab biosimilar, Whole mAb, Anti-ITGA4 Antibody: Anti-CD49D/IA4 therapeutic antibody | Natalizumab | | ITGA4 | Whole mAb |  |
GMP-Bios-ab-368 | Pre-Made Navivumab biosimilar, Whole Mab: Anti-Influenza A HA therapeutic antibody | Navivumab | | Influenza A HA | Whole mAb |  |
GMP-Bios-ab-369 | Pre-Made Navicixizumab biosimilar, Bispecific mAb, Anti-DLL4;VEGFA Antibody: Anti-AOS6/delta4/hdelta2;VPF/VEGF/MVCD1 therapeutic antibody | Navicixizumab | | DLL4;VEGFA | Bispecific mAb |  |
GMP-Bios-ab-370 | Pre-Made Naxitamab biosimilar, Whole Mab: Anti-Ganglioside GD2 therapeutic antibody | Naxitamab | | Ganglioside GD2 | Whole mAb |  |
GMP-Bios-ab-371 | Pre-Made Necitumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Necitumumab | | EGFR | Whole mAb |  |
GMP-Bios-ab-372 | Pre-Made Nemolizumab biosimilar, Whole mAb, Anti-IL31RA/IL31R Antibody: Anti-CRL/CRL3/GLM-R/GLMR/GPL/IL-31RA/PLCA2/PRO21384/hGLM-R/zcytoR17 therapeutic antibody | Nemolizumab | | IL31RA/IL31R | Whole mAb |  |
GMP-Bios-ab-373 | Pre-Made Nesvacumab biosimilar, Whole mAb, Anti-ANGPT2 Antibody: Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody | Nesvacumab | | ANGPT2 | Whole mAb |  |
GMP-Bios-ab-374 | Pre-Made Netakimab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Netakimab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-375 | Pre-Made Nidanilimab biosimilar, Whole mAb, Anti-IL1RAP Antibody: Anti-C3orf13/IL-1RAcP/IL1R3 therapeutic antibody | Nidanilimab | Nadunolimab | IL1RAP | Whole mAb |  |
GMP-Bios-ab-376 | Pre-Made Nimacimab biosimilar, Whole mAb, Anti-CNR1/CB1 Antibody: Anti-CANN6/CB-R therapeutic antibody | Nimacimab | | CNR1/CB1 | Whole mAb |  |
GMP-Bios-ab-377 | Pre-Made Nimotuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Nimotuzumab | | EGFR | Whole mAb |  |
GMP-Bios-ab-378 | Pre-Made Nipocalimab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody | Nipocalimab | | FCGRT | Whole mAb |  |
GMP-Bios-ab-379 | Pre-Made Nirsevimab biosimilar, Whole Mab: Anti-RSV therapeutic antibody | Nirsevimab | | RSV | Whole mAb |  |
GMP-Bios-ab-380 | Pre-Made Nivatrotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-GD2;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Nivatrotamab | | GD2;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-381 | Pre-Made Nivolumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Nivolumab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-382 | Pre-Made Nurulimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Nurulimab | | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-383 | Pre-Made Obexelimab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody | Obexelimab | | CD19 | Whole mAb |  |
GMP-Bios-ab-384 | Pre-Made Obiltoxaximab biosimilar, Whole Mab: Anti-Anthrax Protective Antigen therapeutic antibody | Obiltoxaximab | | Anthrax Protective Antigen | Whole mAb |  |
GMP-Bios-ab-385 | Pre-Made Obinutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Obinutuzumab | Afutuzumab | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-386 | Pre-Made Obrindatamab biosimilar, Bispecific scFv with Domain Crossover, Anti-CD276;CD3E Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2;T3E/TCRE/IMD18 therapeutic antibody | Obrindatamab | | CD276;CD3E | Bispecific scFv with Domain Crossover |  |
GMP-Bios-ab-387 | Pre-Made Ocaratuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Ocaratuzumab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-388 | Pre-Made Ociperlimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody | Ociperlimab | | TIGIT | Whole mAb |  |
GMP-Bios-ab-389 | Pre-Made Ocrelizumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Ocrelizumab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-390 | Pre-Made Odesivimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody | Odesivimab | | Zaire Ebolavirus GP | Whole mAb |  |
GMP-Bios-ab-391 | Pre-Made Odronextamab biosimilar, Bispecific mAb, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody | Odronextamab | | MS4A1/CD20;CD3E | Bispecific mAb |  |
GMP-Bios-ab-392 | Pre-Made Ofatumumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Ofatumumab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-393 | Pre-Made Olaratumab biosimilar, Whole mAb, Anti-PDGFRA Antibody: Anti-CD140A/PDGFR-2/PDGFR2 therapeutic antibody | Olaratumab | | PDGFRA | Whole mAb |  |
GMP-Bios-ab-394 | Pre-Made Oleclumab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody | Oleclumab | | NT5E/CD73 | Whole mAb |  |
GMP-Bios-ab-395 | Pre-Made Olendalizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Olendalizumab | Lendalizumab | C5/CO5 | Whole mAb |  |
GMP-Bios-ab-396 | Pre-Made Olinvacimab biosimilar, Whole mAb, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody | Olinvacimab | Tanibirumab | KDR | Whole mAb |  |
GMP-Bios-ab-397 | Pre-Made Olokizumab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody | Olokizumab | | IL6 | Whole mAb |  |
GMP-Bios-ab-398 | Pre-Made Omalizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody | Omalizumab | | IGHE/IgE | Whole mAb |  |
GMP-Bios-ab-399 | Pre-Made Omburtamab biosimilar, Whole mAb Radiolabelled, Anti-CD276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody | Omburtamab | | CD276 | Whole mAb Radiolabelled |  |
GMP-Bios-ab-400 | Pre-Made Omodenbamab biosimilar, Whole Mab: Anti-SpA therapeutic antibody | Omodenbamab | | SpA | Whole mAb |  |
GMP-Bios-ab-401 | Pre-Made Onartuzumab biosimilar, Fab + di-Fc, Anti-MET Antibody: Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody | Onartuzumab | | MET | Fab + di-Fc |  |
GMP-Bios-ab-402 | Pre-Made Onfekafusp biosimilar, Whole mAb Fusion: Anti-FN extra domain B therapeutic antibody | Onfekafusp | | FN extra domain B | Whole mAb Fusion |  |
GMP-Bios-ab-403 | Pre-Made Ongericimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Ongericimab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-404 | Pre-Made Ontamalimab biosimilar, Whole Mab: Anti-MADCAM1 therapeutic antibody | Ontamalimab | | MADCAM1 | Whole mAb |  |
GMP-Bios-ab-405 | Pre-Made Ontuxizumab biosimilar, Whole mAb, Anti-CD248 Antibody: Anti-CD164L1/TEM1 therapeutic antibody | Ontuxizumab | | CD248 | Whole mAb |  |
GMP-Bios-ab-406 | Pre-Made Onvatilimab biosimilar, Whole mAb, Anti-VSIR Antibody: Anti-B7-H5/B7H5/C10orf54/DD1alpha/Dies1/GI24/PD-1H/PP2135/SISP1/VISTA therapeutic antibody | Onvatilimab | | VSIR | Whole mAb |  |
GMP-Bios-ab-407 | Pre-Made Opicinumab biosimilar, Whole mAb, Anti-LINGO1 Antibody: Anti-LERN1/LRRN6A/MRT64/UNQ201 therapeutic antibody | Opicinumab | | LINGO1 | Whole mAb |  |
GMP-Bios-ab-408 | Pre-Made Oportuzumab biosimilar, scFv, Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody | Oportuzumab | | EPCAM | scFv |  |
GMP-Bios-ab-409 | Pre-Made Opucolimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Opucolimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-410 | Pre-Made Ordesekimab biosimilar, Whole Mab: Anti-IL15 therapeutic antibody | Ordesekimab | | IL15 | Whole mAb |  |
GMP-Bios-ab-411 | Pre-Made Orilanolimab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody | Orilanolimab | | FCGRT | Whole mAb |  |
GMP-Bios-ab-412 | Pre-Made Orticumab biosimilar, Whole Mab: Anti-OxLDL therapeutic antibody | Orticumab | | OxLDL | Whole mAb |  |
GMP-Bios-ab-413 | Pre-Made Osocimab biosimilar, Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA therapeutic antibody | Osocimab | | F11 | Whole mAb |  |
GMP-Bios-ab-414 | Pre-Made Otelixizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Otelixizumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-415 | Pre-Made Otilimab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody | Otilimab | | CSF2 | Whole mAb |  |
GMP-Bios-ab-416 | Pre-Made Otlertuzumab biosimilar, di-scFv+Fc, Anti-CD37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody | Otlertuzumab | | CD37 | di-scFv+Fc |  |
GMP-Bios-ab-417 | Pre-Made Oxelumab biosimilar, Whole mAb, Anti-TNFSF4/OX40 Antibody: Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1 therapeutic antibody | Oxelumab | | TNFSF4/OX40 | Whole mAb |  |
GMP-Bios-ab-418 | Pre-Made Ozanezumab biosimilar, Whole mAb, Anti-RTN4 Antibody: Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2 therapeutic antibody | Ozanezumab | | RTN4 | Whole mAb |  |
GMP-Bios-ab-419 | Pre-Made Ozoralizumab biosimilar, Bispecific Single Domains (VH-VH'-VH), Anti-TNFA/TNF;ALB Antibody: Anti-DIF/TNF-alpha/TNFSF2/TNLG1F;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibody | Ozoralizumab | | TNFA/TNF;ALB | Bispecific Single Domains (VH-VH'-VH) |  |
GMP-Bios-ab-420 | Pre-Made Pabinafusp biosimilar, Whole mAb Fusion, Anti-TFRC Antibody: Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 therapeutic antibody | Pabinafusp | | TFRC | Whole mAb Fusion |  |
GMP-Bios-ab-421 | Pre-Made Pacanalotamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Pacanalotamab | | TNFRSF17; CD3E | Bispecific scFv |  |
GMP-Bios-ab-422 | Pre-Made Pacmilimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Pacmilimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-423 | Pre-Made Palivizumab biosimilar, Whole Mab: Anti-RSV gpF therapeutic antibody | Palivizumab | | RSV gpF | Whole mAb |  |
GMP-Bios-ab-424 | Pre-Made Pamrevlumab biosimilar, Whole mAb, Anti-CTGF/CCN2 Antibody: Anti-HCS24/IGFBP8/NOV2 therapeutic antibody | Pamrevlumab | | CTGF/CCN2 | Whole mAb |  |
GMP-Bios-ab-425 | Pre-Made Panitumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Panitumumab | | EGFR | Whole mAb |  |
GMP-Bios-ab-426 | Pre-Made PankoMab biosimilar, Whole mAb, Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | PankoMab | gatipotuzumab | MUC1 | Whole mAb |  |
GMP-Bios-ab-427 | Pre-Made Panobacumab biosimilar, Whole Mab: Anti-Serotype IATS O11 therapeutic antibody | Panobacumab | | Serotype IATS O11 | Whole mAb |  |
GMP-Bios-ab-428 | Pre-Made Parsatuzumab biosimilar, Whole mAb, Anti-EGFL7 Antibody: Anti-NEU1/VE-STATIN/ZNEU1 therapeutic antibody | Parsatuzumab | | EGFL7 | Whole mAb |  |
GMP-Bios-ab-429 | Pre-Made Pasotuxizumab biosimilar, Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody | Pasotuxizumab | | FOLH1/GCPII;CD3E | Bispecific scFv |  |
GMP-Bios-ab-430 | Pre-Made Pateclizumab biosimilar, Whole mAb, Anti-LTA Antibody: Anti-LT/TNFB/TNFSF1/TNLG1E therapeutic antibody | Pateclizumab | | LTA | Whole mAb |  |
GMP-Bios-ab-431 | Pre-Made Patritumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Patritumab | | ERBB3/Erbb-3 | Whole mAb |  |
GMP-Bios-ab-432 | Pre-Made Pavunalimab biosimilar, Bispecific Mixed mAb and scFv, Anti-LAG3;CTLA4/CTLA-4 Antibody: Anti-CD223;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Pavunalimab | Bavunalimab | LAG3;CTLA4/CTLA-4 | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-433 | Pre-Made Pavurutamab biosimilar, Bispecific scFv, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Pavurutamab | | TNFRSF17; CD3E | Bispecific scFv |  |
GMP-Bios-ab-434 | Pre-Made Pelgifatamab biosimilar, Whole mAb ADC, Anti-FOLH1/GCPII Antibody: Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP therapeutic antibody | Pelgifatamab | | FOLH1/GCPII | Whole mAb ADC |  |
GMP-Bios-ab-435 | Pre-Made Pembrolizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Pembrolizumab | Lambrolizumab | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-436 | Pre-Made Penpulimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Penpulimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-437 | Pre-Made Pepinemab biosimilar, Whole mAb, Anti-SEMA4D Antibody: Anti-A8/BB18/C9orf164/CD100/COLL4/GR3/M-sema-G/SEMAJ/coll-4 therapeutic antibody | Pepinemab | | SEMA4D | Whole mAb |  |
GMP-Bios-ab-438 | Pre-Made Perakizumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Perakizumab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-439 | Pre-Made Pertuzumab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Pertuzumab | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-ab-440 | Pre-Made Petosemtamab biosimilar, Bispecific mAb, Anti-EGFR;LGR5 Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;FEX/GPR49/GPR67/GRP49/HG38 therapeutic antibody | Petosemtamab | | EGFR;LGR5 | Bispecific mAb |  |
GMP-Bios-ab-441 | Pre-Made Pidilizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Pidilizumab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-442 | Pre-Made Pimivalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Pimivalimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-443 | Pre-Made Pimurutamab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Pimurutamab | | EGFR | Whole mAb |  |
GMP-Bios-ab-444 | Pre-Made Pinatuzumab biosimilar, Whole mAb ADC, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody | Pinatuzumab | | CD22 | Whole mAb ADC |  |
GMP-Bios-ab-445 | Pre-Made Placulumab biosimilar, Single Domain Variable Fragment (VL + Fc), Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Placulumab | | TNFA/TNF | Single Domain Variable Fragment (VL) + Fc |  |
GMP-Bios-ab-446 | Pre-Made Plamotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-MS4A1/CD20;CD3E Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7;T3E/TCRE/IMD18 therapeutic antibody | Plamotamab | | MS4A1/CD20;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-447 | Pre-Made Plozalizumab biosimilar, Whole mAb, Anti-CCR2 Antibody: Anti-CKR2/CD192/CKR2A/CKR2B/CMKBR2/MCP-1-R/CC-CKR-2 therapeutic antibody | Plozalizumab | | CCR2 | Whole mAb |  |
GMP-Bios-ab-448 | Pre-Made Pogalizumab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Pogalizumab | Vonlerolizumab | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-449 | Pre-Made Polatuzumab biosimilar, Whole mAb ADC, Anti-CD79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody | Polatuzumab | | CD79B | Whole mAb ADC |  |
GMP-Bios-ab-450 | Pre-Made Ponezumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Ponezumab | | APP | Whole mAb |  |
GMP-Bios-ab-451 | Pre-Made Ponsegromab biosimilar, Whole mAb, Anti-GDF15 Antibody: Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB therapeutic antibody | Ponsegromab | | GDF15 | Whole mAb |  |
GMP-Bios-ab-452 | Pre-Made Porgaviximab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody | Porgaviximab | | Zaire Ebolavirus GP | Whole mAb |  |
GMP-Bios-ab-453 | Pre-Made Plonmarlimab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody | Plonmarlimab | | CSF2 | Whole mAb |  |
GMP-Bios-ab-454 | Pre-Made Praluzatamab biosimilar, Whole mAb, Anti-CD166/ALCAM Antibody: Anti-MEMD therapeutic antibody | Praluzatamab | | CD166/ALCAM | Whole mAb |  |
GMP-Bios-ab-455 | Pre-Made Prasinezumab biosimilar, Whole mAb, Anti-SNCA Antibody: Anti-NACP/PARK1/PARK4/PD1 therapeutic antibody | Prasinezumab | | SNCA | Whole mAb |  |
GMP-Bios-ab-456 | Pre-Made Prezalumab biosimilar, Whole mAb, Anti-ICOSLG/B7RP1 Antibody: Anti-B7-H2/B7H2/B7h/CD275/GL50/ICOS-L/ICOSL/LICOS therapeutic antibody | Prezalumab | | ICOSLG/B7RP1 | Whole mAb |  |
GMP-Bios-ab-457 | Pre-Made Pritoxaximab biosimilar, Whole Mab: Anti-Shiga Toxin Type 1 therapeutic antibody | Pritoxaximab | | Shiga Toxin Type 1 | Whole mAb |  |
GMP-Bios-ab-458 | Pre-Made Prolgolimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Prolgolimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-459 | Pre-Made Pucotenlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Pucotenlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-460 | Pre-Made Quavonlimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Quavonlimab | | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-461 | Pre-Made Quetmolimab biosimilar, Whole mAb, Anti-CX3CL1 Antibody: Anti-ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin therapeutic antibody | Quetmolimab | | CX3CL1 | Whole mAb |  |
GMP-Bios-ab-462 | Pre-Made Quilizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody | Quilizumab | | IGHE/IgE | Whole mAb |  |
GMP-Bios-ab-463 | Pre-Made Racotumomab biosimilar, Whole Mab: Anti-Idiotope of Anti-NeuGc-ganliosides therapeutic antibody | Racotumomab | | Idiotope of anti-NeuGc-ganliosides | Whole mAb |  |
GMP-Bios-ab-464 | Pre-Made Radretumab biosimilar, di-scFv + CH4: Anti-FN extra domain B therapeutic antibody | Radretumab | | FN extra domain B | di-scFv + CH4 |  |
GMP-Bios-ab-465 | Pre-Made Rafivirumab biosimilar, Whole Mab: Anti-RV Antigenic Site III therapeutic antibody | Rafivirumab | | RV Antigenic Site III | Whole mAb |  |
GMP-Bios-ab-466 | Pre-Made Ragifilimab biosimilar, Whole mAb, Anti-TNFRSF18 Antibody: Anti-AITR/CD357/ENERGEN/GITR/GITR-D therapeutic antibody | Ragifilimab | | TNFRSF18 | Whole mAb |  |
GMP-Bios-ab-467 | Pre-Made Ralpancizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Ralpancizumab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-468 | Pre-Made Ramucirumab biosimilar, Whole mAb, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody | Ramucirumab | | KDR | Whole mAb |  |
GMP-Bios-ab-469 | Pre-Made Ranevetmab biosimilar, Canine Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody | Ranevetmab | | NGFB/NGF | Canine Whole mAb |  |
GMP-Bios-ab-470 | Pre-Made Ranibizumab biosimilar, Fab, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody | Ranibizumab | | VEGFA | Fab |  |
GMP-Bios-ab-471 | Pre-Made Ravagalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Ravagalimab | | CD40 | Whole mAb |  |
GMP-Bios-ab-472 | Pre-Made Ravulizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Ravulizumab | | C5/CO5 | Whole mAb |  |
GMP-Bios-ab-473 | Pre-Made Recaticimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Recaticimab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-474 | Pre-Made Refanezumab biosimilar, Whole mAb, Anti-MAG Antibody: Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75 therapeutic antibody | Refanezumab | | MAG | Whole mAb |  |
GMP-Bios-ab-476 | Pre-Made Relatlimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody | Relatlimab | | LAG3 | Whole mAb |  |
GMP-Bios-ab-477 | Pre-Made Relfovetmab biosimilar, Feline Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody | Relfovetmab | | NGFB/NGF | Feline Whole mAb |  |
GMP-Bios-ab-478 | Pre-Made Remtolumab biosimilar, Bispecific Dual Variable Domain IG: Anti-IL17A/IL17;TNFA/TNF therapeutic antibody | Remtolumab | | IL17A/IL17; TNFA/TNF | Bispecific Dual Variable Domain IG |  |
GMP-Bios-ab-479 | Pre-Made Reslizumab biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody | Reslizumab | | IL5 | Whole mAb |  |
GMP-Bios-ab-480 | Pre-Made Retifanlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Retifanlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-481 | Pre-Made Retlirafusp biosimilar, Whole mAb Fusion, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Retlirafusp | | CD274/PD-L1 | Whole mAb Fusion |  |
GMP-Bios-ab-482 | Pre-Made Revdofilimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Revdofilimab | | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-483 | Pre-Made Rilotumumab biosimilar, Whole mAb, Anti-HGF Antibody: Anti-DFNB39/F-TCF/HPTA/SF therapeutic antibody | Rilotumumab | | HGF | Whole mAb |  |
GMP-Bios-ab-484 | Pre-Made Rinucumab biosimilar, Whole mAb, Anti-PDGFRB Antibody: Anti-IMF1/KOGS/IBGC4/JTK12/PDGFR/PENTT/CD140B/PDGFR1/PDGFR-1 therapeutic antibody | Rinucumab | | PDGFRB | Whole mAb |  |
GMP-Bios-ab-485 | Pre-Made Ripertamab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Ripertamab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-486 | Pre-Made Risankizumab biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody: Anti-IL23P19/P19/SGRF therapeutic antibody | Risankizumab | | IL23A/IL23 | Whole mAb |  |
GMP-Bios-ab-487 | Pre-Made Rituximab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Rituximab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-488 | Pre-Made Rivabazumab biosimilar, Fab: Anti-PcrV type III secretion system therapeutic antibody | Rivabazumab | | PcrV type III secretion system | Fab |  |
GMP-Bios-ab-489 | Pre-Made Robatumumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Robatumumab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-490 | Pre-Made Roledumab biosimilar, Whole mAb, Anti-RHD Antibody: Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI therapeutic antibody | Roledumab | | RHD | Whole mAb |  |
GMP-Bios-ab-491 | Pre-Made Rolinsatamab biosimilar, Whole mAb ADC, Anti-PRLR Antibody: Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic antibody | Rolinsatamab | | PRLR | Whole mAb ADC |  |
GMP-Bios-ab-492 | Pre-Made Romilkimab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL13;IL4 Antibody: Anti-IL-13/P600;BCGF-1/BCGF1/BSF-1/BSF1/IL-4 therapeutic antibody | Romilkimab | | IL13;IL4 | Bispecific Dual Variable Domain IG |  |
GMP-Bios-ab-493 | Pre-Made Romosozumab biosimilar, Whole mAb, Anti-SOST Antibody: Anti-CDD/DAND6/VBCH therapeutic antibody | Romosozumab | | SOST | Whole mAb |  |
GMP-Bios-ab-494 | Pre-Made Rontalizumab biosimilar, Whole mAb, Anti-IFNA1 Antibody: Anti-IFL/IFN3/leIF DD therapeutic antibody | Rontalizumab | | IFNA1 | Whole mAb |  |
GMP-Bios-ab-495 | Pre-Made Rosmantuzumab biosimilar, Whole mAb, Anti-RSPO3 Antibody: Anti-CRISTIN1/PWTSR/THSD2 therapeutic antibody | Rosmantuzumab | | RSPO3 | Whole mAb |  |
GMP-Bios-ab-496 | Pre-Made Rosopatamab biosimilar, Whole mAb, Anti-FOLH1/GCPII Antibody: Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP therapeutic antibody | Rosopatamab | | FOLH1/GCPII | Whole mAb |  |
GMP-Bios-ab-497 | Pre-Made Rovalpituzumab biosimilar, Whole mAb ADC, Anti-DLL3 Antibody: Anti-SCDO1 therapeutic antibody | Rovalpituzumab | | DLL3 | Whole mAb ADC |  |
GMP-Bios-ab-498 | Pre-Made Rozanolixizumab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody | Rozanolixizumab | | FCGRT | Whole mAb |  |
GMP-Bios-ab-499 | Pre-Made Rozibafusp biosimilar, Whole mAb Fusion, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody | Rozibafusp | | ICOS | Whole mAb Fusion |  |
GMP-Bios-ab-500 | Pre-Made Runimotamab biosimilar, Bispecific mAb, Anti-ERBB2/HER2;CD3E Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;T3E/TCRE/IMD18 therapeutic antibody | Runimotamab | | ERBB2/HER2;CD3E | Bispecific mAb |  |
GMP-Bios-ab-501 | Pre-Made Ruplizumab biosimilar, Whole mAb, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody | Ruplizumab | | CD40LG | Whole mAb |  |
GMP-Bios-ab-502 | Pre-Made Sabatolimab biosimilar, Whole mAb, Anti-HAVCR2/TIM3 Antibody: Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2 therapeutic antibody | Sabatolimab | | HAVCR2/TIM3 | Whole mAb |  |
GMP-Bios-ab-503 | Pre-Made Sacituzumab biosimilar, Whole mAb ADC, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody | Sacituzumab | | TACSTD2 | Whole mAb ADC |  |
GMP-Bios-ab-504 | Pre-Made Samalizumab biosimilar, Whole mAb, Anti-CD200 Antibody: Anti-MRC/MOX1/MOX2/OX-2 therapeutic antibody | Samalizumab | | CD200 | Whole mAb |  |
GMP-Bios-ab-505 | Pre-Made Samrotamab biosimilar, Whole mAb ADC, Anti-LRRC15 Antibody: Anti-LIB therapeutic antibody | Samrotamab | | LRRC15 | Whole mAb ADC |  |
GMP-Bios-ab-506 | Pre-Made Sapelizumab biosimilar, Whole mAb, Anti-IL6R Antibody: Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80 therapeutic antibody | Sapelizumab | Satralizumab | IL6R | Whole mAb |  |
GMP-Bios-ab-507 | Pre-Made Sarilumab biosimilar, Whole mAb, Anti-IL6R Antibody: Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80 therapeutic antibody | Sarilumab | | IL6R | Whole mAb |  |
GMP-Bios-ab-508 | Pre-Made Sasanlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Sasanlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-509 | Pre-Made Satralizumab biosimilar, Whole mAb, Anti-IL6R Antibody: Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80 therapeutic antibody | Satralizumab | Sapelizumab | IL6R | Whole mAb |  |
GMP-Bios-ab-510 | Pre-Made Secukinumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Secukinumab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-511 | Pre-Made Selicrelumab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Selicrelumab | | CD40 | Whole mAb |  |
GMP-Bios-ab-512 | Pre-Made Semorinemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40 therapeutic antibody | Semorinemab | | MAPT | Whole mAb |  |
GMP-Bios-ab-513 | Pre-Made Serclutamab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Serclutamab | | EGFR | Whole mAb ADC |  |
GMP-Bios-ab-514 | Pre-Made Seribantumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody | Seribantumab | | ERBB3/Erbb-3 | Whole mAb |  |
GMP-Bios-ab-515 | Pre-Made Serplulimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Serplulimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-516 | Pre-Made Setoxaximab biosimilar, Whole Mab: Anti-Shiga Toxin Type 2 therapeutic antibody | Setoxaximab | | Shiga Toxin Type 2 | Whole mAb |  |
GMP-Bios-ab-517 | Pre-Made Setrusumab biosimilar, Whole mAb, Anti-SOST Antibody: Anti-CDD/DAND6/VBCH therapeutic antibody | Setrusumab | | SOST | Whole mAb |  |
GMP-Bios-ab-518 | Pre-Made Sibeprenlimab biosimilar, Whole mAb, Anti-TNFSF13/APRIL Antibody: Anti-CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2 therapeutic antibody | Sibeprenlimab | | TNFSF13/APRIL | Whole mAb |  |
GMP-Bios-ab-519 | Pre-Made Sifalimumab biosimilar, Whole mAb, Anti-IFNA1 Antibody: Anti-IFL/IFN3/leIF DD therapeutic antibody | Sifalimumab | | IFNA1 | Whole mAb |  |
GMP-Bios-ab-520 | Pre-Made Siltuximab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody | Siltuximab | | IL6 | Whole mAb |  |
GMP-Bios-ab-521 | Pre-Made Simlukafusp biosimilar, Whole mAb Fusion, Anti-FAP Antibody: Anti-FAPA/SIMP/DPPIV/FAPalpha therapeutic antibody | Simlukafusp | | FAP | Whole mAb Fusion |  |
GMP-Bios-ab-522 | Pre-Made Simtuzumab biosimilar, Whole mAb, Anti-LOXL2 Antibody: Anti-LOR/LOR2/WS9-14 therapeutic antibody | Simtuzumab | | LOXL2 | Whole mAb |  |
GMP-Bios-ab-523 | Pre-Made Sintilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Sintilimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-524 | Pre-Made Sirtratumab biosimilar, Whole mAb ADC, Anti-SLITRK6 Antibody: Anti-DFNMYP therapeutic antibody | Sirtratumab | | SLITRK6 | Whole mAb ADC |  |
GMP-Bios-ab-525 | Pre-Made Sirukumab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody | Sirukumab | | IL6 | Whole mAb |  |
GMP-Bios-ab-526 | Pre-Made Sofituzumab biosimilar, Whole mAb ADC, Anti-MUC16 Antibody: Anti-CA125 therapeutic antibody | Sofituzumab | | MUC16 | Whole mAb ADC |  |
GMP-Bios-ab-527 | Pre-Made Solanezumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody | Solanezumab | | APP | Whole mAb |  |
GMP-Bios-ab-528 | Pre-Made Solitomab biosimilar, Bispecific scFv, Anti-EPCAM;CD3E Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1;T3E/TCRE/IMD18 therapeutic antibody | Solitomab | | EPCAM;CD3E | Bispecific scFv |  |
GMP-Bios-ab-529 | Pre-Made Sotigalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Sotigalimab | | CD40 | Whole mAb |  |
GMP-Bios-ab-530 | Pre-Made Sotrovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Sotrovimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-531 | Pre-Made Spartalizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Spartalizumab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-532 | Pre-Made Spesolimab biosimilar, Whole mAb, Anti-IL36RN/IL-36R Antibody: Anti-FIL1/FIL1(DELTA)/FIL1D/IL1F5/IL1HY1/IL1L1/IL1RP3/IL36RA/PSORP/PSORS14 therapeutic antibody | Spesolimab | | IL36RN/IL-36R | Whole mAb |  |
GMP-Bios-ab-533 | Pre-Made Sudubrilimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Sudubrilimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-534 | Pre-Made Sugemalimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Sugemalimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-535 | Pre-Made Suptavumab biosimilar, Whole Mab: Anti-RSV gpF therapeutic antibody | Suptavumab | | RSV gpF | Whole mAb |  |
GMP-Bios-ab-536 | Pre-Made Surzebiclimab biosimilar, Whole mAb, Anti-HAVCR2/TIM3 Antibody: Anti-CD366/KIM-3/SPTCL/TIMD3/Tim-3/TIMD-3/HAVcr-2 therapeutic antibody | Surzebiclimab | | HAVCR2/TIM3 | Whole mAb |  |
GMP-Bios-ab-537 | Pre-Made Sutimlimab biosimilar, Whole mAb, Anti-C1S Antibody: Anti-EDSPD2 therapeutic antibody | Sutimlimab | | C1S | Whole mAb |  |
GMP-Bios-ab-538 | Pre-Made Suvizumab biosimilar, Whole Mab: Anti-HIV-1 gp120 therapeutic antibody | Suvizumab | | HIV-1 gp120 | Whole mAb |  |
GMP-Bios-ab-539 | Pre-Made Suvratoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody | Suvratoxumab | | Toxin A | Whole mAb |  |
GMP-Bios-ab-540 | Pre-Made Tabalumab biosimilar, Whole mAb, Anti-TNFSF13B Antibody: Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4 therapeutic antibody | Tabalumab | | TNFSF13B | Whole mAb |  |
GMP-Bios-ab-541 | Pre-Made Tabituximab biosimilar, Whole mAb ADC, Anti-FZD10 Antibody: Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic antibody | Tabituximab | | FZD10 | Whole mAb ADC |  |
GMP-Bios-ab-542 | Pre-Made Tadocizumab biosimilar, Fab, Anti-ITGA2B;ITGB3 Antibody: Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2 therapeutic antibody | Tadocizumab | | ITGA2B;ITGB3 | Fab |  |
GMP-Bios-ab-543 | Pre-Made Tafasitamab biosimilar, Whole mAb, Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody | Tafasitamab | | CD19 | Whole mAb |  |
GMP-Bios-ab-544 | Pre-Made Tafolecimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody | Tafolecimab | | PCSK9 | Whole mAb |  |
GMP-Bios-ab-545 | Pre-Made Talacotuzumab biosimilar, Whole mAb, Anti-IL3RA Antibody: Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic antibody | Talacotuzumab | | IL3RA | Whole mAb |  |
GMP-Bios-ab-546 | Pre-Made Talquetamab biosimilar, Bispecific mAb, Anti-GPRC5D;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Talquetamab | | GPRC5D;CD3E | Bispecific mAb |  |
GMP-Bios-ab-547 | Pre-Made Tamrintamab biosimilar, Whole mAb ADC, Anti-DPEP3 Antibody: Anti-MBD3 therapeutic antibody | Tamrintamab | | DPEP3 | Whole mAb ADC |  |
GMP-Bios-ab-548 | Pre-Made Tamtuvetmab biosimilar, Canine Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody | Tamtuvetmab | | CD52 | Canine Whole mAb |  |
GMP-Bios-ab-549 | Pre-Made Tanezumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody | Tanezumab | | NGFB/NGF | Whole mAb |  |
GMP-Bios-ab-550 | Pre-Made Tanibirumab biosimilar, Whole mAb, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody | Tanibirumab | olinvacimab | KDR | Whole mAb |  |
GMP-Bios-ab-551 | Pre-Made Tarextumab biosimilar, Whole mAb, Anti-NOTCH2&3 Antibody: Anti-AGS2/HJCYS/hN2;CADASIL/CADASIL1/CASIL/IMF2/LMNS therapeutic antibody | Tarextumab | | NOTCH2&3 | Whole mAb |  |
GMP-Bios-ab-552 | Pre-Made Tarlatamab biosimilar, Bispecific scFv, Anti-DLL3;CD3E Antibody: Anti-SCDO1;T3E/TCRE/IMD18 therapeutic antibody | Tarlatamab | | DLL3;CD3E | Bispecific scFv |  |
GMP-Bios-ab-553 | Pre-Made Tavolimab biosimilar, Whole mAb, Anti-TNFSF4/OX40 Antibody: Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1 therapeutic antibody | Tavolimab | Tavolixizumab | TNFSF4/OX40 | Whole mAb |  |
GMP-Bios-ab-554 | Pre-Made Tavolixizumab biosimilar, Whole mAb, Anti-TNFSF4/OX40 Antibody: Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1 therapeutic antibody | Tavolixizumab | Tavolimab | TNFSF4/OX40 | Whole mAb |  |
GMP-Bios-ab-555 | Pre-Made Tebentafusp biosimilar, scFv Fusion, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Tebentafusp | | CD3E | scFv Fusion |  |
GMP-Bios-ab-556 | Pre-Made Tebotelimab biosimilar, Bispecific scFv with Crossover, Anti-PDCD1/PD-1;LAG3 Antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD223 therapeutic antibody | Tebotelimab | | PDCD1/PD-1;LAG3 | Bispecific scFv with Crossover |  |
GMP-Bios-ab-557 | Pre-Made Teclistamab biosimilar, Bispecific mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Teclistamab | | TNFRSF17;CD3E | Bispecific mAb |  |
GMP-Bios-ab-558 | Pre-Made Telazorlimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Telazorlimab | | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-559 | Pre-Made Telisotuzumab biosimilar, Whole mAb ADC, Anti-MET Antibody: Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody | Telisotuzumab | | MET | Whole mAb ADC |  |
GMP-Bios-ab-561 | Pre-Made Tenatumomab biosimilar, Whole mAb Radiolabelled, Anti-TNC Antibody: Anti-150-225/DFNA56/GMEM/GP/HXB/JI/TN/TN-C therapeutic antibody | Tenatumomab | | TNC | Whole mAb Radiolabelled |  |
GMP-Bios-ab-562 | Pre-Made Teplizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Teplizumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-563 | Pre-Made Tepoditamab biosimilar, Bispecific mAb, Anti-CLEC12A/CD371;CD3E Antibody: Anti-CLL-1/CLL1/DCAL-2/MICL;T3E/TCRE/IMD18 therapeutic antibody | Tepoditamab | | CLEC12A/CD371;CD3E | Bispecific mAb |  |
GMP-Bios-ab-564 | Pre-Made Teprotumumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody | Teprotumumab | | IGF1R | Whole mAb |  |
GMP-Bios-ab-565 | Pre-Made Tesidolumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Tesidolumab | | C5/CO5 | Whole mAb |  |
GMP-Bios-ab-566 | Pre-Made Tesnatilimab biosimilar, Whole mAb, Anti-KLRK1 Antibody: Anti-CD314/D12S2489E/KLR/NKG2-D/NKG2D therapeutic antibody | Tesnatilimab | | KLRK1 | Whole mAb |  |
GMP-Bios-ab-567 | Pre-Made Tezepelumab biosimilar, Whole Mab: Anti-TSLP therapeutic antibody | Tezepelumab | | TSLP | Whole mAb |  |
GMP-Bios-ab-568 | Pre-Made Tibulizumab biosimilar, Bispecific Mixed mAb and scFv, Anti-TNFSF13B;IL17A/IL17 Antibody: Anti-BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4;CTLA-8/CTLA8A therapeutic antibody | Tibulizumab | | TNFSF13B;IL17A/IL17 | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-569 | Pre-Made Ticilimumab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Ticilimumab | tremelimumab | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-570 | Pre-Made Tidutamab biosimilar, Bispecific Mixed mAb and scFv, Anti-SSTR2;CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Tidutamab | | SSTR2;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-571 | Pre-Made Tigatuzumab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody | Tigatuzumab | | TNFRSF10B/TRAIL-R2 | Whole mAb |  |
GMP-Bios-ab-572 | Pre-Made Tilavonemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40 therapeutic antibody | Tilavonemab | | MAPT | Whole mAb |  |
GMP-Bios-ab-573 | Pre-Made Tildrakizumab biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody: Anti-IL23P19/P19/SGRF therapeutic antibody | Tildrakizumab | | IL23A/IL23 | Whole mAb |  |
GMP-Bios-ab-574 | Pre-Made Tilogotamab biosimilar, Whole mAb, Anti-TNFRSF10B/TRAIL-R2 Antibody: Anti-DR5/CD262/KILLER/TRICK2/TRICKB/ZTNFR9/TRAILR2/TRICK2A/TRICK2B/KILLER/DR5 therapeutic antibody | Tilogotamab | | TNFRSF10B/TRAIL-R2 | Whole mAb |  |
GMP-Bios-ab-575 | Pre-Made Tilvestamab biosimilar, Whole mAb, Anti-AXL Antibody: Anti-ARK/UFO/JTK11/Tyro7 therapeutic antibody | Tilvestamab | | AXL | Whole mAb |  |
GMP-Bios-ab-576 | Pre-Made Timigutuzumab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Timigutuzumab | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-ab-577 | Pre-Made Timolumab biosimilar, Whole mAb, Anti-AOC3 Antibody: Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic antibody | Timolumab | | AOC3 | Whole mAb |  |
GMP-Bios-ab-578 | Pre-Made Tinurilimab biosimilar, Whole mAb, Anti-CEACAM6/CD66c Antibody: Anti-CEAL/NCA therapeutic antibody | Tinurilimab | | CEACAM6/CD66c | Whole mAb |  |
GMP-Bios-ab-579 | Pre-Made Tiragolumab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody | Tiragolumab | | TIGIT | Whole mAb |  |
GMP-Bios-ab-580 | Pre-Made Tirnovetmab biosimilar, Whole mAb (Canine): Anti-IL31 (Canine) therapeutic antibody | Tirnovetmab | | IL31 (Canine) | Whole mAb (Canine) |  |
GMP-Bios-ab-581 | Pre-Made Tislelizumab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Tislelizumab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-582 | Pre-Made Tisotumab biosimilar, Whole mAb, Anti-F3 Antibody: Anti-CD142/TF/TFA therapeutic antibody | Tisotumab | | F3 | Whole mAb |  |
GMP-Bios-ab-583 | Pre-Made Tixagevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Tixagevimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-584 | Pre-Made Tocilizumab biosimilar, Whole mAb, Anti-IL6R Antibody: Anti-CD126/HIES5/IL-1Ra-1A/IL6Q/IL6QTL/gp80 therapeutic antibody | Tocilizumab | | IL6R | Whole mAb |  |
GMP-Bios-ab-585 | Pre-Made Tomaralimab biosimilar, Whole mAb, Anti-TLR2 Antibody: Anti-CD282/TIL4 therapeutic antibody | Tomaralimab | | TLR2 | Whole mAb |  |
GMP-Bios-ab-586 | Pre-Made Tomuzotuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Tomuzotuximab | | EGFR | Whole mAb |  |
GMP-Bios-ab-587 | Pre-Made Toripalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Toripalimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-588 | Pre-Made Torudokimab biosimilar, Whole mAb, Anti-IL33 Antibody: Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV therapeutic antibody | Torudokimab | | IL33 | Whole mAb |  |
GMP-Bios-ab-589 | Pre-Made Tosatoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody | Tosatoxumab | | Toxin A | Whole mAb |  |
GMP-Bios-ab-590 | Pre-Made Tovetumab biosimilar, Whole mAb, Anti-PDGFRA Antibody: Anti-CD140A/PDGFR-2/PDGFR2 therapeutic antibody | Tovetumab | | PDGFRA | Whole mAb |  |
GMP-Bios-ab-591 | Pre-Made Tozorakimab biosimilar, Whole mAb, Anti-IL33 Antibody: Anti-C9orf26/DVS27/IL1F11/NF-HEV/NFEHEV therapeutic antibody | Tozorakimab | | IL33 | Whole mAb |  |
GMP-Bios-ab-592 | Pre-Made Tralokinumab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody | Tralokinumab | | IL13 | Whole mAb |  |
GMP-Bios-ab-593 | Pre-Made Trastuzumab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Trastuzumab | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-ab-594 | Pre-Made Tregalizumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Tregalizumab | | CD4 | Whole mAb |  |
GMP-Bios-ab-595 | Pre-Made Tremelimumab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Tremelimumab | Ticilimumab | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-596 | Pre-Made Trevogrumab biosimilar, Whole mAb, Anti-MSTN/GDF-8 Antibody: Anti-GDF8/MSLHP therapeutic antibody | Trevogrumab | | MSTN/GDF-8 | Whole mAb |  |
GMP-Bios-ab-597 | Pre-Made Tusamitamab biosimilar, Whole mAb, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody | Tusamitamab | | CEACAM5/CD66e | Whole mAb |  |
GMP-Bios-ab-598 | Pre-Made Ublituximab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Ublituximab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-599 | Pre-Made Uliledlimab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody | Uliledlimab | | NT5E/CD73 | Whole mAb |  |
GMP-Bios-ab-600 | Pre-Made Ulocuplumab biosimilar, Whole mAb, Anti-CXCR4 Antibody: Anti-FB22/HM89/LAP3/LCR1/NPYR/WHIM/CD184/LAP-3/LESTR/NPY3R/NPYRL/WHIMS/HSY3RR/NPYY3R/WHIMS1/D2S201E therapeutic antibody | Ulocuplumab | | CXCR4 | Whole mAb |  |
GMP-Bios-ab-602 | Pre-Made Upifitamab biosimilar, Whole mAb, Anti-SLC34A2 Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic antibody | Upifitamab | | SLC34A2 | Whole mAb |  |
GMP-Bios-ab-603 | Pre-Made Urabrelimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody | Urabrelimab | | CD47 | Whole mAb |  |
GMP-Bios-ab-604 | Pre-Made Urelumab biosimilar, Whole mAb, Anti-TNFRSF9/CD137 Antibody: Anti-ILA/4-1BB/CDw137 therapeutic antibody | Urelumab | | TNFRSF9/CD137 | Whole mAb |  |
GMP-Bios-ab-605 | Pre-Made Ustekinumab biosimilar, Whole mAb, Anti-IL12B Antibody: Anti-CLMF/CLMF2/IL-12B/IMD28/IMD29/NKSF/NKSF2 therapeutic antibody | Ustekinumab | | IL12B | Whole mAb |  |
GMP-Bios-ab-606 | Pre-Made Utomilumab biosimilar, Whole mAb, Anti-TNFRSF9/CD137 Antibody: Anti-ILA/4-1BB/CDw137 therapeutic antibody | Utomilumab | | TNFRSF9/CD137 | Whole mAb |  |
GMP-Bios-ab-607 | Pre-Made Vadastuximab biosimilar, Whole mAb ADC, Anti-CD33 Antibody: Anti-p67/SIGLEC3/SIGLEC-3 therapeutic antibody | Vadastuximab | | CD33 | Whole mAb ADC |  |
GMP-Bios-ab-608 | Pre-Made Valanafusp biosimilar, Whole mAb Fusion, Anti-INSR Antibody: Anti-CD220/HHF5 therapeutic antibody | Valanafusp | | INSR | Whole mAb Fusion |  |
GMP-Bios-ab-609 | Pre-Made Vanalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody | Vanalimab | Mitazalimab | CD40 | Whole mAb |  |
GMP-Bios-ab-610 | Pre-Made Vandortuzumab biosimilar, Whole mAb ADC, Anti-STEAP1 Antibody: Anti-PRSS24/STEAP therapeutic antibody | Vandortuzumab | | STEAP1 | Whole mAb ADC |  |
GMP-Bios-ab-611 | Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody | Vantictumab | | FZD Family | Whole mAb |  |
GMP-Bios-ab-612 | Pre-Made Vanucizumab biosimilar, Bispecific mAb, Anti-ANGPT2;VEGFA Antibody: Anti-AGPT2/ANG2/LMPHM10;VPF/VEGF/MVCD1 therapeutic antibody | Vanucizumab | | ANGPT2;VEGFA | Bispecific mAb |  |
GMP-Bios-ab-613 | Pre-Made Varisacumab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody | Varisacumab | | VEGFA | Whole mAb |  |
GMP-Bios-ab-614 | Pre-Made Varlilumab biosimilar, Whole mAb, Anti-CD27 Antibody: Anti-T14/S152/Tp55/TNFRSF7/S152. LPFS2 therapeutic antibody | Varlilumab | | CD27 | Whole mAb |  |
GMP-Bios-ab-615 | Pre-Made Vatelizumab biosimilar, Whole mAb, Anti-ITGA2 Antibody: Anti-BR/CD49B/GPIa/HPA-5/VLA-2/VLAA2 therapeutic antibody | Vatelizumab | | ITGA2 | Whole mAb |  |
GMP-Bios-ab-616 | Pre-Made Vedolizumab biosimilar, Whole mAb, Anti-ITGA4;ITGB7 Antibody: Anti-CD49D/IA4 therapeutic antibody | Vedolizumab | | ITGA4;ITGB7 | Whole mAb |  |
GMP-Bios-ab-617 | Pre-Made Veltuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Veltuzumab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-618 | Pre-Made Vesencumab biosimilar, Whole mAb, Anti-NRP1 Antibody: Anti-BDCA4/CD304/NP1/NRP/VEGF165R therapeutic antibody | Vesencumab | | NRP1 | Whole mAb |  |
GMP-Bios-ab-619 | Pre-Made Vibecotamab biosimilar, Bispecific Mixed mAb and scFv, Anti-IL3RA;CD3E Antibody: Anti-CD123/IL3RX/IL3RY/IL3RAY/hIL-3Ra;T3E/TCRE/IMD18 therapeutic antibody | Vibecotamab | | IL3RA;CD3E | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-620 | Pre-Made Vibostolimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody | Vibostolimab | | TIGIT | Whole mAb |  |
GMP-Bios-ab-621 | Pre-Made Vilobelimab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Vilobelimab | | C5/CO5 | Whole mAb |  |
GMP-Bios-ab-622 | Pre-Made Visilizumab biosimilar, Whole mAb, Anti-CD3E Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Visilizumab | | CD3E | Whole mAb |  |
GMP-Bios-ab-623 | Pre-Made Vixarelimab biosimilar, Whole mAb, Anti-OSMR Antibody: Anti-IL-31R-beta/IL-31RB/OSMRB/OSMRbeta/PLCA1 therapeutic antibody | Vixarelimab | | OSMR | Whole mAb |  |
GMP-Bios-ab-624 | Pre-Made Vixtimotamab biosimilar, Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody)), Anti-CD3E;CD33 Antibody: Anti-T3E/TCRE/IMD18;p67/SIGLEC3/SIGLEC-3 therapeutic antibody | Vixtimotamab | | CD3E;CD33 | Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody) |  |
GMP-Bios-ab-625 | Pre-Made Vobarilizumab biosimilar, Bispecific Single Domains (VH-VH'), Anti-IL6R;ALB Antibody: Anti-CD126/HIES5/IL-1Ra/IL-6R/IL-6R-1/IL-6RA/IL6Q/IL6QTL/IL6RA/IL6RQ/gp80;FDAHT/HSA/PRO0883/PRO0903/PRO1341 therapeutic antibody | Vobarilizumab | | IL6R;ALB | Bispecific Single Domains (VH-VH') |  |
GMP-Bios-ab-626 | Pre-Made Vofatamab biosimilar, Whole mAb, Anti-FGFR3 Antibody: Anti-ACH/CEK2/JTK4/CD333/HSFGFR3EX therapeutic antibody | Vofatamab | | FGFR3 | Whole mAb |  |
GMP-Bios-ab-627 | Pre-Made Volagidemab biosimilar, Whole mAb, Anti-GCCR/NR3C1 Antibody: Anti-GCR/GCRST/GR/GRL therapeutic antibody | Volagidemab | | GCCR/NR3C1 | Whole mAb |  |
GMP-Bios-ab-628 | Pre-Made Vonlerolizumab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Vonlerolizumab | Pogalizumab | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-629 | Pre-Made Vopratelimab biosimilar, Whole mAb, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody | Vopratelimab | | ICOS | Whole mAb |  |
GMP-Bios-ab-630 | Pre-Made Vorsetuzumab biosimilar, Whole mAb ADC, Anti-CD70/CD27-L Antibody: Anti-CD27L/LPFS3/CD27LG/TNFSF7/TNLG8A therapeutic antibody | Vorsetuzumab | | CD70/CD27-L | Whole mAb ADC |  |
GMP-Bios-ab-631 | Pre-Made Vudalimab biosimilar, Bispecific Mixed mAb and scFv, Anti-CTLA4/CTLA-4;PDCD1/PD-1 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3;CD279/SLEB2/hPD-1/hPD-l/hSLE1 therapeutic antibody | Vudalimab | | CTLA4/CTLA-4; PDCD1/PD-1 | Bispecific Mixed mAb and scFv |  |
GMP-Bios-ab-632 | Pre-Made Vulinacimab biosimilar, Whole mAb, Anti-VEGFR2/KDR Antibody: Anti-CD309/FLK1/VEGFR therapeutic antibody | Vulinacimab | | VEGFR2/KDR | Whole mAb |  |
GMP-Bios-ab-633 | Pre-Made Vunakizumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Vunakizumab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-634 | Pre-Made Xentuzumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody | Xentuzumab | | IGF1;IGF2 | Whole mAb |  |
GMP-Bios-ab-635 | Pre-Made Zagotenemab biosimilar, Whole mAb, Anti-MAPT Antibody: Anti-DDPAC/FTDP-17/MSTD/MTBT1/MTBT2/PPND/PPP1R103/TAU/tau-40 therapeutic antibody | Zagotenemab | | MAPT | Whole mAb |  |
GMP-Bios-ab-636 | Pre-Made Zalifrelimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Zalifrelimab | | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-637 | Pre-Made Zalutumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Zalutumumab | | EGFR | Whole mAb |  |
GMP-Bios-ab-638 | Pre-Made Zampilimab biosimilar, Whole mAb, Anti-TGM2/TG2 Antibody: Anti-G(h)/TG(C)/TGC/hTG2/tTG therapeutic antibody | Zampilimab | | TGM2/TG2 | Whole mAb |  |
GMP-Bios-ab-639 | Pre-Made Zanidatamab biosimilar, Bispecific mAb, Anti-ERBB2/HER2;ERBB2/HER2 Antibody: Anti-CD340/HER-2/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Zanidatamab | | ERBB2/HER2; ERBB2/HER2 | Bispecific mAb |  |
GMP-Bios-ab-640 | Pre-Made Zanolimumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Zanolimumab | | CD4 | Whole mAb |  |
GMP-Bios-ab-641 | Pre-Made Zansecimab biosimilar, Whole mAb, Anti-ANGPT2 Antibody: Anti-AGPT2/ANG2/LMPHM10 therapeutic antibody | Zansecimab | | ANGPT2 | Whole mAb |  |
GMP-Bios-ab-642 | Pre-Made Zatuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody | Zatuximab | modotuximab | EGFR | Whole mAb |  |
GMP-Bios-ab-643 | Pre-Made Zelminemab biosimilar, Whole mAb, Anti-ADCYAP1R1/PAC1R Antibody: Anti-PAC1/PACAPR/PACAPRI therapeutic antibody | Zelminemab | | ADCYAP1R1/PAC1R | Whole mAb |  |
GMP-Bios-ab-644 | Pre-Made Zeluvalimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Zeluvalimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-645 | Pre-Made Zenocutuzumab biosimilar, Bispecific mAb, Anti-ERBB3/Erbb-3;ERBB2/HER2 Antibody: Anti-FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Zenocutuzumab | | ERBB3/Erbb-3; ERBB2/HER2 | Bispecific mAb |  |
GMP-Bios-ab-646 | Pre-Made Ziltivekimab biosimilar, Whole mAb, Anti-IL6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody | Ziltivekimab | | IL6 | Whole mAb |  |
GMP-Bios-ab-647 | Pre-Made Zilovertamab biosimilar, Whle mAb, Anti-ROR1 Antibody: Anti-NTRKR1/dJ537F10.1 therapeutic antibody | Zilovertamab | | ROR1 | Whle mAb |  |
GMP-Bios-ab-648 | Pre-Made Zimberelimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Zimberelimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-649 | Pre-Made Zolbetuximab biosimilar, Whole mAb, Anti-CLDN18 Antibody: Anti-SFTA5/SFTPJ therapeutic antibody | Zolbetuximab | Claudiximab | CLDN18 | Whole mAb |  |
GMP-Bios-ab-650 | Pre-Made Zolimomab biosimilar, Whole mAb, Anti-CD5 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon therapeutic antibody | Zolimomab | | CD5 | Whole mAb |  |
GMP-Bios-ab-651 | Pre-Made Zuberitamab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Zuberitamab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-ab-652 | Pre-Made Adintrevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike therapeutic antibody | Adintrevimab | | SARS-CoV-2 Spike | Whole mAb |  |
GMP-Bios-ab-653 | Pre-Made Amubarvimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Amubarvimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-654 | Pre-Made Anselamimab biosimilar, Whole mAb, Anti-SAA1 Antibody: Anti-PIG4/SAA/SAA2/TP53I4 therapeutic antibody | Anselamimab | | SAA1 | Whole mAb |  |
GMP-Bios-ab-655 | Pre-Made Anumigilimab biosimilar, Whole mAb, Anti-CSF3R/G-CSF-R Antibody: Anti-CD114/GCSFR/SCN7 therapeutic antibody | Anumigilimab | | CSF3R/G-CSF-R | Whole mAb |  |
GMP-Bios-ab-656 | Pre-Made Bafisontamab biosimilar, Whole mAb, Anti-EGFR;MET Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody | Bafisontamab | | EGFR;MET | Bispecific Mixed mAb and Fab |  |
GMP-Bios-ab-657 | Pre-Made Barzolvolimab biosimilar, Whole mAb, Anti-KIT Antibody: Anti-C-Kit/CD117/MASTC/PBT/SCFR therapeutic antibody | Barzolvolimab | | KIT | Whole mAb |  |
GMP-Bios-ab-658 | Pre-Made Beludavimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Beludavimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-659 | Pre-Made Dalutrafusp biosimilar, Whole mAb, Anti-TGFBR2 Antibody: Anti-AAT3/FAA3/LDS1B/LDS2/LDS2B/MFS2/RIIC/TAAD2/TBR-ii/TBRII/TGFR-2-RII therapeutic antibody | Dalutrafusp | | TGFBR2 | Whole mAb Fusion |  |
GMP-Bios-ab-660 | Pre-Made Dresbuxelimab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody | Dresbuxelimab | | NT5E/CD73 | Whole mAb |  |
GMP-Bios-ab-661 | Pre-Made Eblasakimab biosimilar, Whole mAb, Anti-IL13RA1 Antibody: Anti-CD213A1/CT19/IL-13Ra/NR4 therapeutic antibody | Eblasakimab | | IL13RA1 | Whole mAb |  |
GMP-Bios-ab-662 | Pre-Made Ecleralimab biosimilar, Whole Mab: Anti-TSLP therapeutic antibody | Ecleralimab | | TSLP | Whole mAb |  |
GMP-Bios-ab-663 | Pre-Made Elranatamab biosimilar, Whole mAb, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody | Elranatamab | | TNFRSF17;CD3E | Bispecific Whole mAb |  |
GMP-Bios-ab-664 | Pre-Made Ensomafusp Biosimilar, Fusion Protein targeting CD19: Recombinant therapeutic protein targeting B4/CVID3 | Ensomafusp | | CD19 | Fusion Protein |  |
GMP-Bios-ab-665 | Pre-Made Enuzovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Enuzovimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-666 | Pre-Made Exidavnemab biosimilar, Whole mAb, Anti-SNCA Antibody: Anti-NACP/PARK1/PARK4/PD1 therapeutic antibody | Exidavnemab | | SNCA | Whole mAb |  |
GMP-Bios-ab-667 | Pre-Made Fidasimtamab biosimilar, Whole mAb, Anti-PDCD1/PD-1;ERBB2/HER2 Antibody: Anti-CD279/PD1/SLEB2/hSLE1;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Fidasimtamab | | PDCD1/PD-1; ERBB2/HER2 | Bispecific Whole mAb |  |
GMP-Bios-ab-668 | Pre-Made Galegenimab biosimilar, Whole mAb, Anti-HTRA1 Antibody: Anti-ARMD7/CADASIL2/CARASIL/HtrA/L56/ORF480/PRSS11 therapeutic antibody | Galegenimab | | HTRA1 | Whole mAb |  |
GMP-Bios-ab-669 | Pre-Made Ginisortamab biosimilar, Whole mAb, Anti-GREM1/Gremlin-1 Antibody: Anti-C15DUPq/CKTSF1B1/CRAC1/CRCS4/DAND2/DRM/DUP15q/GREMLIN/HMPS/HMPS1/IHG-2/MPSH/PIG2 therapeutic antibody | Ginisortamab | | GREM1/Gremlin-1 | Whole mAb |  |
GMP-Bios-ab-670 | Pre-Made Gresonitamab biosimilar, Whole mAb, Anti-CLDN18;CD3E Antibody: Anti-SFTA5/SFTPJ;T3E/TCRE/IMD18 therapeutic antibody | Gresonitamab | | CLDN18;CD3E | Bispecific scFv-scFv-scFc |  |
GMP-Bios-ab-671 | Pre-Made Gumokimab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Gumokimab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-672 | Pre-Made Iparomlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Iparomlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-673 | Pre-Made Ivicentamab biosimilar, Whole mAb, Anti-CD37;CD37 Antibody: Anti-GP52-40/TSPAN26;GP52-40/TSPAN26 therapeutic antibody | Ivicentamab | | CD37;CD37 | Bispecific Whole mAb |  |
GMP-Bios-ab-674 | Pre-Made Ivonescimab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody | Ivonescimab | | VEGFA | scFv-IGHC |  |
GMP-Bios-ab-675 | Pre-Made Lepunafusp biosimilar, Whole mAb, Anti-TfR1/TFRC Antibody: Anti-CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 therapeutic antibody | Lepunafusp | | TfR1/TFRC | Whole mAb Fusion |  |
GMP-Bios-ab-676 | Pre-Made Ligufalimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody | Ligufalimab | | CD47 | Whole mAb |  |
GMP-Bios-ab-677 | Pre-Made Livmoniplimab biosimilar, Whole mAb, Anti-LRRC32 Antibody: Anti-CPPRDD/D11S833E/GARP therapeutic antibody | Livmoniplimab | | LRRC32 | Whole mAb |  |
GMP-Bios-ab-678 | Pre-Made Lomtegovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Lomtegovimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-679 | Pre-Made Lorigerlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1;CTLA4/CTLA-4 Antibody: Anti-CD279/PD1/SLEB2/hPD-1/hPD-l/hSLE1;CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Lorigerlimab | | PDCD1/PD-1; CTLA4/CTLA-4 | Bispecific Mixed scFv (scFv-CH2-CH3-scFv) |  |
GMP-Bios-ab-680 | Pre-Made Manfidokimab biosimilar, Whole mAb, Anti-IL4R Antibody: Anti-CD124 therapeutic antibody | Manfidokimab | | IL4R | Whole mAb |  |
GMP-Bios-ab-681 | Pre-Made Mazorelvimab biosimilar, Whole Mab: Anti-Rabies Virus Spike Glycoprotein G therapeutic antibody | Mazorelvimab | | Rabies Virus Spike Glycoprotein G | Whole mAb |  |
GMP-Bios-ab-682 | Pre-Made Melredableukin biosimilar, Whole Mab: Anti-Non-Binding therapeutic antibody | Melredableukin | | Non-Binding | Whole mAb Fusion |  |
GMP-Bios-ab-683 | Pre-Made Mupadolimab biosimilar, Whole mAb, Anti-NT5E/CD73 Antibody: Anti-NT/eN/NT5/NTE/eNT/E5NT/CALJA therapeutic antibody | Mupadolimab | | NT5E/CD73 | Whole mAb |  |
GMP-Bios-ab-684 | Pre-Made Nofazinlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Nofazinlimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-685 | Pre-Made Ormutivimab biosimilar, Whole Mab: Anti-Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 therapeutic antibody | Ormutivimab | | Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 | Whole mAb |  |
GMP-Bios-ab-686 | Pre-Made Pivekimab biosimilar, Whole mAb, Anti-IL3RA Antibody: Anti-IL3R/CD123/IL3RX/IL3RY/hIL-3Ra therapeutic antibody | Pivekimab | | IL3RA | Whole mAb |  |
GMP-Bios-ab-687 | Pre-Made Pulocimab biosimilar, Whole mAb, Anti-VEGFR2/KDR Antibody: Anti-CD309/FLK1/VEGFR therapeutic antibody | Pulocimab | | VEGFR2/KDR | Whole mAb |  |
GMP-Bios-ab-688 | Pre-Made Quisovalimab biosimilar, Whole mAb, Anti-TNFSF14/CD258 Antibody: Anti-HVEML/LIGHT/LTg therapeutic antibody | Quisovalimab | | TNFSF14/CD258 | Whole mAb |  |
GMP-Bios-ab-689 | Pre-Made Rimteravimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Rimteravimab | | SARS-CoV-2 Spike RBD | Mixed Nanobody (VHH-CH2-CH3 dimer) |  |
GMP-Bios-ab-690 | Pre-Made Rocatinlimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody | Rocatinlimab | | TNFRSF4/CD134 | Whole mAb |  |
GMP-Bios-ab-691 | Pre-Made Romlusevimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Romlusevimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-692 | Pre-Made Rulonilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Rulonilimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-ab-693 | Pre-Made Simridarlimab biosimilar, Whole mAb, Anti-CD47;CD274/PD-L1 Antibody: Anti-IAP/OA3/MER6;B7-H/B7H1/PD-L1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1 therapeutic antibody | Simridarlimab | | CD47;CD274/PD-L1 | Bispecific Mixed mAb/VH-VH-CH2-CH3 |  |
GMP-Bios-ab-694 | Pre-Made Sirexatamab biosimilar, Whole mAb, Anti-DKK1 Antibody: Anti-SK/DKK-1 therapeutic antibody | Sirexatamab | | DKK1 | Whole mAb |  |
GMP-Bios-ab-695 | Pre-Made Socazolimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Socazolimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-696 | Pre-Made Sotevtamab biosimilar, Whole mAb, Anti-CLU/Clusterinm Antibody: Anti-AAG4/APO-J/APOJ/CLI/KUB1/NA1/NA2/SGP-2/SGP2/SP-40/TRPM-2/TRPM2 therapeutic antibody | Sotevtamab | | CLU/Clusterin | Whole mAb |  |
GMP-Bios-ab-697 | Pre-Made Suciraslimab biosimilar, Whole mAb, Anti-CD22 Antibody: Anti-SIGLEC2/SIGLEC-2 therapeutic antibody | Suciraslimab | | CD22 | Whole mAb |  |
GMP-Bios-ab-698 | Pre-Made Tagitanlimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody | Tagitanlimab | | CD274/PD-L1 | Whole mAb |  |
GMP-Bios-ab-699 | Pre-Made Tamgiblimab biosimilar, Whole mAb, Anti-TIGIT Antibody: Anti-VSIG9/VSTM3/WUCAM therapeutic antibody | Tamgiblimab | | TIGIT | Whole mAb |  |
GMP-Bios-ab-700 | Pre-Made Tarcolimab biosimilar, Whole mAb, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody | Tarcolimab | | VEGFA | Whole mAb |  |
GMP-Bios-ab-701 | Pre-Made Tecaginlimab biosimilar, Whole mAb, Anti-CD40;TNFRSF9/CD137 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5;ILA/4-1BB/CDw137 therapeutic antibody | Tecaginlimab | | CD40;TNFRSF9/CD137 | Bispecific Whole mAb |  |
GMP-Bios-ab-702 | Pre-Made Teropavimab biosimilar, Whole Mab: Anti-HIV-1 gp120 CD4bs therapeutic antibody | Teropavimab | | HIV-1 gp120 CD4bs | Whole mAb |  |
GMP-Bios-ab-703 | Pre-Made Trinbelimab biosimilar, Whole mAb, Anti-RhD Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody | Trinbelimab | | RhD | Whole mAb |  |
GMP-Bios-ab-704 | Pre-Made Tuvonralimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody | Tuvonralimab | | CTLA4/CTLA-4 | Whole mAb |  |
GMP-Bios-ab-705 | Pre-Made Ubamatamab biosimilar, Whole mAb, Anti-MUC16;CD3E Antibody: Anti-CA125;T3E/TCRE/IMD18 therapeutic antibody | Ubamatamab | | MUC16;CD3E | Bispecific Whole mAb |  |
GMP-Bios-ab-706 | Pre-Made Ulenistamab biosimilar, Whole Mab: Anti-PAUF therapeutic antibody | Ulenistamab | | PAUF | Whole mAb |  |
GMP-Bios-ab-707 | Pre-Made Upanovimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike RBD therapeutic antibody | Upanovimab | | SARS-CoV-2 Spike RBD | Whole mAb |  |
GMP-Bios-ab-708 | Pre-Made Vepsitamab biosimilar, Whole mAb, Anti-MUC17;CD3E Antibody: Anti-MUC-17/MUC-3/MUC3;T3E/TCRE/IMD18 therapeutic antibody | Vepsitamab | | MUC17;CD3E | Bispecific scFv-scFv-scFc |  |
GMP-Bios-ab-709 | Pre-Made Voxalatamab biosimilar, Whole mAb, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody | Voxalatamab | | FOLH1/GCPII;CD3E | Bispecific Whole mAb |  |
GMP-Bios-ab-710 | Pre-Made Xeligekimab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody | Xeligekimab | | IL17A/IL17 | Whole mAb |  |
GMP-Bios-ab-711 | Pre-Made Zamerovimab biosimilar, Whole Mab: Anti-Rabies Virus Spike Glycoprotein G therapeutic antibody | Zamerovimab | | Rabies Virus Spike Glycoprotein G | Whole mAb |  |
GMP-Bios-INN-712 | Pre-Made Abatacept Biosimilar, Fusion Protein targeting CTLA4/CTLA-4 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 | Abatacept | | CTLA-4 | Fusion Protein |  |
GMP-Bios-INN-713 | Pre-Made Abciximab Biosimilar, Fab Fusion, Anti-Itga2B/Itgb3 Antibody: Anti-BDPLT16/BDPLT2/CD41/CD41B/GP2B/GPIIb/GT/GT1/GTA/HPA3/PPP1R93;BDPLT16/BDPLT2/BDPLT24/CD61/GP3A/GPIIIa/GT/GT2 therapeutic antibody | Abciximab | | ITGA2B;ITGB3 | Fab Fusion |  |
GMP-Bios-INN-715 | Pre-Made Acazicolcept Biosimilar, Fusion Protein targeting CD28 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting Tp44 | Acazicolcept | | CD28 | Fusion Protein |  |
GMP-Bios-INN-717 | Pre-Made Actinium (225Ac) Lintuzumab Satetraxetan Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody: Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody Drug Conjugate | Actinium (225Ac) Lintuzumab Satetraxetan | | CD33 | Whole mAb ADC |  |
GMP-Bios-INN-718 | Pre-Made Adalimumab Beta Biosimilar, Whole Mab, Anti-Tnf Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Adalimumab Beta | | TNF | Whole mAb |  |
GMP-Bios-INN-719 | Pre-Made Adecatumumab Biosimilar, Whole Mab, Anti-Epcam Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody | Adecatumumab | | EPCAM | Whole mAb |  |
GMP-Bios-INN-721 | Pre-Made Afelimomab Biosimilar, Fab Fusion, Anti-Tnf Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Afelimomab | | TNF | Fab Fusion |  |
GMP-Bios-INN-722 | Pre-Made Aflibercept Biosimilar, Fusion Protein targeting VEGFA fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting MVCD1/VEGF/VPF | Aflibercept | | VEGFA | Fusion Protein |  |
GMP-Bios-INN-724 | Pre-Made Albiglutide Biosimilar, Peptide Protein Fusion targeting GLP1R: (Glp-1)2 Peptide-Albumin(Alb) Fusion Protein targetingGLP-1-R/GLP-1R | Albiglutide | | GLP1R | Peptide Protein fusion |  |
GMP-Bios-INN-725 | Pre-Made Albinterferon Alfa- 2B Biosimilar, Fusion Protein targeting IFNAR1 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC | Albinterferon Alfa- 2B | | IFNAR1 | Fusion Protein |  |
GMP-Bios-INN-726 | Pre-Made Albutrepenonacog Alfa Biosimilar, Fusion Protein targeting F9 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 | Albutrepenonacog Alfa | | F9 | Fusion Protein |  |
GMP-Bios-INN-727 | Pre-Made Aldafermin Biosimilar, Recombinant Protein targeting FGFR4: Recombinant therapeutic protein targeting CD334/JTK2/TKF | Aldafermin | | FGFR4 | Recombinant Protein |  |
GMP-Bios-INN-728 | Pre-Made Aldesleukin biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting IL2 | Aldesleukin | | IL2
| Recombinant Protein |  |
GMP-Bios-INN-729 | Pre-Made Alefacept Biosimilar, Fusion Protein targeting CD2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting LFA-2/SRBC/T11 | Alefacept | | CD2 | Fusion Protein |  |
GMP-Bios-INN-730 | Pre-Made Altumomab Biosimilar, Radiolabelled Antibody, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody | Altumomab | | CEACAM5/CD66e | Radiolabelled antibody |  |
GMP-Bios-INN-731 | Pre-Made Alvircept Sudotox biosimilar, Fusion Protein: Recombinant therapeutic protein targeting HIV-1 gp120 fused with Pseudomonas aeruginosa exotoxin A | Alvircept Sudotox | | HIV-1 gp120 | Fusion Protein |  |
GMP-Bios-INN-732 | Pre-Made Anakinra Biosimilar, Recombinant Protein targeting IL1R1: Recombinant therapeutic protein targeting CD121A/D2S1473/IL-1R-alpha/IL1R/IL1RA/P80 | Anakinra | | IL1R1 | Recombinant Protein |  |
GMP-Bios-INN-733 | Anatumomab-Anti-TAG-72 therapeutic antibody fused with Staphylococcus aureus
enterotoxin A (Pre-made Anatumomab Mafenatox biosimilar, Fusion Protein) | Anatumomab Mafenatox | | TAG-72 | Fusion Protein |  |
GMP-Bios-INN-734 | Pre-Made Anetumab Corixetan Biosimilar, Whole Mab Adc, Anti-Msln Antibody: Anti-MPF/SMRP therapeutic antibody Drug Conjugate | Anetumab Corixetan | | MSLN | Whole mAb ADC |  |
GMP-Bios-INN-735 | Pre-Made Anetumab Ravtansine Biosimilar, Whole Mab Adc, Anti-Msln Antibody: Anti-MPF/SMRP therapeutic antibody Drug Conjugate | Anetumab Ravtansine | | MSLN | Whole mAb ADC |  |
GMP-Bios-INN-736 | Pre-Made Apolizumab Biosimilar, Whole Mab, Anti-HLA-DRB/HLA-DRB1 Antibody: Anti-DRB1/SS1 therapeutic antibody | Apolizumab | | HLA-DRB/HLA-DRB1 | Whole mAb |  |
GMP-Bios-INN-737 | Pre-Made Aprutumab Ixadotin Biosimilar, Whole Mab Adc, Anti-Fgfr2 Antibody: Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25 therapeutic antibody Drug Conjugate | Aprutumab Ixadotin | | FGFR2 | Whole mAb ADC |  |
GMP-Bios-INN-738 | Pre-Made Arcitumomab Biosimilar, Radiolabelled Antibody, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody | Arcitumomab | | CEACAM5/CD66e | Radiolabelled antibody |  |
GMP-Bios-INN-739 | Pre-Made Aselizumab Biosimilar, Whole Mab, Anti-Sell Antibody: Anti-CD62L/LAM1/LECAM1/LEU8/LNHR/LSEL/LYAM1/PLNHR/TQ1 therapeutic antibody | Aselizumab | | SELL | Whole mAb |  |
GMP-Bios-INN-740 | Pre-Made Asfotase Alfa biosimilar, Fusion Protein: Recombinant therapeutic protein targeting Enzyme fused with human IGHG1 Fc (Fragment constant) | Asfotase Alfa | | Enzyme | Fusion Protein |  |
GMP-Bios-INN-741 | Pre-Made Asunercept Biosimilar, Fusion Protein targeting FASLG/CD178 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting ALPS1B/APT1LG1/APTL/CD95-L/CD95L/FASL/TNFSF6/TNLG1A | Asunercept | | FASLG/CD178 | Fusion Protein |  |
GMP-Bios-INN-742 | Pre-Made Atacicept Biosimilar, Fusion Protein targeting TNFSF13/APRIL fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD256/TALL-2/TALL2/TNLG7B/TRDL-1/UNQ383/PRO715/ZTNF2 | Atacicept | | TNFSF13/APRIL | Fusion Protein |  |
GMP-Bios-INN-743 | Pre-Made Atorolimumab Biosimilar, Whole Mab, Anti-Rhd Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody | Atorolimumab | | RHD | Whole mAb |  |
GMP-Bios-INN-746 | Pre-Made Azintuxizumab Vedotin Biosimilar, Whole Mab Adc, Anti-SLAMF7/CS1 Antibody: Anti-19A/CD319/CRACC therapeutic antibody Drug Conjugate | Azintuxizumab Vedotin | | SLAMF7/CS1 | Whole mAb ADC |  |
GMP-Bios-INN-748 | Pre-Made Balugrastim Biosimilar, Fusion Protein targeting CSF3R/G-CSF-R fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting CD114/GCSFR/SCN7 | Balugrastim | | CSF3R/G-CSF-R | Fusion Protein |  |
GMP-Bios-INN-749 | Pre-Made Baminercept Biosimilar, Fusion Protein targeting LTA fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting LT/TNFB/TNFSF1/TNLG1E | Baminercept | | LTA | Fusion Protein |  |
GMP-Bios-INN-750 | Pre-Made Batiraxcept Biosimilar, Fusion Protein targeting GAS6 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AXLLG/AXSF | Batiraxcept | | GAS6 | Fusion Protein |  |
GMP-Bios-INN-751 | Pre-Made Bectumomab Biosimilar, Fab Fusion, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody | Bectumomab | | CD22 | Fab Fusion |  |
GMP-Bios-INN-752 | Pre-Made Belantamab Mafodotin Biosimilar, Whole Mab Adc, Anti-Tnfrsf17 Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A therapeutic antibody Drug Conjugate | Belantamab Mafodotin | | TNFRSF17 | Whole mAb ADC |  |
GMP-Bios-INN-753 | Pre-Made Belatacept Biosimilar, Fusion Protein targeting CD80 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting B7/B7-1/B7.1/BB1/CD28LG/CD28LG1/LAB7 | Belatacept | | CD80 | Fusion Protein |  |
GMP-Bios-INN-755 | Pre-Made Bertilimumab Biosimilar, Whole Mab, Anti-Ccl11 Antibody: Anti-SCYA11 therapeutic antibody | Bertilimumab | | CCL11 | Whole mAb |  |
GMP-Bios-INN-756 | Pre-Made Besilesomab Biosimilar, Radiolabelled Antibody, Anti-Ceacam8/NCA-95 Antibody: Anti-CD66b/CD67/CGM6 therapeutic antibody | Besilesomab | | CEACAM8/NCA-95 | Radiolabelled antibody |  |
GMP-Bios-INN-757 | Pre-Made Bevacizumab Beta Biosimilar, Whole Mab, Anti-Vegfa Antibody: Anti-MVCD1/VEGF/VPF therapeutic antibody | Bevacizumab Beta | | VEGFA | Whole mAb |  |
GMP-Bios-INN-758 | Pre-Made Bevifimod biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting Staphylococcal protein A | Bevifimod | | Staphylococcal protein A | Recombinant Protein |  |
GMP-Bios-INN-759 | Pre-Made Biciromab Biosimilar, Radiolabelled Antibody: Anti-Fibrin Ii therapeutic antibody | Biciromab | | fibrin II | Radiolabelled antibody |  |
GMP-Bios-INN-760 | Pre-Made Bifarcept Biosimilar, Recombinant Protein targeting IFNA1: Recombinant therapeutic protein targeting IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D | Bifarcept | | IFNA1 | Recombinant Protein |  |
GMP-Bios-INN-761 | Pre-Made Bifikafusp Alfa Biosimilar, Fusion Protein targeting FN/FN1 fused with human IL2 (interleukin 2, IL-2) Pr21-153 (100%) (1:1), noncovalent dimer: Recombinant therapeutic protein targeting CIG/ED-B/FINCZ/GFND/GFND2/LETS/MSF/SMDCF | Bifikafusp Alfa | | FN/FN1 | Fusion Protein |  |
GMP-Bios-INN-762 | Pre-Made Bintrafusp Alfa Biosimilar, Fusion Protein targeting CD274/PD-L1 fused with human TGFBR2 (transforming growth factor beta receptor 2) (1:2) via a peptidyl linker: Recombinant therapeutic protein targeting B7-H/B7H1/PDCD1L1/PDCD1LG1 | Bintrafusp Alfa | | CD274/PD-L1 | Fusion Protein |  |
GMP-Bios-INN-763 | Pre-Made Bivatuzumab Biosimilar, Whole Mab, Anti-Cd44 Antibody: Anti-CDW44/CSPG8/ECMR-III/HCELL/HUTCH-I/IN/LHR/MC56/MDU2/MDU3/MIC4/Pgp1 therapeutic antibody | Bivatuzumab | | CD44 | Whole mAb |  |
GMP-Bios-INN-764 | Pre-Made Blisibimod Biosimilar, Fusion Protein targeting TNFSF13B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4 | Blisibimod | | TNFSF13B | Fusion Protein |  |
GMP-Bios-INN-765 | Pre-Made Brentuximab Vedotin Biosimilar, Whole Mab Adc, Anti-Tnfrsf8 Antibody: Anti-CD30/D1S166E/Ki-1 therapeutic antibody Drug Conjugate | Brentuximab Vedotin | | TNFRSF8 | Whole mAb ADC |  |
GMP-Bios-INN-767 | Pre-Made Briobacept Biosimilar, Fusion Protein targeting TNFSF13B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4 | Briobacept | | TNFSF13B | Fusion Protein |  |
GMP-Bios-INN-768 | Pre-Made Camidanlumab Tesirine Biosimilar, Whole Mab Adc, Anti-Il2Ra Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody Drug Conjugate | Camidanlumab Tesirine | | IL2RA | Whole mAb ADC |  |
GMP-Bios-INN-769 | Pre-Made Cantuzumab Mertansine Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody Drug Conjugate | Cantuzumab Mertansine | | MUC1 | Whole mAb ADC |  |
GMP-Bios-INN-770 | Pre-Made Cantuzumab Ravtansine Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody Drug Conjugate | Cantuzumab Ravtansine | | MUC1 | Whole mAb ADC |  |
GMP-Bios-INN-771 | Pre-Made Capromab Biosimilar, Radiolabelled Antibody, Anti-FOLH1/GCPII Antibody: Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP therapeutic antibody | Capromab | | FOLH1/GCPII | Radiolabelled antibody |  |
GMP-Bios-INN-772 | Pre-Made Catumaxomab Biosimilar, Bispecific, Anti-Cd3E; Epcam Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody | Catumaxomab | | CD3E;EPCAM | Bispecific |  |
GMP-Bios-INN-773 | Pre-Made Cedelizumab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Cedelizumab | | CD4 | Whole mAb |  |
GMP-Bios-INN-775 | Pre-Made Cergutuzumab Amunaleukin biosimilar, Fusion Protein, Cergutuzumab-Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody fused with human IL2 (interleukin 2, IL-2) Pr21-153 | Cergutuzumab Amunaleukin | | CEACAM5/CD66e | Fusion Protein |  |
GMP-Bios-INN-777 | Pre-Made Cetuximab Sarotalocan Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate | Cetuximab Sarotalocan | | EGFR | Whole mAb ADC |  |
GMP-Bios-INN-778 | Pre-Made Choriogonadotropin Beta Biosimilar, Recombinant Protein targeting LHCGR: Recombinant therapeutic protein targeting HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5 | Choriogonadotropin Beta | | LHCGR | Recombinant Protein |  |
GMP-Bios-INN-780 | Pre-Made Cinrebafusp Alfa P Alfaiosimilar, Bispecific, Anti-ERBB2/HER2;TNFRSF9 Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;ILA/4-1BB/CDw137 therapeutic antibody | Cinrebafusp Alfa | | ERBB2/HER2; TNFRSF9 | Bispecific |  |
GMP-Bios-INN-781 | Pre-Made Citatuzumab Bogatox biosimilar, Fusion Protein, Citatuzumab-Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody fused with Bougainvillea spectabilis Willd bouganin | Citatuzumab Bogatox | | EPCAM | Fusion Protein |  |
GMP-Bios-INN-782 | Pre-Made Clenoliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Clenoliximab | | CD4 | Whole mAb |  |
GMP-Bios-INN-783 | Pre-Made Clervonafusp Alfa Biosimilar, Fusion Protein targeting SLC29A2/ENT2 fused with human GAA (glucosidase alpha, acid, lysosomal alpha-glucosidase )(Pr67-952) (1:2) Enzyme substitute: Recombinant therapeutic protein targeting DER12/HNP36 | Clervonafusp Alfa | | SLC29A2/ENT2 | Fusion Protein |  |
GMP-Bios-INN-784 | Pre-Made Clivatuzumab Tetraxetan Biosimilar, Whole Mab Adc, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody Drug Conjugate | Clivatuzumab Tetraxetan | | MUC1 | Whole mAb ADC |  |
GMP-Bios-INN-785 | Pre-Made Cofetuzumab Pelidotin Biosimilar, Whole Mab Adc, Anti-Ptk7 Antibody: Anti-CCK-4/CCK4 therapeutic antibody Drug Conjugate | Cofetuzumab Pelidotin | | PTK7 | Whole mAb ADC |  |
GMP-Bios-INN-786 | Pre-Made Coltuximab Ravtansine Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate | Coltuximab Ravtansine | | CD19 | Whole mAb ADC |  |
GMP-Bios-INN-787 | Pre-Made Conbercept Biosimilar, Fusion Protein targeting VEGFA fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting MVCD1/VEGF/VPF | Conbercept | | VEGFA | Fusion Protein |  |
GMP-Bios-INN-788 | Pre-Made Corifollitropin Alfa Biosimilar, Fusion Protein targeting FSHR fused with CTP (C-terminal peptide of hCG): Recombinant therapeutic protein targeting FSHRO/LGR1/ODG1 | Corifollitropin Alfa | | FSHR | Fusion Protein |  |
GMP-Bios-INN-789 | Pre-Made Daclizumab Beta Biosimilar, Whole Mab, Anti-Il2Ra Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody | Daclizumab Beta | | IL2RA | Whole mAb |  |
GMP-Bios-INN-790 | Pre-Made Dafsolimab Setaritox Biosimilar, Whole Mab Adc, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody Drug Conjugate | Dafsolimab Setaritox | | CD3E | Whole mAb ADC |  |
GMP-Bios-INN-791 | Pre-Made Dalantercept biosimilar, Fusion Protein: Recombinant therapeutic protein targeting BMP10 fused with human IGHG1 Fc (Fragment constant) | Dalantercept | | BMP10 | Fusion Protein |  |
GMP-Bios-INN-792 | Pre-Made Dalcinonacog Alfa Biosimilar, Recombinant Protein targeting F9: Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 | Dalcinonacog Alfa | | F9 | Recombinant Protein |  |
GMP-Bios-INN-793 | Pre-Made Dalutrafusp Alfa P Alfaiosimilar, Bispecific, Anti-NT5E/CD73;TGFB1;TGFB3 Antibody: Anti-eN/NTE/eNT/CALJA;CED/DPD1/IBDIMDE/LAP/TGF-beta1/TGFbeta;ARVD/ARVD1/LDS5/RNHF therapeutic antibody | Dalutrafusp Alfa | | NT5E/CD73; TGFB1;TGFB3 | Bispecific |  |
GMP-Bios-INN-795 | Pre-Made Darbepoetin Alfa biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting EPOR | Darbepoetin Alfa | | EPOR | Recombinant Protein |  |
GMP-Bios-INN-796 | Pre-Made Datopotamab Deruxtecan Biosimilar, Whole Mab Adc, Anti-Tacstd2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody Drug Conjugate | Datopotamab Deruxtecan | | TACSTD2 | Whole mAb ADC |  |
GMP-Bios-INN-797 | Pre-Made Davoceticept Biosimilar, Fusion Protein targeting CD274/PD-L1 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting B7-H/B7H1/PDCD1L1/PDCD1LG1 | Davoceticept | | CD274/PD-L1 | Fusion Protein |  |
GMP-Bios-INN-798 | Pre-Made Dazodalibep Biosimilar, Fusion Protein targeting CD40LG fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L | Dazodalibep | | CD40LG | Fusion Protein |  |
GMP-Bios-INN-799 | Pre-Made Denileukin Diftitox Biosimilar, Fusion Protein targeting IL1RL2 fused with human IL2 (interleukin 2, IL-2): Recombinant therapeutic protein targeting IL-1Rrp2/IL-36R/IL1R-rp2/IL1RRP2 | Denileukin Diftitox | | IL1RL2 | Fusion Protein |  |
GMP-Bios-INN-800 | Pre-Made Denintuzumab Mafodotin Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate | Denintuzumab Mafodotin | | CD19 | Whole mAb ADC |  |
GMP-Bios-INN-801 | Pre-Made Depatuxizumab Mafodotin Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate | Depatuxizumab Mafodotin | | EGFR | Whole mAb ADC |  |
GMP-Bios-INN-802 | Pre-Made Detumomab biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting human B-cell lymphoma | Detumomab | | human B-cell lymphoma | Recombinant Protein |  |
GMP-Bios-INN-803 | Pre-Made Dinutuximab Beta Biosimilar, Whole Mab: Anti-Ganglioside Gd2 therapeutic antibody | Dinutuximab Beta | | ganglioside GD2 | Whole mAb |  |
GMP-Bios-INN-804 | Pre-Made Disitamab Vedotin Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate | Disitamab Vedotin | | ERBB2/HER2 | Whole mAb ADC |  |
GMP-Bios-INN-805 | Pre-Made Dorlimomab Aritox Biosimilar, Whole Mab Adc: Anti-40S Ribosomal Protein S18 therapeutic antibody | Dorlimomab Aritox | | 40S ribosomal protein S18 | ADC |  |
GMP-Bios-INN-806 | Pre-Made Dulaglutide Biosimilar, Peptide Protein Fusion targeting GLP1R: (Glp-12) Peptide-Human Igg4 Fc Fusion Protein targeting GLP-1/GLP-1-R/GLP-1R | Dulaglutide | | GLP1R | Peptide Protein fusion |  |
GMP-Bios-INN-807 | Pre-Made Ecromeximab Biosimilar, Whole Mab: Anti-Ganglioside Gd3 therapeutic antibody | Ecromeximab | | ganglioside GD3 | Whole mAb |  |
GMP-Bios-INN-808 | Pre-Made Edobacomab Biosimilar, Whole Mab: Anti-Endotoxin (Lipid A, Domain Of Lipopolyaccharide, Lps) [Gram Negative Bacteria] therapeutic antibody | Edobacomab | | endotoxin (lipid A, domain of lipopolyaccharide, LPS) [gram negative bacteria] | Whole mAb |  |
GMP-Bios-INN-809 | Pre-Made Efanesoctocog Alfa Biosimilar, Fusion Protein targeting F8 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AHF/F8B/F8C/HEMA/FVIII/DXS1253E | Efanesoctocog Alfa | | F8 | Fusion Protein |  |
GMP-Bios-INN-810 | Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D | Efaprinermin Alfa | | TNFRSF18 | Fusion Protein |  |
GMP-Bios-INN-811 | Pre-Made Efavaleukin Alfa Biosimilar, Fusion Protein targeting IL2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting IL-2/TCGF/lymphokine | Efavaleukin Alfa | | IL2 | Fusion Protein |  |
GMP-Bios-INN-812 | Pre-Made Efbemalenograstim Alfa Biosimilar, Fusion Protein targeting CSF3R/G-CSF-R fused with human IGHG2 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting CD114/GCSFR/SCN7 | Efbemalenograstim Alfa | | CSF3R/G-CSF-R | Fusion Protein |  |
GMP-Bios-INN-813 | Pre-Made Efdamrofusp Alfa P Alfaiosimilar, Bispecific, Anti-C3/CO3;C4B;VEGFA Antibody: Anti-AHUS5/ARMD9/ASP/CPAMD1/HEL-S-62p;CH/C4F/CO4/C4BD/C4B12/CPAMD3;VPF/MVCD1 therapeutic antibody | Efdamrofusp Alfa | | C3/CO3;C4B;VEGFA | Bispecific |  |
GMP-Bios-INN-814 | Pre-Made Efgartigimod Alfa Biosimilar, Recombinant Protein targeting FCGRT: Recombinant therapeutic protein targeting FCRN/FcgammaRn/alpha-chain | Efgartigimod Alfa | | FCGRT | Recombinant Protein |  |
GMP-Bios-INN-815 | Pre-Made Efgivanermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D | Efgivanermin Alfa | | TNFRSF18 | Fusion Protein |  |
GMP-Bios-INN-816 | Pre-Made Efineptakin Alfa Biosimilar, Fusion Protein targeting IL7R fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting CD127/CDW127 | Efineptakin Alfa | | IL7R | Fusion Protein |  |
GMP-Bios-INN-819 | Pre-Made Eflepedocokin Alfa Biosimilar, Fusion Protein targeting IL10RB fused with human IGHG2 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting CDW210B/CRF2-4/CRFB4/D21S58/D21S66/IL-10R2 | Eflepedocokin Alfa | | IL10RB | Fusion Protein |  |
GMP-Bios-INN-820 | Pre-Made Eflimrufusp Alfa Biosimilar, Fusion Protein targeting FGF2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BFGF/FGF-2/FGFB/HBGF-2 | Eflimrufusp Alfa | | FGF2 | Fusion Protein |  |
GMP-Bios-INN-821 | Pre-Made Efmarodocokin Alfa Biosimilar, Fusion Protein targeting IL22RA1/IL22R1 fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting CRF2-9 | Efmarodocokin Alfa | | IL22RA1/IL22R1 | Fusion Protein |  |
GMP-Bios-INN-822 | Pre-Made Efmitermant Alfa Biosimilar, Fusion Protein targeting MSTN/GDF-8 fused with human IGHG2 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting GDF8/MSLHP | Efmitermant Alfa | | MSTN/GDF-8 | Fusion Protein |  |
GMP-Bios-INN-823 | Pre-Made Efmoroctocog Alfa Biosimilar, Fusion Protein targeting F8 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AHF/F8B/F8C/HEMA/FVIII/DXS1253E | Efmoroctocog Alfa | | F8 | Fusion Protein |  |
GMP-Bios-INN-826 | Pre-Made Efruxifermin Biosimilar, Fusion Protein targeting FGFR1 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting BFGFR/CD331/CEK/ECCL/FGFBR/FGFR-1/FLG/FLT-2/FLT2/HBGFR/HH2/HRTFDS/KAL2/N-SAM/OGD/bFGF-R-1 | Efruxifermin | | FGFR1 | Fusion Protein |  |
GMP-Bios-INN-827 | Pre-Made Eftansomatropin Alfa Biosimilar, Fusion Protein targeting GHR fused with human IGHG4 Fc (Fragment constant): Recombinant therapeutic protein targeting GHBP/GHIP | Eftansomatropin Alfa | | GHR | Fusion Protein |  |
GMP-Bios-INN-828 | Pre-Made Eftilagimod Alfa biosimilar, Fusion Protein: Recombinant therapeutic protein targeting MH2 fused with human IGHG1 Fc (Fragment constant) | Eftilagimod Alfa | | MH2 | Fusion Protein |  |
GMP-Bios-INN-829 | Pre-Made Eftozanermin Alfa Biosimilar, Fusion Protein targeting TNFRSF10B/TRAIL-R2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD262/DR5/KILLER/KILLER/DR5/TRICK2/TRICK2A/TRICK2B/TRICKB/ZTNFR9 | Eftozanermin Alfa | | TNFRSF10B/TRAIL-R2 | Fusion Protein |  |
GMP-Bios-INN-830 | Pre-Made Eftrenonacog Alfa Biosimilar, Fusion Protein targeting F9 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 | Eftrenonacog Alfa | | F9 | Fusion Protein |  |
GMP-Bios-INN-831 | Pre-Made Elsilimomab Biosimilar, Whole Mab, Anti-Il6 Antibody: Anti-BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 therapeutic antibody | Elsilimomab | | IL6 | Whole mAb |  |
GMP-Bios-INN-832 | Pre-Made Enapotamab Vedotin Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate | Enapotamab Vedotin | | AXL | Whole mAb ADC |  |
GMP-Bios-INN-833 | Pre-Made Enfortumab Vedotin Biosimilar, Whole Mab Adc, Anti-PVRL4/NECTIN4 Antibody: Anti-EDSS1/LNIR/PRR4/nectin-4 therapeutic antibody Drug Conjugate | Enfortumab Vedotin | | PVRL4/NECTIN4 | Whole mAb ADC |  |
GMP-Bios-INN-834 | Pre-Made Enlimomab Biosimilar, Whole Mab, Anti-ICAM1 Antibody: Anti-BB2/CD54/P3.58 therapeutic antibody | Enlimomab | | ICAM1 | Whole mAb |  |
GMP-Bios-INN-836 | Pre-Made Ensomafusp Alfa Alfaiosimilar, Bispecific, Anti-Cd19; Tnfrsf9 Antibody: Anti-B4/CVID3;ILA/4-1BB/CDw137 therapeutic antibody | Ensomafusp Alfa | | CD19;TNFRSF9 | Bispecific |  |
GMP-Bios-INN-837 | Pre-Made Ensovibep biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting Severe acute respiratory syndrome coronavirus 2 RBD | Ensovibep | | Severe acute respiratory syndrome coronavirus 2 RBD | Recombinant Protein |  |
GMP-Bios-INN-838 | Pre-Made Epitumomab Biosimilar, Whole Mab, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Epitumomab | | MS4A1/CD20 | Whole mAb |  |
GMP-Bios-INN-839 | Pre-Made Epitumomab Cituxetan Biosimilar, Radiolabelled Antibody, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | Epitumomab Cituxetan | | MUC1 | Radiolabelled antibody |  |
GMP-Bios-INN-840 | Pre-Made Epoetin Alfa biosimilar, Recombinant Protein: Recombinant EPO(erythropoietin) therapeutic protein targeting EPOR | Epoetin Alfa | | EPOR | Recombinant Protein |  |
GMP-Bios-INN-842 | Pre-Made Eptacog Alfa (Actived Biosimilar, Recombinant Protein targeting F7: Recombinant therapeutic protein targeting SPCA | Eptacog Alfa (Actived) | | F7 | Recombinant Protein |  |
GMP-Bios-INN-843 | Pre-Made Eramkafusp Alfa Biosimilar, Fusion Protein targeting MS4A1/CD20 fused with human IFNA2 (interferon alpha 2) via a peptidyl linker: Recombinant therapeutic protein targeting B1/Bp35/CVID5/FMC7/LEU-16/S7 | Eramkafusp Alfa | | MS4A1/CD20 | Fusion Protein |  |
GMP-Bios-INN-844 | Pre-Made Erlizumab Biosimilar, Whole Mab, Anti-Itgb2 Antibody: Anti-CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7 therapeutic antibody | Erlizumab | | ITGB2 | Whole mAb |  |
GMP-Bios-INN-845 | Pre-Made Ertumaxomab Biosimilar, Bispecific, Anti-Cd3E;Erbb2 Antibody: Anti-T3E/TCRE/IMD18/CD3epsilon;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody | Ertumaxomab | | CD3E;ERBB2 | Bispecific |  |
GMP-Bios-INN-846 | Pre-Made Etanercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F | Etanercept | | TNF | Fusion Protein |  |
GMP-Bios-INN-848 | Pre-Made Exbivirumab Biosimilar, Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface Antigen (Hbsag) [Hepatitis B Virus] therapeutic antibody | Exbivirumab | | HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus] | Whole mAb |  |
GMP-Bios-INN-849 | Pre-Made Faralimomab Biosimilar, Whole Mab, Anti-Ifna1 Antibody: Anti-IFL/IFN/IFN-ALPHA/IFN-alphaD/IFNA13/leIF D therapeutic antibody | Faralimomab | | IFNA1 | Whole mAb |  |
GMP-Bios-INN-850 | Pre-Made Farletuzumab Ecteribulin Biosimilar, Whole Mab Adc, Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody Drug Conjugate | Farletuzumab Ecteribulin | | FOLR1 | Whole mAb ADC |  |
GMP-Bios-INN-851 | Pre-Made Felvizumab Biosimilar, Whole Mab: Anti-Rsv (Respiratory Syncytial Virus) Glycoprotein F [Respiratory Syncytial Virus] therapeutic antibody | Felvizumab | | RSV (respiratory syncytial virus) glycoprotein F [Respiratory syncytial virus] | Whole mAb |  |
GMP-Bios-INN-852 | Pre-Made Filgrastim Biosimilar, Recombinant Protein targeting CSF3R: Recombinant therapeutic protein targeting CD114/GCSFR/SCN7 | Filgrastim | | CSF3R/G-CSF-R | Recombinant Protein |  |
GMP-Bios-INN-853 | Pre-Made Gavilimomab Biosimilar, Whole Mab, Anti-Bsg Antibody: Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF therapeutic antibody | Gavilimomab | | BSG | Whole mAb |  |
GMP-Bios-INN-855 | Pre-Made Gemtuzumab Ozogamicin Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody: Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody Drug Conjugate | Gemtuzumab Ozogamicin | | CD33 | Whole mAb ADC |  |
GMP-Bios-INN-856 | Pre-Made Glembatumumab Vedotin Biosimilar, Whole Mab Adc, Anti-Gpnmb Antibody: Anti-HGFIN/NMB/PLCA3 therapeutic antibody Drug Conjugate | Glembatumumab Vedotin | | GPNMB | Whole mAb ADC |  |
GMP-Bios-INN-857 | Pre-Made Glucagon Biosimilar, Recombinant Protein targeting GCGR: Recombinant therapeutic protein targeting GGR/GL-R/MVAH | Glucagon | | GCGR | Recombinant Protein |  |
GMP-Bios-INN-858 | Pre-Made Grisnilimab Setaritox Biosimilar, Whole Mab Adc, Anti-Cd7 Antibody: Anti-GP40/LEU-9/TP41/Tp40 therapeutic antibody Drug Conjugate | Grisnilimab Setaritox | | CD7 | Whole mAb ADC |  |
GMP-Bios-INN-859 | Pre-Made Ibritumomab Tiuxetan Biosimilar, Radiolabelled Antibody, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Ibritumomab Tiuxetan | | MS4A1/CD20 | Radiolabelled antibody |  |
GMP-Bios-INN-861 | Pre-Made Igovomab Biosimilar, Radiolabelled Antibody, Anti-Muc16 Antibody: Anti-CA125 therapeutic antibody | Igovomab | | MUC16 | Radiolabelled antibody |  |
GMP-Bios-INN-862 | Pre-Made Iladatuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody Drug Conjugate | Iladatuzumab Vedotin | | CD79B | Whole mAb ADC |  |
GMP-Bios-INN-863 | Pre-Made Imciromab Biosimilar, Radiolabelled Antibody: Anti-Myosin therapeutic antibody | Imciromab | | myosin | Radiolabelled antibody |  |
GMP-Bios-INN-864 | Pre-Made Inbakicept biosimilar, Fusion Protein: Recombinant therapeutic protein targeting IL15 fused with human IGHG1 Fc (Fragment constant) | Inbakicept | | IL15 | Fusion Protein |  |
GMP-Bios-INN-865 | Pre-Made Indatuximab Ravtansine Biosimilar, Whole Mab Adc, Anti-Sdc1 Antibody: Anti-CD138/SDC/SYND1/syndecan therapeutic antibody Drug Conjugate | Indatuximab Ravtansine | | SDC1 | Whole mAb ADC |  |
GMP-Bios-INN-866 | Pre-Made Indusatumab Vedotin Biosimilar, Whole Mab Adc, Anti-Gucy2C Antibody: Anti-DIAR6/GC-C/GUC2C/MECILIL/STAR therapeutic antibody Drug Conjugate | Indusatumab Vedotin | | GUCY2C | Whole mAb ADC |  |
GMP-Bios-INN-867 | Pre-Made Inolimomab Biosimilar, Whole Mab, Anti-Il2Ra Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody | Inolimomab | | IL2RA | Whole mAb |  |
GMP-Bios-INN-868 | Pre-Made Inotuzumab Ozogamicin Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug Conjugate | Inotuzumab Ozogamicin | | CD22 | Whole mAb ADC |  |
GMP-Bios-INN-869 | Pre-Made Insulin Biosimilar, Recombinant Protein targeting INSR: Recombinant therapeutic protein targeting CD220/HHF5 | Insulin | | INSR | Recombinant Protein |  |
GMP-Bios-INN-870 | Pre-Made Insulin Efsitora Alfa Biosimilar, Fusion Protein targeting INSR fused with human IGHG2 Fc (Fragment constant): Recombinant therapeutic protein targeting CD220/HHF5 | Insulin Efsitora Alfa | | INSR | Fusion Protein |  |
GMP-Bios-INN-871 | Pre-Made Interferon Alfa Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC | Interferon Alfa | | IFNAR1 | Recombinant Protein |  |
GMP-Bios-INN-872 | Pre-Made Interferon Alfacon-1 Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC | Interferon Alfacon-1 | | IFNAR1 | Recombinant Protein |  |
GMP-Bios-INN-873 | Pre-Made Interferon Beta Biosimilar, Recombinant Protein targeting IFNAR1: Recombinant therapeutic protein targeting AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC | Interferon Beta | | IFNAR1 | Recombinant Protein |  |
GMP-Bios-INN-874 | Pre-Made Interferon Gamma Biosimilar, Recombinant Protein targeting IFNGR1: Recombinant therapeutic protein targeting CD119/IFNGR/IMD27A/IMD27B | Interferon Gamma | | IFNGR1 | Recombinant Protein |  |
GMP-Bios-INN-875 | Pre-Made Iodine (131I) Apamistamab Biosimilar, Radiolabelled Antibody, Anti-Ptprc Antibody: Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200 therapeutic antibody | Iodine (131I) Apamistamab | | PTPRC | Radiolabelled antibody |  |
GMP-Bios-INN-876 | Pre-Made Iodine (131I) Derlotuximab Biotin Biosimilar, Radiolabelled Antibody: Anti-Dna/Histone (H1) Complex therapeutic antibody | Iodine (131I) Derlotuximab Biotin | | DNA;histone (H1) complex | Radiolabelled antibody |  |
GMP-Bios-INN-877 | Pre-Made Iodo (124I) Girentuximab Biosimilar, Radiolabelled Antibody, Anti-CA9/CA-IX Antibody: Anti-CAIX/MN therapeutic antibody | Iodo (124I) Girentuximab | | CA9/CA-IX | Radiolabelled antibody |  |
GMP-Bios-INN-878 | Pre-Made Ipafricept biosimilar, Fusion Protein: Recombinant therapeutic protein targeting Wnt fused with human IGHG1 Fc (Fragment constant) | Ipafricept | | Wnt | Fusion Protein |  |
GMP-Bios-INN-880 | Pre-Made Izokibep Biosimilar, Bispecific, Anti-ALB;IL17A/IL17 Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8A therapeutic antibody | Izokibep | | ALB;IL17A/IL17 | trivalent bispecific |  |
GMP-Bios-INN-881 | Pre-Made Keliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Keliximab | | CD4 | Whole mAb |  |
GMP-Bios-INN-882 | Pre-Made Labetuzumab Govitecan Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody Drug Conjugate | Labetuzumab Govitecan | | CEACAM5/CD66e | Whole mAb ADC |  |
GMP-Bios-INN-883 | Pre-Made Ladiratuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Slc39A6 Antibody: Anti-LIV-1/LIV1/ZIP6 therapeutic antibody Drug Conjugate | Ladiratuzumab Vedotin | | SLC39A6 | Whole mAb ADC |  |
GMP-Bios-INN-884 | Pre-Made Laprituximab Emtansine Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate | Laprituximab Emtansine | | EGFR | Whole mAb ADC |  |
GMP-Bios-INN-885 | Pre-Made Ledelabricin Alfa biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting PRG4(PROTEOGLYCAN 4) | Ledelabricin Alfa | | PRG4 (PROTEOGLYCAN 4) | Recombinant Protein |  |
GMP-Bios-INN-886 | Pre-Made Lemalesomab Biosimilar, Whole Mab: Anti-Nca-90 (Nonspecific Cross- Reacting Antigens 90Kda Glycoproteins, Granulocyte Cell Antigen) [human] therapeutic antibody | Lemalesomab | | NCA-90 (nonspecific cross- reacting antigens 90kDa glycoproteins, granulocyte cell antigen) [human] | Whole mAb |  |
GMP-Bios-INN-887 | Pre-Made Lenercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F | Lenercept | | TNF | Fusion Protein |  |
GMP-Bios-INN-888 | Pre-Made Lepunafusp Alfa Biosimilar, Fusion Protein targeting TFRC fused with human IDUA (iduronidase, alpha-L-) isoform 1 via a peptidyl linker: Recombinant therapeutic protein targeting CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 | Lepunafusp Alfa | | TFRC | Fusion Protein |  |
GMP-Bios-INN-889 | Pre-Made Lerdelimumab Biosimilar, Whole Mab, Anti-Tgfb2 Antibody: Anti-G-TSF/LDS4/TGF-beta2 therapeutic antibody | Lerdelimumab | | TGFB2 | Whole mAb |  |
GMP-Bios-INN-890 | Pre-Made Lerodalcibep Biosimilar, Fusion Protein targeting PCSK9 fused with ALB (albumin, human serum albumin, HSA): Recombinant therapeutic protein targeting FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 | Lerodalcibep | | PCSK9 | Fusion Protein |  |
GMP-Bios-INN-892 | Pre-Made Libivirumab Biosimilar, Whole Mab: Anti-Hbv (Hepatitis B Virus) Surface Antigen (Hbsag) [Hepatitis B Virus] therapeutic antibody | Libivirumab | | HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus] | Whole mAb |  |
GMP-Bios-INN-893 | Pre-Made Lifastuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Slc34A2 Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic antibody Drug Conjugate | Lifastuzumab Vedotin | | SLC34A2 | Whole mAb ADC |  |
GMP-Bios-INN-896 | Pre-Made Loncastuximab Tesirine Biosimilar, Whole Mab Adc, Anti-Cd19 Antibody: Anti-B4/CVID3 therapeutic antibody Drug Conjugate | Loncastuximab Tesirine | | CD19 | Whole mAb ADC |  |
GMP-Bios-INN-897 | Pre-Made Lonigutamab Ugodotin Biosimilar, Whole Mab Adc, Anti-Igf1R Antibody: Anti-CD221/IGFIR/IGFR/JTK13 therapeutic antibody Drug Conjugate | Lonigutamab Ugodotin | | IGF1R | Whole mAb ADC |  |
GMP-Bios-INN-898 | Pre-Made Lorukafusp Alfa biosimilar, Fusion Protein: Recombinant therapeutic protein targeting ganglioside GD2 fused with human IL2 (interleukin 2, IL-2) | Lorukafusp Alfa | | ganglioside GD2 | Fusion Protein |  |
GMP-Bios-INN-899 | Pre-Made Lorvotuzumab Mertansine Biosimilar, Whole Mab Adc, Anti-Ncam1 Antibody: Anti-CD56/MSK39/NCAM therapeutic antibody Drug Conjugate | Lorvotuzumab Mertansine | | NCAM1 | Whole mAb ADC |  |
GMP-Bios-INN-900 | Pre-Made Losatuxizumab Vedotin Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate | Losatuxizumab Vedotin | | EGFR | Whole mAb ADC |  |
GMP-Bios-INN-902 | Pre-Made Lupartumab Amadotin Biosimilar, Whole Mab Adc, Anti-Lypd3 Antibody: Anti-C4.4A therapeutic antibody Drug Conjugate | Lupartumab Amadotin | | LYPD3 | Whole mAb ADC |  |
GMP-Bios-INN-903 | Pre-Made Luspatercept Biosimilar, Fusion Protein targeting GDF11 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BMP-11/BMP11/VHO | Luspatercept | | GDF11 | Fusion Protein |  |
GMP-Bios-INN-904 | Pre-Made Lutetium (177Lu) Lilotomab Satetraxetan Biosimilar, Radiolabelled Antibody, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody | Lutetium (177Lu) Lilotomab Satetraxetan | | CD37 | Radiolabelled antibody |  |
GMP-Bios-INN-905 | Pre-Made Mapatumumab Biosimilar, Whole Mab, Anti-TNFRSF10A/TRAIL-R1 Antibody: Anti-APO2/CD261/DR4/TRAILR-1/TRAILR1 therapeutic antibody | Mapatumumab | | TNFRSF10A/TRAIL-R1 | Whole mAb |  |
GMP-Bios-INN-906 | Pre-Made Maslimomab Biosimilar, Whole Mab: Anti-T Cell Receptor (Tr, Tr Alpha_Beta) [human] therapeutic antibody | Maslimomab | | T cell receptor (TR, TR alpha_beta) [human] | Whole mAb |  |
GMP-Bios-INN-907 | Pre-Made Melredableukin Alfa Biosimilar, Fusion Protein targeting IL2RA fused with human IL2 (interleukin 2, IL-2) via a peptidyl linker: Recombinant therapeutic protein targeting CD25/IDDM10/IL2R/IMD41/TCGFR/p55 | Melredableukin Alfa | | IL2RA | Fusion Protein |  |
GMP-Bios-INN-908 | Pre-Made Metelimumab Biosimilar, Whole Mab, Anti-Tgfb1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody | Metelimumab | | TGFB1 | Whole mAb |  |
GMP-Bios-INN-909 | Pre-Made Minretumomab Biosimilar, Whole Mab: Anti-Tag-72 therapeutic antibody | Minretumomab | | TAG-72 | Whole mAb |  |
GMP-Bios-INN-910 | Pre-Made Mipasetamab Uzoptirine Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate | Mipasetamab Uzoptirine | | AXL | Whole mAb ADC |  |
GMP-Bios-INN-913 | Pre-Made Mirococept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting C3b/C4b | Mirococept | | C3b/CO3;C4b | Recombinant Protein |  |
GMP-Bios-INN-914 | Pre-Made Mirvetuximab Soravtansine Biosimilar, Whole Mab Adc, Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody Drug Conjugate | Mirvetuximab Soravtansine | | FOLR1 | Whole mAb ADC |  |
GMP-Bios-INN-915 | Pre-Made Mirzotamab Clezutoclax Biosimilar, Whole Mab Adc, Anti-Cd276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody Drug Conjugate | Mirzotamab Clezutoclax | | CD276 | Whole mAb ADC |  |
GMP-Bios-INN-916 | Pre-Made Mitumomab Biosimilar, Whole Mab: Anti-Ganglioside Gd3 therapeutic antibody | Mitumomab | | ganglioside GD3 | Whole mAb |  |
GMP-Bios-INN-917 | Pre-Made Modakafusp Alfa Biosimilar, Fusion Protein targeting CD38 fused with human IFNA2 (interferon alpha 2) *b (R46,H57) 24-188: Recombinant therapeutic protein targeting ADPRC 1/ADPRC1 | Modakafusp Alfa | | CD38 | Fusion Protein |  |
GMP-Bios-INN-918 | Pre-Made Morolimumab Biosimilar, Whole Mab, Anti-Rhd Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody | Morolimumab | | RHD | Whole mAb |  |
GMP-Bios-INN-920 | Pre-Made Moxetumomab Pasudotox biosimilar, Fusion Protein, Moxetumomab-Anti-CD22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody fused with Pseudomonas aeruginosa exotoxin A | Moxetumomab Pasudotox | | CD22 | Fusion Protein |  |
GMP-Bios-INN-921 | Pre-Made Muromonab-Cd3 3Iosimilar, Whole Mab, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody | Muromonab-Cd3 | | CD3E | Whole mAb |  |
GMP-Bios-INN-922 | Pre-Made Nacolomab Tafenatox biosimilar, Fusion Protein, Nacolomab-Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody fused with Staphylococcus aureus enterotoxin A | Nacolomab Tafenatox | | MUC1 | Fusion Protein |  |
GMP-Bios-INN-923 | Pre-Made Naptumomab Estafenatox biosimilar, Fusion Protein, Naptumomab-Anti-TPBG Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic antibody fused with Staphylococcus aureus enterotoxin E SEA/E120 superantigen (synthetic) | Naptumomab Estafenatox | | TPBG | Fusion Protein |  |
GMP-Bios-INN-924 | Pre-Made Naratuximab Emtansine Biosimilar, Whole Mab Adc, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody Drug Conjugate | Naratuximab Emtansine | | CD37 | Whole mAb ADC |  |
GMP-Bios-INN-925 | Pre-Made Nebacumab Biosimilar, Whole Mab: Anti-Endotoxin (Lipid A, Domain Of Lipopolyaccharide, Lps) [Gram Negative Bacteria] therapeutic antibody | Nebacumab | | endotoxin (lipid A, domain of lipopolyaccharide, LPS) [gram negative bacteria] | Whole mAb |  |
GMP-Bios-INN-926 | Pre-Made Nemvaleukin Alfa Biosimilar, Fusion Protein targeting IL2RA fused with human IL2RA (interleukin 2 receptor alpha subunit, IL-2RA, TAC, p55, CD25) 139-303 (1-165): Recombinant therapeutic protein targeting CD25/IDDM10/IL2R/IMD41/TCGFR/p55 | Nemvaleukin Alfa | | IL2RA | Fusion Protein |  |
GMP-Bios-INN-927 | Pre-Made Nerelimomab Biosimilar, Whole Mab, Anti-Tnf Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody | Nerelimomab | | TNF | Whole mAb |  |
GMP-Bios-INN-928 | Pre-Made Nogapendekin Alfa Biosimilar, Recombinant Protein targeting IL15RA: Recombinant therapeutic protein targeting CD215 | Nogapendekin Alfa | | IL15RA | Recombinant Protein |  |
GMP-Bios-INN-929 | Pre-Made Nonacog Gamma Biosimilar, Recombinant Protein targeting F9: Recombinant therapeutic protein targeting FIX/P19/PTC/HEMB/THPH8 | Nonacog Gamma | | F9 | Recombinant Protein |  |
GMP-Bios-INN-931 | Pre-Made Odulimomab Biosimilar, Fab Fusion, Anti-Itgal Antibody: Anti-CD11A/LFA-1/LFA1A therapeutic antibody | Odulimomab | | ITGAL | Fab Fusion |  |
GMP-Bios-INN-932 | Pre-Made Olamkicept Biosimilar, Fusion Protein targeting IL6 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BSF-2/BSF2/CDF/HGF/HSF/IFN-beta-2/IFNB2/IL-6 | Olamkicept | | IL6 | Fusion Protein |  |
GMP-Bios-INN-934 | Pre-Made Omfiloctocog Alfa Biosimilar, Recombinant Protein targeting F8: Recombinant therapeutic protein targeting AHF/F8B/F8C/HEMA/FVIII/DXS1253E | Omfiloctocog Alfa | | F8 | Recombinant Protein |  |
GMP-Bios-INN-935 | Pre-Made Onercept Biosimilar, Recombinant Protein targeting TNF: Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F | Onercept | | TNF | Recombinant Protein |  |
GMP-Bios-INN-936 | Pre-Made Onfekafusp Alfa Biosimilar, Fusion Protein targeting FN/FN1 fused with human TNF (tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA) - trimer: Recombinant therapeutic protein targeting CIG/ED-B/FINCZ/GFND/GFND2/LETS/MSF/SMDCF | Onfekafusp Alfa | | FN/FN1 | Fusion Protein |  |
GMP-Bios-INN-937 | Pre-Made Ontorpacept Biosimilar, Fusion Protein targeting CD47 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting IAP/MER6/OA3 | Ontorpacept | | CD47 | Fusion Protein |  |
GMP-Bios-INN-938 | Pre-Made Opinercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F | Opinercept | | TNF | Fusion Protein |  |
GMP-Bios-INN-939 | Pre-Made Oportuzumab Monatox biosimilar, Fusion Protein, Oportuzumab-Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody fused with Pseudomonas aeruginosa exotoxin A | Oportuzumab Monatox | | EPCAM | Fusion Protein |  |
GMP-Bios-INN-940 | Pre-Made Oregovomab Biosimilar, Whole Mab, Anti-Muc16 Antibody: Anti-CA125 therapeutic antibody | Oregovomab | | MUC16 | Whole mAb |  |
GMP-Bios-INN-941 | Pre-Made Oreptacog Alfa Biosimilar, Recombinant Protein targeting F7: Recombinant therapeutic protein targeting SPCA | Oreptacog Alfa | | F7 | Recombinant Protein |  |
GMP-Bios-INN-943 | Pre-Made Pabinafusp Alfa Biosimilar, Fusion Protein targeting TFRC fused with iduronate-2-sulfatase: Recombinant therapeutic protein targeting CD71/IMD46/T9/TFR/TFR1/TR/TRFR/p90 | Pabinafusp Alfa | | TFRC | Fusion Protein |  |
GMP-Bios-INN-944 | Pre-Made Pagibaximab Biosimilar, Whole Mab: Anti-Staphylococcus Epidermidis Lipoteichoic Acid therapeutic antibody | Pagibaximab | | Staphylococcus epidermidis lipoteichoic acid | Whole mAb |  |
GMP-Bios-INN-945 | Pre-Made Pascolizumab Biosimilar, Whole Mab, Anti-Il4 Antibody: Anti-BCGF-1/BCGF1/BSF-1/BSF1/IL-4 therapeutic antibody | Pascolizumab | | IL4 | Whole mAb |  |
GMP-Bios-INN-946 | Pre-Made Patritumab Deruxtecan Biosimilar, Whole Mab Adc, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody Drug Conjugate | Patritumab Deruxtecan | | ERBB3/Erbb-3 | Whole mAb ADC |  |
GMP-Bios-INN-958 | Pre-Made Pelgifatamab Corixetan Biosimilar, Whole Mab Adc, Anti-FOLH1/GCPII Antibody: Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP therapeutic antibody Drug Conjugate | Pelgifatamab Corixetan | | FOLH1/GCPII | Whole mAb ADC |  |
GMP-Bios-INN-959 | Pre-Made Pexelizumab Biosimilar, Scfv, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Pexelizumab | | C5/CO5 | scFv |  |
GMP-Bios-INN-960 | Pre-Made Pinatuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody Drug Conjugate | Pinatuzumab Vedotin | | CD22 | Whole mAb ADC |  |
GMP-Bios-INN-961 | Pre-Made Pivekimab Sunirine Biosimilar, Whole Mab Adc, Anti-Il3Ra Antibody: Anti-CD123/IL3R/IL3RX/IL3RY/hIL-3Ra therapeutic antibody Drug Conjugate | Pivekimab Sunirine | | IL3RA | Whole mAb ADC |  |
GMP-Bios-INN-962 | Pre-Made Polatuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody Drug Conjugate | Polatuzumab Vedotin | | CD79B | Whole mAb ADC |  |
GMP-Bios-INN-963 | Pre-Made Pozelimab Biosimilar, Whole Mab, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody | Pozelimab | | C5/CO5 | Whole mAb |  |
GMP-Bios-INN-964 | Pre-Made Praluzatamab Ravtansine Biosimilar, Whole Mab Adc, Anti-Alcam Antibody: Anti-CD166/MEMD therapeutic antibody Drug Conjugate | Praluzatamab Ravtansine | | ALCAM | Whole mAb ADC |  |
GMP-Bios-INN-965 | Pre-Made Priliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody | Priliximab | | CD4 | Whole mAb |  |
GMP-Bios-INN-966 | Pre-Made Pritumumab Biosimilar, Whole Mab: Anti-Vim/Vimentin therapeutic antibody | Pritumumab | | VIM/Vimentin
| Whole mAb |  |
GMP-Bios-INN-967 | Pre-Made Ramatercept Biosimilar, Fusion Protein targeting MSTN/GDF-8 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting GDF8/MSLHP | Ramatercept | | MSTN/GDF-8 | Fusion Protein |  |
GMP-Bios-INN-968 | Pre-Made Raxibacumab Biosimilar, Whole Mab: Anti-Anthrax Protective Antigen (Pa) [Bacillus Anthracis] therapeutic antibody | Raxibacumab | | anthrax protective antigen (PA) [Bacillus anthracis] | Whole mAb |  |
GMP-Bios-INN-969 | Pre-Made Recifercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting FGF | Recifercept | | FGF | Recombinant Protein |  |
GMP-Bios-INN-970 | Pre-Made Regavirumab Biosimilar, Whole Mab: Anti-Hcmv (Human Cytomegalovirus) Envelope Glycoprotein B (Gb) [Human Betaherpesvirus 5] therapeutic antibody | Regavirumab | | HCMV (human cytomegalovirus) envelope glycoprotein B (gB) [Human betaherpesvirus 5] | Whole mAb |  |
GMP-Bios-INN-972 | Pre-Made Retlirafusp Alfa Biosimilar, Fusion Protein targeting CD274/PD-L1 fused with human TGFBR2 (transforming growth factor beta receptor 2) extracellular fragment (20-136) via a peptidyl linker: Recombinant therapeutic protein targeting B7-H/B7H1/PDCD1L1/PDCD1LG1 | Retlirafusp Alfa | | CD274/PD-L1 | Fusion Protein |  |
GMP-Bios-INN-973 | Pre-Made Rilonacept Biosimilar, Fusion Protein targeting IL1B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting IL-1/IL1-BETA/IL1F2/IL1beta | Rilonacept | | IL1B | Fusion Protein |  |
GMP-Bios-INN-974 | Pre-Made Ripafollitropin Alfa (Bovine) biosimilar, Fusion Protein: Recombinant therapeutic protein targeting Bostau FSHR fused with CTP (C-terminal peptide of hCG) | Ripafollitropin Alfa (Bovine) | | Bostau FSHR | Fusion Protein |  |
GMP-Bios-INN-976 | Pre-Made Rolinsatamab Talirine Biosimilar, Whole Mab Adc, Anti-Prlr Antibody: Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic antibody Drug Conjugate | Rolinsatamab Talirine | | PRLR | Whole mAb ADC |  |
GMP-Bios-INN-977 | Pre-Made Romiplostim Biosimilar, Fusion Protein targeting MPL fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting C-MPL/CD110/MPLV/THCYT2/THPOR/TPOR | Romiplostim | | MPL | Fusion Protein |  |
GMP-Bios-INN-979 | Pre-Made Rosopatamab Tetraxetan Biosimilar, Whole Mab Adc, Anti-FOLH1/GCPII Antibody: Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP therapeutic antibody Drug Conjugate | Rosopatamab Tetraxetan | | FOLH1/GCPII | Whole mAb ADC |  |
GMP-Bios-INN-980 | Pre-Made Rovalpituzumab Tesirine Biosimilar, Whole Mab Adc, Anti-Dll3 Antibody: Anti-SCDO1 therapeutic antibody Drug Conjugate | Rovalpituzumab Tesirine | | DLL3 | Whole mAb ADC |  |
GMP-Bios-INN-981 | Pre-Made Rovelizumab Biosimilar, Bispecific, Anti-Itgal;Itgb2 Antibody: Anti-CD11A/LFA-1/LFA1A;CD18/LAD/LCAMB/LFA-1/MAC-1/MF17/MFI7 therapeutic antibody | Rovelizumab | | ITGAL;ITGB2 | Bispecific |  |
GMP-Bios-INN-982 | Pre-Made Rozibafusp Alfa Biosimilar, Fusion Protein targeting ICOS fused with human TNFSF13B (tumor necrosis factor (TNF) superfamily member 13B, BAFF, THANK, TALL1, TALL-1, BLYS, BLyS, B cell activating factor, B lymphocyte activator, CD257): Recombinant therapeutic protein targeting AILIM/CD278/CVID1 | Rozibafusp Alfa | | ICOS | Fusion Protein |  |
GMP-Bios-INN-983 | Pre-Made Sacituzumab Govitecan Biosimilar, Whole Mab Adc, Anti-Tacstd2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody Drug Conjugate | Sacituzumab Govitecan | | TACSTD2 | Whole mAb ADC |  |
GMP-Bios-INN-985 | Pre-Made Samrotamab Vedotin Biosimilar, Whole Mab Adc, Anti-Lrrc15 Antibody: Anti-LIB therapeutic antibody Drug Conjugate | Samrotamab Vedotin | | LRRC15 | Whole mAb ADC |  |
GMP-Bios-INN-986 | Pre-Made Sargramostim Biosimilar, Recombinant Protein targeting CSF2RA: Recombinant therapeutic protein targeting CD116/CDw116/CSF2R/CSF2RAX/CSF2RAY/CSF2RX/CSF2RY/GM-CSF-R-alpha/GMCSFR/GMCSFR-alpha/GMR/GMR-alpha/SMDP4/alphaGMR | Sargramostim | | CSF2RA | Recombinant Protein |  |
GMP-Bios-INN-987 | Pre-Made Satumomab Biosimilar, Radiolabelled Antibody: Anti-Tag-72 therapeutic antibody | Satumomab | | TAG-72 | Radiolabelled antibody |  |
GMP-Bios-INN-988 | Pre-Made Serclutamab Talirine Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate | Serclutamab Talirine | | EGFR | Whole mAb ADC |  |
GMP-Bios-INN-989 | Pre-Made Sevirumab Biosimilar, Whole Mab: Anti-Hcmv (Human Cytomegalovirus) Envelope Glycoprotein H (Gh) [Human Betaherpesvirus 5] therapeutic antibody | Sevirumab | | HCMV (human cytomegalovirus) envelope glycoprotein H (gH) [Human betaherpesvirus 5] | Whole mAb |  |
GMP-Bios-INN-990 | Pre-Made Sibrotuzumab Biosimilar, Whole Mab, Anti-Fap Antibody: Anti-DPPIV/FAPA/FAPalpha/SIMP therapeutic antibody | Sibrotuzumab | | FAP | Whole mAb |  |
GMP-Bios-INN-991 | Pre-Made Simlukafusp Alfa Biosimilar, Fusion Protein targeting FAP fused with human IL2 (interleukin 2, IL-2): Recombinant therapeutic protein targeting DPPIV/FAPA/FAPalpha/SIMP | Simlukafusp Alfa | | FAP | Fusion Protein |  |
GMP-Bios-INN-992 | Pre-Made Siplizumab Biosimilar, Whole Mab, Anti-Cd2 Antibody: Anti-LFA-2/SRBC/T11 therapeutic antibody | Siplizumab | | CD2 | Whole mAb |  |
GMP-Bios-INN-993 | Pre-Made Sirtratumab Vedotin Biosimilar, Whole Mab Adc, Anti-Slitrk6 Antibody: Anti-DFNMYP therapeutic antibody Drug Conjugate | Sirtratumab Vedotin | | SLITRK6 | Whole mAb ADC |  |
GMP-Bios-INN-994 | Pre-Made Sofituzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Muc16 Antibody: Anti-CA125 therapeutic antibody Drug Conjugate | Sofituzumab Vedotin | | MUC16 | Whole mAb ADC |  |
GMP-Bios-INN-995 | Pre-Made Somatropin Biosimilar, Recombinant Protein targeting GHR: Recombinant therapeutic protein targeting GHBP/GHIP | Somatropin | | GHR | Recombinant Protein |  |
GMP-Bios-INN-996 | Pre-Made Sonelokimab Biosimilar, Bispecific, Anti-ALB;IL17A/IL17;IL17F Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;CTLA-8/CTLA8/IL-17A/ILA17;CANDF6/ML-1/ML1 therapeutic antibody | Sonelokimab | | ALB;IL17A/IL17;IL17F | Bispecific |  |
GMP-Bios-INN-997 | Pre-Made Sontuzumab Biosimilar, Whole Mab, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | Sontuzumab | | MUC1 | Whole mAb |  |
GMP-Bios-INN-998 | Pre-Made Sotatercept Biosimilar, Fusion Protein targeting INHBA/ACT fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting EDF/FRP | Sotatercept | | INHBA/ACT | Fusion Protein |  |
GMP-Bios-INN-999 | Pre-Made Stamulumab Biosimilar, Whole Mab, Anti-MSTN/GDF-8 Antibody: Anti-GDF8/MSLHP therapeutic antibody | Stamulumab | | MSTN/GDF-8 | Whole mAb |  |
GMP-Bios-INN-1000 | Pre-Made Sulesomab Biosimilar, Radiolabelled Antibody: Anti-Nca-90 (Nonspecific Cross- Reacting Antigens 90Kda Glycoproteins, Granulocyte Cell Antigen) therapeutic antibody | Sulesomab | | NCA-90 (nonspecific cross- reacting antigens 90kDa glycoproteins, granulocyte cell antigen) | Radiolabelled antibody |  |
GMP-Bios-INN-1001 | Pre-Made Tabituximab Barzuxetan Biosimilar, Whole Mab Adc, Anti-Fzd10 Antibody: Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic antibody Drug Conjugate | Tabituximab Barzuxetan | | FZD10 | Whole mAb ADC |  |
GMP-Bios-INN-1003 | Pre-Made Tagraxofusp biosimilar, Protein drug conjugate: Recombinant therapeutic protein drug conjugate | Tagraxofusp | | IL3 | Protein drug conjugate |  |
GMP-Bios-INN-1004 | Pre-Made Taldefgrobep Alfa Biosimilar, Fusion Protein targeting MSTN/GDF-8 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting GDF8/MSLHP | Taldefgrobep Alfa | | MSTN/GDF-8 | Fusion Protein |  |
GMP-Bios-INN-1005 | Pre-Made Talizumab Biosimilar, Whole Mab: Anti-Ighe/IgE therapeutic antibody | Talizumab | | Ighe/IgE
| Whole mAb |  |
GMP-Bios-INN-1006 | Pre-Made Tamrintamab Pamozirine Biosimilar, Whole Mab Adc, Anti-Dpep3 Antibody: Anti-MBD3 therapeutic antibody Drug Conjugate | Tamrintamab Pamozirine | | DPEP3 | Whole mAb ADC |  |
GMP-Bios-INN-1007 | Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-α receptor | Tanfanercept | | TNF-α receptor | Recombinant Protein |  |
GMP-Bios-INN-1008 | Pre-Made Taplitumomab Paptox biosimilar, Fusion Protein, Taplitumomab-Anti-CD19 Antibody: Anti-B4/CVID3 therapeutic antibody s | Taplitumomab Paptox | | CD19 | Fusion Protein |  |
GMP-Bios-INN-1009 | Pre-Made Tarcocimab Biosimilar, Whole Mab, Anti-Vegfa Antibody: Anti-MVCD1/VEGF/VPF therapeutic antibody | Tarcocimab | | VEGFA | Whole mAb |  |
GMP-Bios-INN-1011 | Pre-Made Technetium (99Mtc) Fanolesomab Biosimilar, Radiolabelled Antibody, Anti-Cd15 Antibody: Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 therapeutic antibody | Technetium (99Mtc) Fanolesomab | | CD15 | Radiolabelled antibody |  |
GMP-Bios-INN-1012 | Pre-Made Technetium (99Mtc) Nofetumomab Merpentan Biosimilar, Radiolabelled Antibody: Anti-MS4A1/CD20 therapeutic antibody | Technetium (99Mtc) Nofetumomab Merpentan | | MS4A1/CD20 | Radiolabelled antibody |  |
GMP-Bios-INN-1013 | Pre-Made Technetium (99Mtc) Pintumomab Biosimilar, Radiolabelled Antibody: Anti-Human Adenocarcinoma Antigen therapeutic antibody | Technetium (99Mtc) Pintumomab | | human adenocarcinoma antigen | Radiolabelled antibody |  |
GMP-Bios-INN-1015 | Pre-Made Tefibazumab Biosimilar, Whole Mab: Anti-Staphylococcus Aureus Fibrin-Binding Surface Epitope Clumping Factor A (Clfa) therapeutic antibody | Tefibazumab | | Staphylococcus aureus fibrin-binding surface epitope clumping factor A (ClfA) | Whole mAb |  |
GMP-Bios-INN-1016 | Pre-Made Telimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody | Telimomab Aritox | | CD5 | ADC |  |
GMP-Bios-INN-1017 | Pre-Made Telisotuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Met Antibody: Anti-AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody Drug Conjugate | Telisotuzumab Vedotin | | MET | Whole mAb ADC |  |
GMP-Bios-INN-1018 | Pre-Made Telitacicept Biosimilar, Fusion Protein targeting TNFSF13B fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BAFF/BLYS/CD257/DTL/TALL-1/TALL1/THANK/TNFSF20/TNLG7A/ZTNF4 | Telitacicept | | TNFSF13B | Fusion Protein |  |
GMP-Bios-INN-1019 | Pre-Made Teneliximab Biosimilar, Whole Mab, Anti-Cd40 Antibody: Anti-Bp50/CDW40/TNFRSF5/p50 therapeutic antibody | Teneliximab | | CD40 | Whole mAb |  |
GMP-Bios-INN-1020 | Pre-Made Tengonermin Biosimilar, Fusion Protein targeting ANPEP fused with human TNF (tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA): Recombinant therapeutic protein targeting APN/CD13/GP150/LAP1/P150/PEPN | Tengonermin | | ANPEP | Fusion Protein |  |
GMP-Bios-INN-1022 | Pre-Made Tifalibep Biosimilar, Bispecific, Anti-Alb;Fcgrt Antibody: Anti-FDAHT/HSA/PRO0883/PRO0903/PRO1341;FCRN/FcgammaRn/alpha-chain therapeutic antibody | Tifalibep | | ALB;FCGRT | trivalent bispecific |  |
GMP-Bios-INN-1024 | Pre-Made Tisotumab Vedotin Biosimilar, Whole Mab Adc, Anti-F3 Antibody: Anti-CD142/TF/TFA therapeutic antibody Drug Conjugate | Tisotumab Vedotin | | F3 | Whole mAb ADC |  |
GMP-Bios-INN-1025 | Pre-Made Topsalysin biosimilar, Fusion Protein: Recombinant therapeutic protein targeting proaerolysin fused with hexahistidine | Topsalysin | | proaerolysin | Fusion Protein |  |
GMP-Bios-INN-1026 | Pre-Made Toralizumab Biosimilar, Whole Mab, Anti-Cd40Lg Antibody: Anti-CD154/CD40L/HIGM1/IGM/IMD3/T-BAM/TNFSF5/TRAP/gp39/hCD40L therapeutic antibody | Toralizumab | | CD40LG | Whole mAb |  |
GMP-Bios-INN-1027 | Pre-Made Torapsel Biosimilar, Fusion Protein targeting SELP fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL | Torapsel | | SELP | Fusion Protein |  |
GMP-Bios-INN-1028 | Pre-Made Tositumomab Biosimilar, Radiolabelled Antibody, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody | Tositumomab | | MS4A1/CD20 | Radiolabelled antibody |  |
GMP-Bios-INN-1029 | Pre-Made Transferrin Aldifitox Biosimilar, Protein Drug Conjugate: Recombinant Therapeutic Protein Drug Conjugate | Transferrin Aldifitox | | transferrin | Protein drug conjugate |  |
GMP-Bios-INN-1030 | Pre-Made Trastuzumab Beta Biosimilar, Whole Mab, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody | Trastuzumab Beta | | ERBB2/HER2 | Whole mAb |  |
GMP-Bios-INN-1031 | Pre-Made Trastuzumab Deruxtecan Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate | Trastuzumab Deruxtecan | | ERBB2/HER2 | Whole mAb ADC |  |
GMP-Bios-INN-1032 | Pre-Made Trastuzumab Duocarmazine Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate | Trastuzumab Duocarmazine | | ERBB2/HER2 | Whole mAb ADC |  |
GMP-Bios-INN-1033 | Pre-Made Trastuzumab Emtansine Biosimilar, Whole Mab Adc, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2/c-ERB-2/c-ERB2 therapeutic antibody Drug Conjugate | Trastuzumab Emtansine | | ERBB2/HER2 | Whole mAb ADC |  |
GMP-Bios-INN-1034 | Pre-Made Trebananib Biosimilar, Fusion Protein targeting ANGPT2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AGPT2/ANG2/LMPHM10 | Trebananib | | ANGPT2 | Fusion Protein |  |
GMP-Bios-INN-1035 | Pre-Made Tucotuzumab Celmoleukin biosimilar, Fusion Protein, Tucotuzumab-Anti-EPCAM Antibody: Anti-Ber-Ep4/BerEp4/DIAR5/EGP-2/EGP314/EGP40/ESA/HNPCC8/KS1/4/KSA/M4S1/MIC18/MK-1/MOC-31/TACSTD1/TROP1 therapeutic antibody fused with human IL2 (interleukin 2, IL-2) Pr21-153 | Tucotuzumab Celmoleukin | | EPCAM | Fusion Protein |  |
GMP-Bios-INN-1036 | Pre-Made Tulinercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F | Tulinercept | | TNF | Fusion Protein |  |
GMP-Bios-INN-1037 | Pre-Made Tusamitamab Ravtansine Biosimilar, Whole Mab Adc, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody Drug Conjugate | Tusamitamab Ravtansine | | CEACAM5/CD66e | Whole mAb ADC |  |
GMP-Bios-INN-1038 | Pre-Made Tuvirumab Biosimilar, Whole Mab: Anti-Hbv (Hepatitis B Virus) [Hepatitis B Virus] therapeutic antibody | Tuvirumab | | HBV (hepatitis B virus) [Hepatitis B virus] | Whole mAb |  |
GMP-Bios-INN-1039 | Pre-Made Upifitamab Rilsodotin Biosimilar, Whole Mab Adc, Anti-Slc34A2 Antibody: Anti-NAPI-3B/NAPI-IIb/NPTIIb/PULAM therapeutic antibody Drug Conjugate | Upifitamab Rilsodotin | | SLC34A2 | Whole mAb ADC |  |
GMP-Bios-INN-1040 | Pre-Made Urtoxazumab Biosimilar, Whole Mab: Anti-E.Coli Shiga-Like Toxin 2 B Subunit therapeutic antibody | Urtoxazumab | | E.coli Shiga-like toxin 2 B subunit | Whole mAb |  |
GMP-Bios-INN-1042 | Pre-Made Vadastuximab Talirine Biosimilar, Whole Mab Adc, Anti-Cd33 Antibody: Anti-SIGLEC-3/SIGLEC3/p67 therapeutic antibody Drug Conjugate | Vadastuximab Talirine | | CD33 | Whole mAb ADC |  |
GMP-Bios-INN-1043 | Pre-Made Valanafusp Alfa Biosimilar, Fusion Protein targeting INSR fused with human IDUA (iduronidase, alpha-L-) (1:2): Recombinant therapeutic protein targeting CD220/HHF5 | Valanafusp Alfa | | INSR | Fusion Protein |  |
GMP-Bios-INN-1044 | Pre-Made Vandortuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Steap1 Antibody: Anti-PRSS24/STEAP therapeutic antibody Drug Conjugate | Vandortuzumab Vedotin | | STEAP1 | Whole mAb ADC |  |
GMP-Bios-INN-1046 | Pre-Made Vapaliximab Biosimilar, Whole Mab, Anti-Aoc3 Antibody: Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic antibody | Vapaliximab | | AOC3 | Whole mAb |  |
GMP-Bios-INN-1047 | Pre-Made Vepalimomab Biosimilar, Whole Mab, Anti-Aoc3 Antibody: Anti-HPAO/SSAO/VAP-1/VAP1 therapeutic antibody | Vepalimomab | | AOC3 | Whole mAb |  |
GMP-Bios-INN-1048 | Pre-Made Verpasep Caltespen biosimilar, Fusion Protein: Recombinant therapeutic protein targeting HspE7(Mycobacterium bovis HSP65-HBV E7) fused with chaperonin 2 (HSP65 from Mycobacterium bovis) | Verpasep Caltespen | | HspE7(Mycobacterium bovis HSP65-HBV E7) | Fusion Protein |  |
GMP-Bios-INN-1049 | Pre-Made Volociximab Biosimilar, Whole Mab, Anti-Itga5 Antibody: Anti-CD49eRA/VLA-5/VLA5A therapeutic antibody | Volociximab | | ITGA5 | Whole mAb |  |
GMP-Bios-INN-1050 | Pre-Made Vorsetuzumab Mafodotin Biosimilar, Whole Mab Adc, Anti-CD70/CD27-L Antibody: Anti-CD27LG/LPFS3/TNFSF7/TNLG8A therapeutic antibody Drug Conjugate | Vorsetuzumab Mafodotin | | CD70/CD27-L | Whole mAb ADC |  |
GMP-Bios-INN-1051 | Pre-Made Votumumab Biosimilar, Radiolabelled Antibody: Anti-Human Carcinoma Associated Antigen Ctaa16 therapeutic antibody | Votumumab | | human carcinoma associated antigen CTAA16 | Radiolabelled antibody |  |
GMP-Bios-INN-1052 | Pre-Made Yttrium (90Y) Clivatuzumab Tetraxetan Biosimilar, Radiolabelled Antibody, Anti-Muc1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therapeutic antibody | Yttrium (90Y) Clivatuzumab Tetraxetan | | MUC1 | Radiolabelled antibody |  |
GMP-Bios-INN-1053 | Pre-Made Yttrium (90Y) Tacatuzumab Tetraxetan Biosimilar, Radiolabelled Antibody, Anti-Afp Antibody: Anti-AFPD/FETA/HPAFP therapeutic antibody | Yttrium (90Y) Tacatuzumab Tetraxetan | | AFP | Radiolabelled antibody |  |
GMP-Bios-INN-1055 | Pre-Made Zanidatamab Zovodotin B Zovodotiniosimilar, Bispecific/Biparatopic, Anti-ERBB2/HER2;ERBB2/HER2 Therapeutic/Biparatopic Antibody Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 | Zanidatamab Zovodotin | | ERBB2/HER2; ERBB2/HER2 | Bispecific /biparatopic |  |
GMP-Bios-INN-1057 | Pre-Made Zilovertamab Vedotin Biosimilar, Whole Mab Adc, Anti-Ror1 Antibody: Anti-NTRKR1/dJ537F10.1 therapeutic antibody Drug Conjugate | Zilovertamab Vedotin | | ROR1 | Whole mAb ADC |  |
GMP-Bios-INN-1058 | Pre-Made Zimbirelimab Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody | Zimbirelimab | | PDCD1/PD-1 | Whole mAb |  |
GMP-Bios-INN-1059 | Pre-Made Ziralimumab Biosimilar, Whole Mab, Anti-Bsg Antibody: Anti-5F7/CD147/EMMPRIN/EMPRIN/HAb18G/OK/TCSF therapeutic antibody | Ziralimumab | | BSG | Whole mAb |  |
GMP-Bios-INN-1060 | Pre-Made Zolimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody | Zolimomab Aritox | | CD5 | ADC |  |